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Abstract 
 
Baculoviruses are arthropod-specific viruses with a circular, double-stranded DNA 
genome (80-180 kb). Two structural forms are produced during virus replication, 
comprising budded virus (BV) and occlusion-derived virus (ODV). The BV is produced 
from 12 hours post infection (hpi) and spreads the infection from tissue to tissue within the 
host. The ODV is formed 20 hpi and enveloped within occlusion bodies (OBs). 
 
The aim of this project was to elucidate the mechanisms involved in ODV production by 
deleting putative genes involved in ODV, but not BV production. A secondary aim of the 
project was to determine whether removing these genes improved the quantity/quality of 
recombinant proteins produced by baculovirus expression vectors. 
 
Genes for ODV structural proteins were selected and individual gene deletion mutants 
were generated. Three of these (∆orf79, ∆odv-e28, and ∆odv-ec43) unexpectedly 
prevented virus replication in insect cell culture. orf79 and odv-ec43 were demonstrated to 
be essential genes as viability could be restored after a rescue assay with the target gene, 
whereas the loss of infectivity in ∆odv-e28 probably resulted from an effect on helicase, an 
essential neighbouring gene. 
 
Three deletion mutant viruses (Ac∆cg30, Ac∆odv-e66 and Ac∆odv-e56) that were viable in 
insect cell culture were studied for any effect on ODV production and OB formation using 
bioassays and electron microscopy imaging. Deletion of odv-e66 and odv-e56 both 
negatively affected oral infectivity of OBs, whereas the deletion of cg30 increased 
infectivity. The electron microscopy imaging of the OBs of these deletion mutant viruses 
identified abnormalities for Ac∆cg30pol+ and Ac∆odv-e56pol+. Ac∆cg30pol+ OBs seemed to 
be degraded due to deformities in the polyhedron envelope (PE) while Ac∆odv-e56pol+ 
OBs were surrounded by another protein structure but had no apparent difference in 
structure or ODV packaging compared to the parental virus. The formation of BV by the 
pif3 deletion mutant virus was reduced, although plaques were still formed in titrations of 
infectivity. BV production could only be restored by a rescue assay with pif3, suggesting 
PIF3 may have another function that is yet to be fully characterized.  
 
The deletion of orf118/pif1 and pif2 were analysed for their effect on recombinant protein 
production expressed from the polh promoter, using activity assays. Both the deletion of 
orf118/pif1 and pif2 caused a reduction in the intracellular protein, beta-galactosidase. 
However, the deletion of pif2 did not impact the expression of urokinase, an extracellular 
recombinant protein. This project also investigated through mutagenesis the possible role 
of the PIF1 RGD motifs in oral infection of larvae. The initial findings suggest that the PIF1 
RGD motifs functional role is not very clear and indicate that PIF1 RGD motifs are not 
involved in integrin binding but could mediate other interactions during viral entry into the 
midgut cells.  
 
While the mechanism involved in the production of ODV was not elucidated, a number of 
interesting observations have been made about the targeted structural components of the 
ODV that were investigated, which could aid the understanding of the major transition 
from BV to ODV production during the baculovirus infection 
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1.1 Introduction to Baculoviruses 
 
The Baculoviridae family contains a wide range of arthropod-specific viruses, which are 
known to infect over 600 host species found in a number of different invertebrate orders 
(Herniou et al., 2003). Many of the baculovirus species identified and characterized so far 
are found in the order Lepidoptera, leaving the non-lepidopteran isolates less well defined. 
Due to the high species specificity among lepidopteran baculovirus isolates, it is believed 
that baculoviruses coevolved with Lepidoptera (Zanotto et al., 1993). Presently, a 
database of more than 4000 genes is available from around 40 completely sequenced 
baculovirus genomes. Thirty-one core genes have been reported to be conserved across 
all the sequenced genomes, which suggests it is likely they serve essential roles in the 
baculovirus life cycle (Hiscock and Upton, 2000; McCarthy and Theilmann, 2008). 
Much research has gone into baculoviruses at the molecular level to improve their use as 
pesticides, expression systems and more recently for gene therapy. In the next sections I 
will briefly discuss each of these applications and give details on their usage. 
Baculoviruses have been used for decades as biocontrol agents against forestry and 
agriculture pests, including the velvetbean caterpillar, cotton bollworm and gypsy moth 
(Zhang, 1994; Moscardi, 1999; Cook et al., 2003). Baculoviruses make good biocontrol 
agents due to their host specificity; they have little impact on the environment and are 
non-hazardous to human health. In contrast, xenobiotic pesticides damage the 
environment by killing beneficial insects and can be hazardous to humans. Baculovirus 
insecticides are restricted to lepidopteran and hymenopteran pests, although 
developments for mosquito insecticides are under way with the characterization of 
mosquito-specific baculoviruses (Moser et al., 2001; Andreadis et al., 2003).  
Since the 1980s, baculoviruses have been used as an expression vector system allowing 
large quantities of recombinant proteins to be produced from insect cells infected with 
recombinant budded virus (BV), which contains a foreign gene usually under the control of 
the polyhedrin gene (polh) promoter. More recently, baculovirus genomes have been 
modified to produce large quantities of heterologous proteins by removing selected non-
essential genes. This reduces the viral protein load on the host cell's mechanisms 
allowing an increase in recombinant protein production (Hitchman et al., 2010a; Hitchman 
et al., 2010b). The development of a baculovirus expression system marketed as 
flashBACTM (FB) (Oxford Expression Technologies Ltd, Oxford UK), has reduced the time 
required to produce recombinant viruses to a one step process, whereas other 
baculovirus expression systems require a screening process to identify recombinant virus 
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from a mixed population (Possee et al., 2008). The key factors for most baculovirus 
expression systems are that they produce high levels of expression of target proteins and 
that the host insect cell’s post-translation modification enables functionally authentic 
proteins to be made (Hitchman et al., 2011; van Oers, 2011; Hitchman et al., 2012). 
Modified baculovirus genomes can be used to transduce mammalian cells for gene 
expression or therapy. One of the primary reasons for using baculoviruses in this way is 
that they cannot cause an infection in human cells (Carbonell et al., 1985). The BacMam 
technology generally uses pFastBac transfer vectors to create recombinant baculoviruses 
in bacterial cells that contain genes under the cytomegalovirus immediate early gene 
(CMV) promoter, which is active in mammalian cells (Kost et al., 2007). Once these 
modifications are introduced into the baculovirus genome via a normal transposition 
method, they are subsequently used to infect insect cells (Kost et al., 2005; Condreay and 
Kost, 2007; Fornwald et al., 2007). The resulting “BacMam” particles are generally 
concentrated prior to use to improve the efficiency of introducing them into mammalian 
cells (Hofmann et al., 1995; Boyce and Bucher, 1996; Monsma et al., 1996). 
Research into the use of baculoviruses as gene therapy vectors has increased over the 
last decade. The literature contains a large number of publications showing the 
applications of the baculovirus vectors towards the treatment of diseases. The more 
recently publications show the possible treatment for myocardial infarction or ischemic 
skeletal muscle and several cancers. In the case of myocardial infarction or ischemic 
skeletal muscle, the expression of vascular endothelial growth factor or Angiopoietin-1 
could be used to treat the disease by inducing angiogenesis, thereby increasing the blood 
supply to target area (Paul et al., 2011; Heikura et al., 2012). The research into the 
possible treatment of cancers using baculovirus vectors is more complex and normally 
results in vectors being constructed to target specific cancers. However, some baculovirus 
vectors do express proteins that could treat a wide range of cancers such as endostatin or 
angiostatin, which are anti-angiogenic proteins (Luo et al., 2011; Rivera-Gonzalez et al., 
2011).  
 
1.2 The Baculoviridae family 
1.2.1 The discovery of baculoviruses 
 
The production of silk from cultured silkworms has been carried out in China for over 5000 
years and this industry is intimately linked with the discovery of baculoviruses. Ancient 
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Chinese texts dating back almost 4000 years on the rearing of silkworm give references to 
a disease with baculovirus characteristics (Tanada and Kaya, 1993; Miller, 1997). The 
culturing of silkworms had spread from Asia to Europe by about 550 C.E due to it being a 
major item of commerce at the time (Steinhaus, 1975). A poem by the Bishop of Alba, 
Marcus Hieronymus Vida (born in Cremona, 1490) describing the liquefaction of Bombyx 
mori silkworm caterpillars is believed to be the earliest description of a baculovirus 
infection in European literature (Granados and Federici, 1986). These descriptions date 
back before the germ theory of disease had even been put forward and it wasn’t until the 
late 19th century that Dimitrii Ivanowsky discovered viruses as a causative agent of 
disease.   
With the discovery of the light microscope in the 19th century, the cause of the disease 
described in Marcus Hieronymus Vida poem could be characterised by highly refractile 
occlusion bodies found in the cells of infected larva. Due to these refractile structures 
being polyhedron shaped, this led to the disease being termed “polyhedroses” by the mid-
1800s (reviewed in Granados and Federici, 1986). However, it had been suggested that 
the infectious particle was encased within these occlusion bodies. This was not confirmed 
until the late 1940s by the visualisation of rod shaped virions using electron microscopy 
(reviewed in Harrison and Hoover, 2012). Further investigation established the crystalline 
polyhedral nature of the occlusion body structure located in the nuclei of infected cells and 
this established the group name nuclear polyhedrosis virus (Bergold, 1953), which was 
later renamed nucleopolyhedroviruses (NPV) (Murphy et al., 1995). In the 1920s, an 
earlier baculovirus occlusion body was characterized that was smaller and granular 
shaped. This group of viruses was termed “granulosis” viruses (reviewed in Jehle, 2009) 
and then renamed granuloviruses in 1995 (GVs) (Murphy et al., 1995). These two 
occlusion body morphologies have divided the baculovirus family and defined the 
taxonomical division. In 1973, Mauro Martignoni proposed the baculovirus family was 
termed Baculoviridae, derived from the latin word baculum, meaning “rod” after the rod-
shape structure of the virions (Vago et al., 1974).   
 
1.2.2 Baculovirus Characteristics  
 
Baculoviruses contain a closed, circular, double-stranded DNA genome, varying in size 
between 80 kb and 180 kb, in a rod-shaped virus particle between 200-400 nm in length 
and 36 nm wide (Funk et al., 1997). This rod-shaped structure is known as the capsid and 
has polarity due to differences in structure at either end. Inside, the DNA is highly 
condensed and has several associated proteins. This structure as a whole is known as 
the core. The capsid and the enclosed core as a whole unit are known as the 
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nucleocapsid (Fraiser, 1986). 
The baculovirus is found in two forms. The BV form buds from infected cells and is 
involved in spreading the infection from tissue to tissue in the host larvae (Volkman and 
Goldsmith, 1985). The initial infection and horizontal transmission of baculoviruses in host 
larvae is mediated by the oral route using the second form, the occlusion-derived virus 
(ODV). Late in infection ODVs are occluded in a protein matrix known as occlusion bodies 
(OBs) and it is this protein matrix that protects the ODV from environmental factors 
(reviewed in Adam and McClintock, 1991; Boucias and Pendland, 1998). 
The evolution of an occlusion viral particle that allows delayed transmission has appeared 
in two other insect-infecting virus taxa: the Entomopoxvirinae subfamily of the Poxviridae 
and the Cypovirus genus of the Reoviridae family (Rohrmann, 1986; Adams and Bonami, 
1991). However, the existence of two virion phenotypes in one virus makes the 
Baculoviridae family unique, compared to other insect viruses.  
 
1.2.3 The Structure of Occlusion Bodies  
 
The structure of the occlusion body is the key factor that divides the Baculoviridae family 
into two genera. The NPV forms polyhedral OBs that are easily observed under a light 
microscope due to their larger size and light refractory polyhedral structure. This allowed 
baculoviruses to be first described in the sixteenth century as previously discussed 
(reviewed in  Adam and McClintock, 1991). The major protein component of the NPV OB 
is a ~30 kDa protein called polyhedrin, which gives the OB structure an average diameter 
range of 800-2000 nm (Bilimoria, 1991). The second genus GV forms granulin OBs, which 
are more difficult to resolve under a light microscope and appear as dark granules. The 
major protein component of the GV OB is a ~30 kDa protein called granulin, which gives 
the OBs an ovoid shape that is roughly 500 nm long and 200 nm wide. Electron 
microscope images of both NPV and GV OBs are shown in Figure 1.1. 
The OBs of both genera become surrounded in a glycoprotein multilayered lattice during 
formation called the calyx or polyhedrin membrane or polyhedral envelope (PE) (Whitt and 
Manning, 1988; Adam and McClintock, 1991). The PE is comprised of a 
protein/carbohydrate matrix that forms a lattice or net, which contains hexagonal pores 
ranging from 6 to 15 nm in diameter. The PE is a physical barrier surrounding the OB, 
giving extra protection from the environment and resistance to digestion from viral and 
other enzymes (Adam and McClintock, 1991). Deletion of the PE results in unstable OBs 
that have an uneven surface and are prone to losing ODVs (Russell and Rohrmann, 1990; 
Russell et al., 1991). 
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Figure 1.1 Electron microscopy of purified OBs 
 
EM images that represent the two structural forms of OBs, (A) EM image of polyhedrin OB from 
Autographa californica nucleopolyhedrovirus and (B) EM image of granulin OBs of Plodia 
interpunctella granulovirus. (Image courtesy of R.D Possee). 
 
Another difference between the two genera is that NPV OBs normally contain many 
virions whereas GV OBs contain just a single virion. NPV also seem to infect a greater 
range of host insects than GV, which have only been isolated from lepidopteran hosts 
(Herniou et al., 2003). The ODV within the NPV polyhedra can contain single (SNPV) or 
multiple (MNPV) nucleocapsids, ranging from 1 to 15 nucleocapsids per ODV (Hughes 
and Addison, 1970; Ackermann and Smirnoff, 1983; Funk et al., 1997). Whereas the 
majority of granulin OBs contain ODV carrying a single nucleocapsid, there are a few rare 
multiple GVs (Falcon and Hess, 1985). An illustration of SNPV, MNPV and GV OBs is 
shown in Figure 1.2. Because of this characteristic being so distinctive for specific 
isolates, it was used in the early taxonomy of NPVs. However, once baculovirus sequence 
data accumulated phylogenetic relationships could be defined. It was discovered that the 
MNPV and SNPV division did not conform to the phylogeny of the viruses. For example 
Bombyx mori nucleopolyhedrovirus (BmNPV) is closely related to Autographa californica 
nucleopolyhedrovirus (AcMNPV) but is considered a SNPV (Rohrmann, 2011). However, 
even though the content of the ODV is not considered a useful taxonomical trait, it is still 
continually used to name baculoviruses because of historical values.  
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Figure 1.2 Major occlusion-derived virion forms  
 
Schematic representation of major occlusion-derived virion forms as described in section 1.3. The 
Figure shows both MNPV and SNPV virions of the NPV polyhedron OB and the smaller GV 
granulum OB with its single embedded virion (Slack and Arif, 2007).  
 
1.2.4 The role of genome heterogeneity in baculovirus virulence 
 
The infection of host larva by insect viruses containing multiple genotypes is a common 
occurrence (Graham et al., 2004; Cory et al., 2005; Hitchman et al., 2007a). Both the 
baculovirus replication cycle within the host larva and the physical structure of the MNPV 
ODV allows the high prevalence of infection by multiple genotypes. The OBs can contain 
between 20 and 80 ODVs, which in turn can contain between 1 to 15 nucleocapsids each 
(Simon et al., 2004; Clavijo et al., 2009). It has been shown that the maintenance of virus 
diversity during horizontal transmission favours the occlusion of genotypically 
heterogeneous ODV in each OB. This allows multiple genotypes to infect individual 
midgut columnar epithelial cells during primary infection (Clavijo et al., 2010). Secondary 
infection caused by BV also allows the infection of multiple genotypes, as it has been 
estimated that each insect cell within the larva is infected by 4 BV (Bull et al., 2001; Simon 
et al., 2006).  
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However, such an infection strategy causes deletion genotypes to occur and these 
typically contain deletions to essential genes for replication and transmission (Roux et al., 
1991). Therefore, these deletion genotypes become reliant on the complete genotype for 
gene products to complete their replication cycle and ODV particles. These multiple 
genotypes are probably important for virus survival and pathogenicity, due to the minority 
genotypes not being eliminated (Munoz et al., 1999).  
The genotypically diverse population isolates of the type I alphabaculovirus, Spodoptera 
frugiperda (SfMNPV) have been investigated (Escribano et al., 1999; Simon et al., 2011). 
The host of SfMNPV is the fall armyworm found throughout the Americas. The Nicaraguan 
SfMNPV isolate (SfNIC), was demonstrated to have nine different genotypes, eight of 
which contained deletions varying in length (4.8–16.4 kb) within a single region of the 
genome. One of these genotypes was comparable to wild type SfMNPV (SfNIC-B) and 
showed greater infectivity than any of the other deletion genotypes when isolated from the 
mixed population. Three of these deletion genotypes were not orally infectious, with 
genotype SfNIC-C the most abundant (Simon et al., 2004). Clavijo et al. (2009) 
demonstrated that mixed population comprising a synthetic deletion genotype, which was 
the same as SfNIC-C, and SfNIC-B were more orally infectious than single populations of 
SfNIC-B. Clavijo et al. (2009) also concluded that most likely cause of this increased oral 
infectivity was the deletion of pif1 and pif2, suggesting a decrease in pif1 and pif2 ratios in 
a viral population could increase the transmission of a pathogen containing mixed 
genotypes.  
 
1.2.5 The classification of baculoviruses 
 
The advance in DNA sequencing method have allowed baculovirus genome sequencing 
to accelerate and this increase in whole baculovirus genome sequences has greatly 
expanded our understanding of their diversity and evolution. It is believed that baculovirus 
evolution is associated with the host that they infect, suggesting that as the host becomes 
genetically isolated so does the virus. This process is known as host dependent evolution 
and is not uncommon in viruses, for example, it is seen in papilloma virus, a small DNA 
virus that infects mammals (Soeda et al., 1980). This host association for baculoviruses is 
based on the N-terminal polyhedrin and granulin sequences (Rohrmann et al., 1981). 
Therefore, the Baculoviridae family has been divided into four major groups; 
Alphabaculoviruses (Lepidopteran NPVs), Betabaculoviruses (Lepidopteran GVs), 
Gammabaculoviruses (Hymenopteran NPVs) and Deltabaculoviruses (Dipteran NPVs) 
(Jehle et al., 2006). The phylogenetic tree shown in Figure 1.3 illustrates this division in 
the Baculoviridae family 
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Figure 1.3 Phylogenetic tree of Baculoviridae family 
 
The phylogenetic tree was contructed using amino acid alignment of 29 baculovirus core genes 
from 29 sequenced baculovirus genomes. This demonstrates the clear division of four groups in 
the baculoviridae family (Jehle et al., 2006).  
 
The alphabaculoviruses are further split into two types due to significant differences in 
gene content. However, the most notable difference is the BV major fusion glycoproteins 
for Type I NPV this is GP64 whereas for Type II NPV it is F protein. It has been put 
forward that ancestral Type I NPV acquired gp64 and this stimulated their distinct 
evolution from Type II (Herniou et al., 2001; Jiang et al., 2009). 
The Type I alphabaculovirus, AcMNPV was isolated from the Alfalfa looper and is the 
model baculovirus for this project (Vail et al., 1973). AcMNPV is genetically very similar to 
other baculoviruses found in Trichoplusia ni, Rachiplusia ou and Plutella xylostella 
(Bonning and Hammock, 1992). The replication times given in the following sections are 
based on AcMNPV and these replication times are generally shorter compared to other 
baculoviruses (Slack and Arif, 2007).  
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1.3 The Baculovirus Life Cycle 
1.3.1 Initial Virus Entry through the Midgut  
 
The OBs allow the baculovirus to remain dormant, but viable in the environment for 
decades, unlike a lipid bilayer enveloped virus that is susceptible to desiccation and loss 
of viability due to damaging factors such as UV (Bergold, 1963). The ability to remain 
dormant in the environment for long lengths of time is beneficial when infecting 
invertebrates as they can undergo population changes due to seasonal and environmental 
factors, in which extensive periods of time can pass before a permissive host is 
reintroduced into the environment allowing further viral transmission (Kukan, 1999). Initial 
infection occurs through the oral route when a larva inadvertently consumes OBs either 
through cannibalization or contaminated plant matter. The OBs travel through the foregut 
that is lined by part of the larva exoskeleton cuticle containing chitin and involved in 
uptake, storage, and physical processing of food, and through a valve into the midgut 
(Slack and Arif, 2007). The midgut does not contain a cuticle and the alkaline environment 
(pH 10-11) of the larval midgut causes the protein matrix forming the OB to dissolve (Terra 
and Ferreiraa, 1994). The PE is most likely degraded by proteinases associated with the 
OB or present in the midgut. This leads to the release of the ODVs into the midgut lumen 
(Terra and Ferreiraa, 1994), around 12 minutes after entry into the midgut (Adam and 
McClintock, 1991).  
After release, ODVs come against their first obstacle, the peritrophic membrane (PM) that 
needs to be breached before infection of the midgut epithelium can be achieved. The PM 
is comprised of chitin, mucopolysaccharides and protein arranged in net or lattice 
formation, which occurs in two forms. In type I, the PM is produced by ring of secretory 
cells located at the entry of the midgut and is delaminated from the entire midgut 
epithelium. In some cases type I PM only form in response to feeding (Lehane, 1997). In 
type II, the PM is always present and produced along the whole length of the midgut. 
Therefore, forming a hollow tube protecting the midgut epithelium from direct contact from 
the content of the midgut lumen (Slack and Arif, 2007; Hegedus et al., 2009). The PM is 
regenerated from the epithelial cells to protect them from abrasive food material that could 
cause damage, to restrict the passage of large particles such as bacteria, fungi and 
viruses and provides the larva with some defence (Barbehenn and Martin, 1995). The 
ODVs cannot rely on chance encounters with lesions in the PM caused by the passage of 
food alone; therefore PM-compromising proteases and chitinase are either co-occluded 
with ODVs in the OB matrix or located on the ODV surface (Wang and Granados, 1997).  
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Some baculoviruses encode these proteases and most are metalloproteinases as they 
contain divalent cations as an integral component of their structure (Lepore et al., 1996; 
Wang and Granados, 1997; Peng et al., 1999). Enhancins are one group of 
metalloproteinases found concentrated in the OB and are believed to digest the mucin 
component of the PM, thus allowing the ODV access to the midgut epithelial cells (Wang 
and Granados, 1997). However, many baculoviruses do not encode these proteases and 
are not inhibited by the PM. Alternative mechanisms could be involved using bacterial 
proteinases that are normally found contaminating the OB. These bacterial proteinases 
can function in the alkaline condition of the midgut and therefore degrade the PM, allowing 
the ODV access to the midgut epithelium (Rubinstein and Polson, 1983).  
 
1.3.2 Infection of the Midgut Epithelium 
 
The larvae midgut epithelium is primarily composed of two cell types, goblet cells that are 
involved in potassium ion transport into the midgut, and the columnar cells, which are 
involved in secreting digestive enzymes and absorbing nutrients through their brush 
border (Adam and McClintock, 1991). The ODV lipid envelope fuses directly to the 
columnar cell membrane, specifically at the apical ends of the microvilli (Haas-Stapleton et 
al., 2004). The fusion process of the ODV membrane to the columnar cell membrane and 
the subsequent entry of the nucleocapsid into the cell are carried out by a group of gene 
products known as per os infectivity factors (Kikhno et al., 2002). This family includes p74 
(pif0/Ac138; (Faulkner et al., 1997)), Ac22 (pif2; (Pijlman et al., 2003)), Ac96 (pif4; (Fang 
et al., 2009)), Ac115 (pif3; (Ohkawa et al., 2005)), Ac119 (pif1; (Kikhno et al., 2002)), and 
Ac148 (pif5; (Sparks et al., 2011a)). All members are found conserved among all 
sequenced baculoviruses and deletion of any of these genes from the baculovirus 
genome has no affect on viral replication in cell culture. However, these deletions do 
cause a loss of oral infectivity. 
All of this provides evidence that the baculovirus family uses a common pathway for oral 
infection and this could involve a proteinase-sensitive cellular receptor that has been 
demonstrated to bind ODV (Horton and Burand, 1993). The ODV also contains two other 
structural proteins, Ac145 (Lapointe et al., 2004) and Ac150 (Zhang et al., 2005) that have 
similar properties to PIF. They both contain chitin binding domains, however, the 
mechanisms of their interaction during oral infection is unknown. It has been suggested 
that they aid in binding of the ODV to the apical tips of the columnar cell microvilli, where 
the enzyme involved in chitin syntheses for the PM is located (Lapointe et al., 2004; 
Zhang et al., 2005; Wang and Zhang, 2006).   
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1.3.3 Virus entry into the nuclei  
 
Once the nucleocapsids are released into the cytosol, they migrate to the nuclear 
membrane by actin polymerisation (Charlton and Volkman, 1991; van Loo et al., 2001; 
Ohkawa et al., 2010). Strong evidence suggests that the nucleocapsid dock with the 
nuclear pore before being transported into the nucleus (Summers, 1971; Granados, 
1978). The baculovirus nucleocapsids have a diameter of 40-70 nm and thus are small 
enough to pass through the nuclear pore complex, which has been characterised to have 
a channel size of 38-78 nm (Alber et al., 2007). In early infection, empty nucleocapsid 
have been observed in the nuclei of infected cells (Granados and Lawler, 1981) and more 
recently, the major capsid protein VP39 has been fluorescently tagged using GFP. This 
allowed nucleocapsids to be localised both to the nuclear pore and within nuclei using 
confocal microscopy (Ohkawa et al., 2010). Once in the nucleus, the viral genome is 
released and this whole process takes roughly 30 minutes (Chisholm and Henner, 1988). 
This leads to a cascade of gene expression where viral genes are expressed, structural 
genes are synthesized, DNA replication begins and new progeny viruses are assembled 
and released (Slack and Arif, 2007). Figure 1.4 A provides an illustration of the primary 
infection process. 
 
1.3.4 Viral exit from the nuclei  
 
The nucleocapsids are released from the nucleus of the midgut epithelial cells by budding 
out of the nuclear membrane (Granados and Lawler, 1981). During this budding process 
the nucleocapsid obtains an envelope, which contains at least one viral protein, GP16 
(Gross et al., 1993). The nucleocapsids are directed through the cytoplasm towards parts 
of the plasma membrane modified with the viral envelope glycoprotein. During this 
transition process the nucleocapsids lose their nuclear-derived envelope. The 
nucleocapsids then bud out of the plasma membrane forming new progeny viruses (BV) 
to allow secondary infection. The viral envelope proteins for Type I alphabaculovirus are 
GP64 and the F protein (Blissard and Rohrmann, 1989; Pearson et al., 2001). However, 
for Type II alphabaculovirus this is a homologue of the F protein as they lack a functional 
GP64 (Pearson et al., 2000). It has been demonstrated that AcMNPV-infected columnar 
cells in T. ni larvae distribute their GP64 towards the basal and lateral regions of the cell. 
This directs the budding of new progeny virus away from the midgut lumen and towards 
susceptible tissues (Engelhard et al., 1994). However, in infected cells where specific 
targeting is not critical for the spread of infection GP64 has a polar distribution (Keddie et 
al., 1989).   
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1.3.5 Midgut Epithelium bypass mechanism  
 
It has been suggested that there could be a mechanism for avoiding replication in midgut 
columnar cells that can be sloughed off into the lumen. This process involves 
nucleocapsids bypassing replication in the columnar cell and instead being transported 
directly to the basal region and budding into tracheal cells or haemolymph (Granados and 
Lawler, 1981; Washburn et al., 1999). As previously mentioned GP64, is required to direct 
nucleocapsids to the plasma membrane and its gene does contains both an early and late 
promoter. Therefore, during early infection GP64 could be present to allow this process to 
occur. Evidence for this mechanism was shown by a delay in oral infection when the early 
promoter of gp64 was eliminated from AcMNPV but no effect on infection time was 
observed when the same virus was injected into the larval hemocoel (Washburn et al., 
2003a; Zhang et al., 2004). 
However, the current model for bypassing replication in columnar cells would only apply to 
MNPV because it requires several nucleocapsids infecting a single cell. These 
nucleocapsids would split into two groups; those that enter the nucleus to begin replication 
and express the gp64 to produce GP64 to allow the other nucleocapsids that remained in 
the cytoplasm to bypass the nucleus. Therefore, it is highly unlikely that SNPV would 
infect a single columnar cell with enough nucleocapsids to achieve this affect (Washburn 
et al., 2003a; Washburn et al., 2003b; Rohrmann, 2011). Figure 1.4 A provides an 
illustration of this bypass mechanism.  
1.3.6 Infection of the inner tissues  
 
The envelope fusion proteins GP64 or active form of F protein, described above, are not 
only required for exiting cells but are also involved in initiating secondary infection in other 
cells. GP64 has been shown to initiate the uptake of the BV via clathin-mediated 
endocytosis in insect cells (Long et al., 2006). Once this process is stimulated clathin 
becomes concentrated on the inside of the plasma membrane at the point of entry 
allowing the uptake of the BV within a vesicle. Clathin-mediated endocytosis is normally 
involved in the selective uptake of proteins. The uptake is stimulated by binding to a 
receptor on the surface of the cell with internalisation signals, which cause the pit to 
invaginate into the cytoplasm of the cell that results in an endocytic vesicle containing the 
protein (Long et al., 2006). This mechanism is commonly used by many viruses 
(Rohrmann, 2011). However, the receptor that GP64 interacts with has not been defined 
nor has a common molecule, such as a phospholipid, due to the ability of the baculovirus 
BV to enter a number of different cell types (Tani et al., 2001).   
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Figure 1.4 The baculovirus replication cycle  
 
Schematic representation of the Baculovirus replication cycle (Friesen and Miller, 2001).  
 
A: Infection of a midgut epithelial cell by ODV (primary phase of infection). The polyhedrin matrix 
dissolves in the midgut lumen (step 1), releasing ODVs. These cross the peritrophic membrane 
(step 2) and enter columnar cells through direct membrane fusion to the microvillus (step 3). 
Released nucleocapsids migrate to the nucleus (step 4) and enter through nuclear pores (step 5). 
The viral genome is released (step 6) and this results in a cascade of gene expression where viral 
genes are expressed, structural genes are synthesized, DNA replication begins and new progeny 
viruses are assembled and released (step 7-11) Alternatively nucleocapsids bypass replication 
stage and instead transported to the basal region then released (step 12) .  
 
B: Infection of a cultured or secondary site of infection by BV. The BV enter the cell through 
receptor mediated endocytoisis (Step 1-2). As the endosome acidifies, virus and endosomal 
envelopes fuse (step 3), releasing nucleocapsids into the cytoplasm. Released nucleocapsids 
migrate to the nucleus (step 4) and enter through a nuclear pore (step 5). The viral genome is 
released (step 6) and the virus replication cycle is initiated as described above (step 7-11). During 
the very late phase, nucleocapsids are retained in the nucleus, acquire envelopes (step 12), and 
are embedded within a crystalline matrix of polyhedrin (step 13) to form OBs. Mature OBs are 
released by cell lysis. 
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The internalised vesicle is then transported using the cytoskeleton network of the cell to 
the endosome, where they merge together releasing the content of the vesicle into the 
endosome. The environment of the endosome is slightly acidic (pH 5.9-6.0) that causes 
a conformational change in the GP64 allowing the viral envelope to merge with the 
endosome membrane. This results in the release of the naked nucleocapsid into the 
cytoplasm of the cell, where it is transported to the nucleus and the viral replication 
begins (Rohrmann, 2011). Interestingly, it has been demonstrated that this 
conformational change of GP64 at low pH has the ability to fuse directly with the insect 
cell plasma membrane independent of endocytosis. However, it is highly unlikely that 
the virus would encounter these low pH conditions outside of the cells within the larva 
(Dong et al., 2010).  
1.3.7 Cell Defence: Apoptosis 
 
Programmed cell death or apoptosis is a self-destructive response evolved in 
multicellular organisms to allow the safe elimination of cells that have either become 
damaged or malfunctioning, or to facilitate the development of the organism (Ashida et 
al., 2011; Fuchs and Steller, 2011). Two classic examples of apoptosis used during 
development are in human embryogenesis to remove webbing between fingers and 
toes (Fuchs and Steller, 2011) or metamorphosis of larva into adult insect (Rohrmann, 
2011). In the case of baculovirus infected larva, apoptosis is one of the primary 
strategies used by a cell to avoid virus infection spreading throughout the organism 
(Engelhard and Volkman, 1995). Apoptosis involves a series of specific events 
including loss of attachment to adjacent cells, cell shrinkage, nuclear fragmentation, 
chromatin condensation, DNA fragmentation and subsequent disintegration of the cell 
into apoptotic bodies, which are then eliminated by phagocytosis (Clem et al., 1991; 
Hershberger et al., 1992; Clem and Miller, 1994; Manji and Friesen, 2001; Schultz and 
Friesen, 2009). All these events of apoptosis are caused by the activation of a family of 
cysteine proteases known as caspases, which are separated into two groups; initiator 
and effector caspases (Thornberry et al., 1992). When a cell is stimulated to undergo 
apoptosis, initiator caspases are activated, which in turn activate the effector caspases 
by proteolytic processing. These effector caspases cleave cellular proteins resulting in 
the observed affects of apoptosis.  
To prevent cellular apoptosis, baculoviruses produce two groups of proteins, P35 and 
inhibitors of apoptosis (IAP). p35 is found in a limited number of Type I 
alphabaculoviruses, which are all closely related to AcMNPV. However, most 
baculoviruses encode multiple copies of iap genes (Clem et al., 1991; Thiem and 
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Chejanovsky, 2004). Both P35 and IAP proteins affect caspases. In insect Sf21 cells, 
P35 has been shown to directly block the activity of mature SF-caspase-1, whereas 
some IAP proteins block SF-caspase-1 at the processing and activation level 
(Prikhod'ko et al., 1999). P35 has also been shown to block other caspases during 
baculovirus infection (Clem, 2007), whereas IAPs function more widely blocking 
caspases, degradation of caspases via targeting for ubiquitination and have been 
shown to interfere with other pro-apoptotic proteins (Vaux and Silke, 2005; Eckelman et 
al., 2006). It has been demonstrated that the deletion of p35 can reduce BV yield by 
15,000-fold during infection of insect cells in culture and also reduces the mortality rate 
of infected larva (Hershberger et al., 1992; Clem and Miller, 1994).  
Because to the midgut cells are prone to apoptosis, it might be beneficial for 
baculoviruses to encode anti-apoptotic proteins that were located to ODV. Neither P35 
nor IAP proteins are located to the ODV, but this isn’t surprising due to their location in 
the cytoplasm of the infected cell and the assembly of nucleocapsids in the nucleus 
(Slack and Arif, 2007). P33 is a nucleocapsid associated protein that could be involved 
in preventing apoptosis as it binds to p53, which itself is a human protein that is 
involved in apoptosis and cell cycle regulation (Prikhod'ko et al., 1999; Collot-Teixeira 
et al., 2004). The existence of an insect homologue to p53 further supports this theory, 
but research on P33 so far has shown no signs of preventing p53-induced apoptosis 
and has in fact shown the opposite effect causing p53-mediated apoptosis to increase 
two-fold when co-expressed (Prikhod'ko et al., 1999). However, this co-expression 
experiment was done using plasmids that expressed only p53 or P33. Therefore P33 
could require other viral proteins to inhibit p53 mediated apoptosis.   
 
1.3.8 Spread of infection throughout the host tissues  
  
The midgut cells undergo constant turn over, where old cells are sloughed off into the 
lumen and replaced by new ones from regenerative cells at the base of the epithelium. 
This combined with the fact that they are prone to apoptosis and cell cycle arrest, 
means that the midgut is a poor tissue for virus infection (Engelhard and Volkman, 
1995; Uwo et al., 2002). The tissues beyond the midgut contain actively dividing cells, 
but ODV are highly specific for the midgut epithelial cells in an alkaline environment 
(Slack and Arif, 2007). This suggests that it was advantageous for the baculovirus to 
evolve the BV phenotype, which can operate in the slightly acidic environment (pH 6.4 
to 6.8) of the host internal tissues such as the tracheoblasts, haemocytes and fat body 
(Haas-Stapleton et al., 2004). The formation of two distinct phenotypes at different 
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times during the infection cycle is known as a bi-phasic replication cycle, shown in 
Figure 1.4.  
It is not surprising therefore that the midgut epithelium is not the major tissue for viral 
replication, but is instead an initial staging ground where BV can be produced to infect 
other susceptible cells and tissues in the larvae. Allowing the midgut epithelium to 
recover is beneficial to the baculovirus as this allows the larvae to continue to feed and 
grow, in turn maximizing production of progeny virus (Slack and Arif, 2007). 
Interestingly, Culex nigripalpus nucleopolyhedrovirus (CuniNPV) (Moser et al., 2001) 
and certain types of GVs (Federici and Stern, 1990) appear to only replicate in the 
midgut epithelium but the development of infection in these viruses is not fully 
understood.   
The tracheal system is an insect’s respiratory system, which branches out and 
penetrates nearly every tissue including the midgut epithelium (Washburn et al., 1995). 
Therefore, progeny BVs derived from midgut epithelium that infect a tracheolar cell, will 
use the tracheal system as a major conduit to allow access to deeper tissues, including 
the haemocoel. The haemocoel is another important target for the baculovirus, as it 
allows the infection of haemocytes. Haemocytes circulate throughout the open 
circulatory system and are involved in immune response, therefore this increases the 
spread of infection in the larvae by allowing greater access to tissues and reducing the 
host defences (Slack and Arif, 2007). The last tissue of importance is the fat body that 
acts as an insect “liver”, and therefore its energy rich cells are ideal for the production 
of viral progeny (Figure 1.4)  
 
1.3.9 The Virogenic Stroma 
 
The baculovirus infection cycle can be broken into distinct stages. The length of these 
stages is virus species specific (Slack and Arif, 2007). The baculovirus replication cycle 
begins soon after the delivery of the genome into the host cell nucleus from the 
nucleocapsid. The host cell begins to be manipulated into a “viral factory” by virion-
associated proteins along with viral immediate early proteins, whose genes are 
expressed within 30 minutes post-infection (Chisholm and Henner, 1988).  The 
virogenic stroma is one of these manipulations, and is the site for viral RNA 
transcription, DNA replication and nucleocapsid assembly.  
The virogenic stroma begins as an electron dense, irregular-shaped, granular region in 
the centre of the nucleus and can be observed in the first 6 hours of AcMNPV infection. 
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The composition of the virogenic stroma is mainly RNA and DNA, along with proteins 
that form support for RNA and DNA complexes (Young et al., 1993). Heterochromatin is 
highly condensed, histone-associated host genomic DNA that is relocated to the edges 
of the nucleus during this time, which gradually disappears as the virogenic stroma 
expands (Williams and Faulkner, 1997). This re-arrangement of the nucleus is carried 
out by viral interaction with tubulin (Volkman and Zaal, 1990).  
The virogenic stroma expands until 12 hours post-infection (hpi) at which point it fills 
most of the nucleus and, during this expansion, cavities form inside it. The edges of 
these cavities are the sites of nucleocapisd assembly. The nucleocapsids assembled 
between 12 and 20 hpi are destined  to become the BV virion phenotype (Slack and 
Arif, 2007). These nucleocapsids leave the virogenic stroma and cross the nuclear ring 
zone, another major partition of the nucleus that surrounds the virogenic stroma, and 
the nucleocapsids reach the nuclear membrane. Once at the nuclear membrane, the 
nucleocapsids are transported through and across the cytosol to the cell membrane, 
where they bud out acquiring an envelope from the host membrane that contains virus 
encoded proteins. Presently, the process of translocation of the nuclecapsids across 
the cell is not well defined and although early studies indicated a role for cellular actin 
(Braunagel et al., 2001; Lu et al., 2004), a more recent study suggest a role also for 
microtubules (Danquah et al., 2012). 
The virogenic stroma composition has been resolved, but the structure is still not well 
understood due to it being essential for viral replication. Two viral proteins have been 
shown to be associated with the virogenic stroma; single-stranded DNA binding protein 
(dbp) (Ac25) and PP31 (Ac36) (Guarino et al., 1992; Mikhailov et al., 2008). The 
deletion of dbp from the virus genome caused the loss of the virogenic stroma that 
resulted in the production of abnormal nucleocapsids (Vanarsdall et al., 2007), whereas 
the deletion of pp31 resulted in an overall decrease in transcription of late genes (Gomi 
et al., 1997; Yamagishi et al., 2007).  
 
1.3.10 The Nucleocapsid 
 
The ODV and BV nucleocapsids are structurally similar; they both contain complete 
viral genomes and have several major proteins in common (Figure 1.5). The 
nucleocapsid length is determined by the size of viral genome packaged. This gives the 
baculovirus nucleocapsids a length ranging from 250-400 nm and a diameter of 40-70 
nm (Boucias and Pendland, 1998). The nucleocapsids are polar with a base on one 
end and an apical cap on the other end. During nucleocapsid assembly the apical cap 
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is oriented towards the virogenic stroma, which is also oriented to the peplomer end of 
BV (Fraiser, 1986) and found associated with the nascent envelopes of the ODV 
(Adam and McClintock, 1991). VP39 is the most abundant structural protein of the 
nucleocapsid and is arranged into stacked rings around the nucleoprotein core. VP39 
is the major capsid protein but there are a number of other minor but important capsid-
associated proteins (Slack and Arif, 2007). An illustration of the nucleocapsid in shown 
Figure 1.5, indicating that the nucleocapsid is a complex structure of multiple protein 
types rather than a simple protein sheath of VP39. 
Contained within the nucleocapsid are super-coiled virus DNA and virus proteins 
known as the nucleoprotein core. The most abundant protein of the nucleoprotein core 
is basic protein (P6.9), which interacts with the negatively-charged DNA backbone 
through positively-charged arginine residues. This interaction allows the viral genome 
to condense into the nucleocapsid and is controlled through Zn2+ levels within the 
nucleoprotein core (Wilson and Consigli, 1985; Funk and Consigli, 1993). 
 
1.3.11 The Occlusion Derived Virus and Occlusion bodies  
 
At ~20 hpi, the virogenic stroma changes to ODV production, which causes it to recede 
and become more condensed. The nucleocapsids produced during this time are 
transported into the nuclear ring zone, which expands to accommodate the 
accumulating nucleocapsids (Slack and Arif, 2007). During this retention in the nuclear 
ring zone, the nucleocapsids become enveloped in a lipid bilayer that resembles the 
inner nuclear membrane (INM) in composition (Braunagel and Summers, 1994). The 
ODV envelope contains more saturated fatty acid phospolipids than the BV envelope, 
which causes the ODV envelope to be more rigid. Another difference between the two 
virion envelopes is that the ODV envelope contains phosphatidylcholine instead of 
phospatidylserine found in the BV envelope (Slack and Arif, 2007). An illustration of 
ODV compared to BV is shown in Figure 1.6. 
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Figure 1.5 Proteins of the nucleocapsid  
 
Schematic representation of nucleocapsid described in section 1.3.10. Some of the AcMNPV 
nucleocapsid proteins are illustrated and proteins marked with * have not had their location 
confirmed to the nucleocapsid (Slack and Arif, 2007).  
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Figure 1.6 The budded and occlusion-derived virus 
 
Schematic representation of the BV and ODV, showing the location of virally encoded proteins 
in BV and ODV, and the composition of their lipid membrane (Federici, 1997). 
 
The mechanism involving this major transition from BV to ODV production during the 
baculovirus infection is still unresolved; however, several theories have been 
suggested. It could simply be a result of the deletion of a viral component essential for 
the transit of nucleocapsid through the cytoplasm or the reorganisation of the virogenic 
stroma that prevents the nucleocapids from leaving the nucleus (Rohrmann, 2011). 
During the later stages of viral infection, the ODV envelope proteins accumulate 
causing the nucleocapsids to become enveloped within the nucleus. This envelope 
could prevent the nucleocapsids from leaving the nucleus, suggesting that only the 
earlier naked nucleocapsids have the ability to leave the nucleus and transit through 
the plasma membrane (Rohrmann, 2011). 
The origin of the ODV envelope is still under debate. It maybe synthesized de novo or 
be acquired from the inner nuclear membrane (INM). There is considerably more 
evidence available for the latter. Late in infection, the INM modified with ODV envelope 
proteins invaginates as microvesicles into the nuclear ring zone. If this mechanism is 
used then the virus must induce “de novo” INM synthesis during infection to produce 
enough material to envelope all nucleocapsids destined to be ODV (Braunagel et al., 
1996).  
The ODV envelope contains a wide range of viral proteins and is more diverse than the 
BV envelope proteins. These proteins are transported to the ODV envelope by unique 
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mechanisms and are mostly non-glycosylated. Prior to envelopment, the ODV 
nucleocapsid is packaged in a proteinaceous virus derived tegument, which becomes 
more condensed around the nucleocapsids after occlusion. Occlusion begins shortly 
after ODVs begin to appear in the nuclear ring zone and the fully formed OBs are 
present by 24 hpi (Slack and Arif, 2007). The OB is composed of polyhedrin that is 
hyperexpressed during the late stages of infection and accumulates within the nucleus 
of an infected cell, before crystallising into a lattice that surrounds ODV (Jarvis et al., 
1991; Carstens et al., 1992). The mechanisms that causes this occlusion process are 
unclear and could be dependent on the concentration of polyhedrin or the ODV 
themselves could cause the formation of OBs. However, in BmNPV at least one protein 
has been shown to be essential for the occlusion process, Bm56. The deletion of Bm56 
caused ODV not to be incorporated into the OB (Xu et al., 2008). Another protein 
known as P10 is also hyperexpressed during late stages of infection, this protein forms 
tubule-like structures with the cell cytoskeleton that penetrate both the nucleus and the 
cytoplasm (Patmanidi et al., 2003; Carpentier et al., 2008; Carpentier and King, 2009). 
P10 has been demonstrated to be involved in assembly of the PE on mature OB during 
the late stages of infection (Lee et al., 1996).  
The OBs are released from the nuclei of an infected cell by a lytic process from 48 hpi 
(Figure 1.7). The viral protein cathepsin plays a role in releasing the OBs from infected 
cells as well liquefaction of the host. This was demonstrated by an AcMNPV cathepsin-
deletion mutant, in which OBs were not released from infected cells in cell culture 
(Slack et al., 1995). P10 is another protein which has been shown to be involved in cell 
lysis and interacts with host cell microtubules (Patmanidi et al., 2003). 
 
 
Figure 1.7 Scanning electron microscopy of OBs 
Scanning EM images that represent the packaging (A, 48hpi) and release of OBs (B, 72hpi) 
from AcMNPV-infected cell (King and Possee, 1992) 
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The larval exoskeleton is comprised of chitin that makes it rigid and strong and this 
obstacle has to be overcome to allow the OBs from the lysed cells to be released into 
the environment. Therefore it is not surprising that some baculoviruses encode 
enzymes (viral chitinase and cathepsin) that breakdown the larval exoskeleton 
facilitating the liquefaction of the host allowing the OBs to be widely dispersed (Slack et 
al., 1995; Hawtin et al., 1997). It has been suggested that viral chitinase is retained in 
the endoplasmic reticulum in infected cells to prevent its early release, therefore 
allowing virus replication to continue before the host is liquefied (Hawtin et al., 1995). 
Deletion of either viral chitinase or cathepsin causes infected larva to remain intact for 
several days after death (Hawtin et al., 1997). 
Predators will also ingest the baculovirus-infected larvae due to them being weakened 
from the infection and disperse OBs in their faeces. The OBs can survive passage 
through the predators digestive system (Abbas and Boucias, 1984). Baculoviruses 
have also been shown to change the wandering behaviour of the host larvae to 
increase the chance of horizontal transmission by moving up the host plant to increase 
OB coverage or moving into less UV exposed areas to increase chances of OB survival 
(Raymond et al., 2005). The RNA processing enzyme encoded by Ac1 is believed to be 
involved in this change in behaviour because larva infected with BmNPV containing a 
deletion of this gene did not present any signs in terminal movement during late 
infection, which was seen in those larva infected with complete BmNPV. However, it is 
unclear how this RNA processing enzyme could account for this behaviour change 
(Kamita et al., 2005).More recently, Hoover et al. (2011) demonstrated using deletion 
mutant viruses that the expression of the viral gene ecdysteroid uridine 5’-diphosphate 
(UDP)-glucosyltransferase (egt) was required for inducing climbing behaviour of 
Lymantria dispar nucleopolyhedrovirus (LdMNPV) infected gypsy moth. 
 
1.3.12 The Budded Virus 
 
The BV is a single nucleocapsid encased in a loosely fitted envelope. This could be 
due to cytoplasmic proteins being present in the space between the nucleocapsid and 
the envelope (Figure 1.6). The BV envelope proteins are transported to the cell 
membrane from the endoplasmic reticulum after being sorted and N-glycosylated 
(Whitford et al., 1989). The BV envelope is bulbous at one end and the surface is 
serrated when viewed by transmission EM (Figure 1.8). These serrations are known as 
peplomers and are believed to contain GP64 and Fusion protein (Volkman et al., 1984). 
The GP64 major viral glycoprotein and the F protein are involved in mediating budding, 
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attachment and entry of BVs in to cells. This leads to the two proteins often being 
referred to as ENV proteins (Hefferon et al., 1999). The F protein requires proteolytic 
cleavage to become active unlike GP64, which does not require any further 
modification after incorporation into the envelope (Westenberg et al., 2002). In Type I 
NPVs, both ENV proteins are present but the F protein seems to have lost its ENV 
functions, whereas Type II NPV just contain a functional F protein (Herniou et al., 
2001). 
 
 
 
Figure 1.8 Electron microscopy of a baculovirus BV 
An EM image that represents the AcMNPV BV showing the characteristic rod-shape of the virion 
with a bulbous serrated surface at one end. Taken from “The Big Picturebook of Viruses” at 
www.virology.net. Attributed to Eric B. Carstens (Queen’s University, Kingston, Ontario, Canada, 
1996)  
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1.4 Baculovirus Expression Vector Systems 
 
1.4.1 Introduction to Baculovirus Expression Vector Systems 
 
The baculovirus expression vector system (BEVS) was first developed in the mid 
1980’s and is now widely used for the production of recombinant proteins in insect cells 
(Smith et al., 1983a; Pennock et al., 1984; Summers, 2006; van Oers, 2011). 
Recombinant BV containing a foreign gene, usually under the control of the polh 
promoter, is used to infect cells and during the later stages of viral infection large 
quantities of recombinant protein are normally produced. The host insect cells have the 
ability to process signal peptides, assemble oligomeric proteins and enable proper 
post-translational modifications such as glycosylation, phosphorylation and disulfide 
bond formation to allow authentically processed proteins to be produced. 
The earliest BEVS were based on polyhedra-negative viruses, which had their 
polyhedrin coding region replaced with a foreign gene to produce a recombinant 
baculovirus. The foreign gene expression was driven by the strong polyhedrin 
promoter. Since the development of the BEVS, it has been widely used and is often the 
first choice for the production of certain classes of proteins e.g. kinases (Hitchman et 
al., 2011; van Oers, 2011; Hitchman et al., 2012). 
The baculovirus genome is too large to insert the foreign gene directly; instead transfer 
vectors are used containing sequences that flank the polyhedrin gene. Using insect cell 
homologous recombination proteins, the foreign gene is inserted into the virus genome 
resulting in recombinant virus. The viral replication cycle produces BV containing the 
recombinant virus genome, which can be harvested from the culture medium (Smith et 
al., 1983a; Pennock et al., 1984).  
Using the baculovirus expression system as described above, both a mixture of 
recombinant and original parental viruses are produced after the initial round of 
replication (Figure 1.9). Before the recombinant virus can be used as the expression 
vector, it has to be separated from the parental virus. This separation is traditionally 
achieved by plaque-purification, however this process is labour-intensive, technically 
demanding and time-consuming (Kitts et al., 1990). 
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Figure 1.9 Illustration of the method used to construct recombinant viruses 
 
The transfer vector containing homologous regions to polyhedrin gene is modified by the direct 
insertion of recombinant protein into the transfer vector. Viral DNA and modified transfer vector 
are introduced into the host cells to allow homologous recombination to occur and finally the 
recombinant virus is selected for using the OBs as a negative marker.  
 
1.4.2 Improvements to the Baculovirus Expression Vector Systems 
 
1.4.2a The BacPAK6 system 
 
The BacPAK6 system replaces polyhedrin with lacZ, which contains a Bsu361 
restriction site, as well as two extra Bsu361 sites in the two genes flanking lacZ (Kitts 
and Possee, 1993). Digestion with Bsu361 removes the lacZ gene and a fragment of 
an essential gene (orf1629) producing linear virus DNA that is unable to replicate within 
insect cells (Figure 1.10). Co-transfection with a transfer vector restores infectivity of 
the now circular virus DNA by replacing orf1629, as well as inserting the foreign gene 
into the virus genome. This resulted in ~90% recovery of recombinant virus plaques. 
However, Bsu361 digestion is never 100% efficient and the final virus population will 
always contain a mixture of recombinant and parental virus that requires purification by 
plaque-assay (Kitts and Possee, 1993). 
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Figure 1.10 BacPAK6 method used to construct recombinant viruses 
 
Sf9 Cells co-tranfected with transfer vector and Bsu361 linearised BacPAK6 DNA, to form 
recombinant virus
lacZ-
. Recombinant virus
lacZ-
 was isolated from parental background using 
plaque purification, selecting for lacZ negative plaques.   
 
1.4.2b The Bac-to-BacTM system 
 
A significant step forward was taken in 1997 with the development of the Bac-to-BacTM 
system, which allows the production of recombinant baculoviruses without the need for 
plaque purification and is marketed by Invitrogen (Figure 1.11). The baculovirus 
genome is maintained in bacteria by a mini-F replicon. A selectable marker gene (lacZ) 
and Tn7 transposition sites are also inserted into the baculovirus genome. The transfer 
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vector encodes Tn7 transposase functions and a foreign gene. Transposition is carried 
out in E. coli, which results in the foreign gene being inserted at the polyhedrin locus 
between left and right arms of Tn7, resulting in the disruption of lacZ. The recombinant 
clones are then selected on agar plates containing appropriate antibiotics and X-gal. 
Non-blue colonies are selected and amplified. The recombinant virus DNA is recovered 
via a simplified alkaline lysis method, and is transfected into insect cells to produce BV 
(Kost et al., 2005; Possee et al., 2008). 
 
Figure 1.11 Bac-to-BacTM method used to construct recombinant viruses 
 
Illustration of the generation of recombinant virus using the Bac-to-Bac
TM 
system (From the 
Invitrogen Bac-to-Bac
TM 
system manual), insertion of target gene into the bacmid disrupts lacZ 
allowing selection of non-blue colonies in the presence of X-gal. The recombinant bacmid DNA 
is then isolated and used to transfect insect cells to produce recombinant viruses.  
 
1.4.2c The flashBAC system 
 
The flashBAC system was developed by Oxford Brookes University and NERC CEH 
oxford (Possee et al., 2008) and is sold by Oxford Expression Technologies. At the 
heart of flashBAC technology is an AcMNPV genome that lacks part of an essential 
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gene (orf1629) and contains a bacterial artificial chromosome (BAC) at the polyhedrin 
gene locus, replacing the polyhedrin coding region. The BAC allows the viral DNA to be 
maintained and propagated, as a circular genome, within bacterial cells (Ho Je et al., 
2001; Possee et al., 2008). 
flashBAC uses the same principles as BacPAK6 but is maintained in bacterial cells 
and doesn’t require linearization prior to use. The flashBAC DNA is co-transfected 
into insect cells with a transfer vector that restores the function of ORF 1629 and 
inserts the foreign gene allowing the virus DNA to replicate and produce virus particles. 
The foreign gene replaces the BAC sequence (Figure 1.12). The key difference 
between flashBAC and BacPAK6, is that no plaque assay selection is required as 
non-recombinant virus are unable to replicate (Ho Je et al., 2001; Possee et al., 2008). 
flashBACGOLDTM (FBG) is an enhanced version of flashBAC, in which both chitinase 
and cathepsin have been deleted to improve protein yield and quality due to them 
being deleterious to recombinant protein production, intracellular transport and stability 
(Hitchman et al., 2010b). Recently flashBACULTRATM (FBU) was developed, which 
contains further deletions of p10, p74 and p26 and this resulted in a further increase in 
protein yield (Hitchman et al., 2010a). The development of FBU strongly suggests that 
further deletions of non-essential genes from the baculovirus genome could increase 
recombinant protein yield by freeing up cellular resources.  
 
 
 
 
Figure 1.12 flashBAC method used to construct recombinant viruses 
 
Sf9 Cells co-tranfected with transfer vector and flashBAC  DNA, to form a recombinant virus. 
The flashBAC  virus is non-infectious due to missing part of the essential gene orf1629. 
Therefore, the recombinant virus does not require isolation from parental virus after the co-
transfection stage. 
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1.5 Aims of Thesis 
 
The overall aim of this thesis is to elucidate the mechanisms involved in the production 
of occlusion-derived virus (ODV) by using the Red/ET recombination system to remove 
auxiliary genes involved in ODV production, which are non-essential for replication in 
insect cell culture. A secondary aim of the thesis is to determine whether deletion of 
ODV-specific genes, and preventing ODV production, will improve the BEVs by 
producing greater levels of high quality recombinant proteins. Chapter 3 describes the 
literature review undertaken to identify structural components of the ODV, which are not 
found in the BV and can be deleted from the AcMNPV genome without affecting 
infectivity. Chapter 4 describes the use of the Red/ET recombination system in deleting 
the target genes from the AcMNPV genome and characterises those deletions that 
prevented replication of the virus in insect cell culture. Chapter 5 characterises those 
deletion mutant viruses that remained viable in insect cell culture, specifically 
considering their effects on ODV production and occlusion into the OBs using 
bioassays and electron microscopy. The thesis also investigates the deletion of 
orf118/pif1, pif2 and pif3 on recombinant protein production (Chapter 6 and Chapter 7). 
In addition, Chapter 7 investigates the RGD motifs of PIF1 and the possible role they 
could have on the function of PIF1 during oral infection of larva with OBs.  
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2.1 Materials 
 
2.1.1 Chemicals 
 
General chemicals were purchased from the following companies unless stated 
otherwise: BDH Chemicals Ltd, Fisher Scientific and Sigma-Aldrich. Molecular biology 
reagents were purchased from Invitrogen, New England Biolabs, Fermentas or 
Promega. Cell culture media was supplied by GIBCO (Invitrogen) or PPA. 
All solutions made were sterilised by either autoclaving (15 pounds per square inch 
(p.s.i.) for 15 minutes or 10 p.s.i. for 20 minutes) or by filtration through 0.45 or 0.2 µm 
filters.  
 
2.1.2 Plasmids 
 
The plasmids used within thesis are shown in Table 2.1 
Table 2.1 Plasmids used in this thesis 
Plasmids Reference Source 
pAcEI-I (Possee, 1986) R. D. Possee 
pAcUW21 (Lopez-Ferber et al., 1995) 
pBluescript-BAC  
pCH110   (Hall et al., 1983) 
pBAC5  Novagen 
pBacPAK8  Clontech 
pBacPAK8-urokinase   R. B. Hitchman 
pBluescriptpif1  Advantagen 
pBluescriptArg96Ala  
pBluescriptArg478Ala  
pBluescriptArg96/478Ala  
pGEM-T  Promega 
pOET3  Oxford Expression 
Technologies, Ltd 
pRedET plasmid (Muyrers et al., 2000) Gene Bridge 
TOPO vector   Invitrogen 
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2.2 Bioinformatics 
 
2.2.1 Baculovirus sequences 
 
The AcMNPV sequence was retrieved from the Viral Genome Project database (Bao et 
al., 2004), hosted by the National Centre for Biotechnology Information (NCBI, 
http://www.ncbi.nlm.nih.gov/). The target open reading frames amino acid sequences 
were obtained from the AcMNPV sequence and used in a BLAST search (NCBI, 
http://blast.ncbi.nlm.nih.gov/Blast.cgi). This allowed amino acid sequences that were 
homologous to the target proteins to be found and used in multiple sequence 
alignments.   
 
2.2.2 Multiple sequence alignments 
 
Sequences were aligned by multiple sequence alignment using the ClustalW2 software 
hosted by the European Bioinformatics Institute (EBI, http://www.ebi.ac.uk/ 
Tools/msa/clustalw2/). The ClustalW2 software default settings were used to calculate 
and generate all the alignments within this thesis. Alignments were then shaded 
according to amino acid similarity using the GenDoc software package, downloaded 
from http://en.bio-soft.net/format/GeneDoc.html (Nicholas et al., 1997) and run locally.  
 
2.2.3 Protein pattern search 
 
The TMPRED software tool, hosted by EXPASY (http://expasy.org/tools/) was used to 
scan the target sequence for any transmembrane regions (Hofmann and Stoffel, 1993). 
The NetNGlyc 1.0 and NetOGlyc 3.1 Server tools, hosted by Center for Biological 
Sequence Analysis (CBS, http://www.cbs.dtu.dk/services/) were used to identify any 
potential N- or O- linked glycosylation sites within the target sequence.  
 
2.3 Insect Larvae, Cells and Viruses  
 
2.3.1 Insect larvae and cell lines 
 
All Trichoplusia ni (T. ni) larvae were provided by T. Carty, from continuous cultures 
reared at the Centre for Ecology & Hydrology, Wallingford. The larvae were maintained 
on a modified Hoffmans Tobacco Hornworm diet at 24C (Hunter et al., 1984). Healthy 
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first-third instar larvae were provided for experiments. Fresh gloves were used for 
handling different virus and insect stocks and all exposed surfaces were covered in 
sheets of Whatman paper, which were regularly changed.  
The cell lines used for propagating virus were T. ni (Tn368) and Spodoptera frugiperda 
(Sf21 and Sf9). Tn368 cells and Sf21 cells were maintained in TC100 medium 
supplemented with 10% foetal calf serum (FCS) and Sf9 cells were maintained in 
serum-free insect express Sf9-s2 as described in King & Possee (1992) 
 
2.3.2 Virus amplification  
 
Virus stocks (Table 2.2) were amplified in Sf9 cells using the method described by King 
& Possee (1992). Cells were seeded at a density of 1.2x106 cells/ml in a shaker culture 
and monitored until they had reached a density of 2x106 cells/ml. Then they were 
infected with virus at a multiplicity of infection (MOI) of 0.1 pfu/cell. The cell suspension 
was harvested when all the cells showed cytopathic effect, approximately 4-6 days post 
infection (dpi). The cell suspension was centrifuged at 4,000 rpm for 15 minutes at 4C 
(TY-JS 4.2 rotor, J6-MI Beckman centrifuge) to remove any cells. The supernatant 
fraction containing the virus was aliquoted into sterile tubes and stored in the dark at 4
C. 
Table 2.2 Viruses used in this thesis1 
Virus Reference Source 
AcMNPV strain C6 (Ayres et al., 1994) R. D. Possee 
BacPAK5 (Kitts and Possee, 1993) 
AcBAC∆chitinase,  (Hawtin et al., 1997) 
Ac∆pif1lacZ  
BacPAK6 (Kitts and Possee, 1993) R. B. Hitchman 
AcBAC∆chitinase/cathepsin (Hitchman et al., 2010b) 
1
Viruses constructed within this thesis not included 
2.3.3 Transfection of insect cells  
 
Sf9 cells were transfected with virus DNA (100 ng) alone or virus DNA (100 ng) plus 
plasmid DNA (500 ng) using the liposome-mediated transfection method (LipofectinTM, 
Invitrogen) as described by King & Possee (1992). In duplicate, TC100 (0.5 ml) was 
added to 7ml tubes containing the virus and plasmid DNA, which was then mixed with 
0.5 ml TC100, containing 10 l lipofectin (1mg/ml). The sample was then left at room 
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temperature for 30 minutes, before being adding to a 35 mm dish containing 1 x 106 
cells. Dishes were incubated overnight at 28C before adding 1 ml of insect express 
Sf9-s2 containing Penicillin/Streptomycin (20 µl/ml) to each dish. The virus sample was 
then harvested after the dishes had been incubated for 5 days at 28C. 
 
2.3.3a Generation of Recombinant viruses 
 
Recombinant viruses were generated using the standard method described by King & 
Possee (1992) or flashBACTM system, which was carried out using the supplier’s 
instructions (Oxford Expression Technologies Ltd) (Possee et al., 2008). The standard 
method used the same technique as described in section 2.3.3. However, Sf9 cells 
were transfected with restriction enzyme linearised virus DNA and plasmid DNA; all 
subsequent steps followed section 2.3.3. Recombinant viruses generated using this 
method were purified from the background parental virus using the method described 
in section 2.3.4b and 2.3.4c. 
 
2.3.4 Titration of virus stocks 
 
Virus stocks were either titrated using the standard plaque assay technique described 
by King & Possee (1992) or a qPCR-based titration system, baculoQUANTTM, which 
was carried out using the supplier’s instructions (Oxford Expression Technologies Ltd) 
(Hitchman et al., 2007b). 
2.3.4a Plaque assay titration 
 
Sf21 or Sf9 cells were seeded in at a density of 1.4x106 or 1x106 cells/35mm dish, 
respectively. The dishes were left at 28C for 1 hour, to allow the attachment of the 
cells. Serial ten-fold dilutions were set up for each virus stock to be titrated in relevant 
media. The media overlay was then removed from the dishes and replaced with 100 µl 
of the relevant virus dilution for 1 hour at room temperature. After the incubation, the 
virus overlay was removed and replaced with 2 ml 1% low gelling temperature agarose 
(1 ml relevant media: 1ml 2% low gelling temperature agarose). The agarose overlay 
was left to set at room temperature (approximately 15 minutes). An additional 1 ml of 
relevant media was then added to each dish, which were then incubated at 28C.  
Once the monolayer was at confluence, the plaques were stained (normally 3-5 dpi). If 
visualisation of lacZ expression was required, the liquid overlay was removed and 
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replaced with 1 ml phosphate buffered saline (PBS) containing 10 µl 5% X-gal (5-
Bromo-4-chloro-3-indolyl β-D-galactopyranoside) in dimethylformimide (DMF). Dishes 
were then incubated for 3-4 hours at 28C, before staining with neutral red.  
All dishes were stained with neutral red that allows the visualisation of plaques, by 
staining live cells. 1 ml of 0.33% neutral red solution (Sigma-Aldrich) diluted 15-fold in 
PBS was added to the liquid overlay. Dishes were then incubated at 28C for 4 or more 
hours to allow the staining of the monolayer. After this incubation, the overlay was 
decanted into disinfectant and dishes briefly dried on tissue paper. The dishes were 
then stored overnight at room temperature in the dark and the next day, plaques were 
manually counted on a light box.  
 
2.3.4b Plaque purification of recombinant viruses 
 
The plaque assay method described in section 2.3.4a, was also used to isolate 
recombinant viruses from their parental background. This involved using X-gal staining 
to visualise recombinant viruses from parental background using blue/white selection 
(as described above). Agar plugs were taken from the centre of plaques and dispersed 
in 500 µl of relevant media. This process was repeated until only plaques containing 
recombinant viruses were present. The final plaque picks were amplified by using the 
dispersed agar plug to infect a T25 tissue culture flask containing 1x106 Sf9 cells. Once 
these virus passage P1 stocks were harvested at 3-5 dpi, the remaining monolayers 
were stained with 2 ml PBS containing 20 µl 5% X-gal to ensure no parental 
background (lacZ) was present. The P1 stocks were titrated and used to generate P2 
working stocks as described under section 2.3.2. 
 
2.3.4c Alternative plaque purification method 
 
An alternative method was also used to isolate recombinant viruses. Agar plugs were 
taken from the centre of plaques and used to infect cells (5x105 Sf9 cells) within a 
single well of a 24 well plate containing in 400 µl insect express Sf9-s2. After 72hpi, 
DNA from the BV was extracted using the High Pure Viral Nucleic Acid Kit (Roche 
Applied Science) as described by the manufacturer and used in PCR to identify the 
virus types present.  
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2.3.5 Temporal analysis of virus replication 
 
Time course studies were carried out by infecting Sf9 cells using the method described 
by King & Possee (1992). The required volume of cells were seeded at a density of 
1.5x106 cells/ml in a shaker culture and monitored until they had reached a density of 
2.5x106 cells/ml. The Sf9 cell culture was then subdivided into 16 ml shaker cultures 
and infected with virus at a multiplicity of infection (MOI) of 5 pfu/cell. However, 
infections were carried out with virus diluted in the relevant culture medium, in a final 
volume of 4 ml, which causes the total volume of the culture to reach 20 ml and 2.0x106 
cells/ml. Triplicate shaker cultures were set up for each virus and cells mock infected 
with medium were also included.  
During the time course study, 1 ml samples from each shaker culture was harvested (0, 
6, 12, 24, 48, 72, 96 and 120 hpi) into 1.5 ml microcentrifuge tube and cells pelleted by 
centrifugation at 13,000 rpm for 5 minutes. The supernatant was carefully removed into 
1.5 ml microcentrifuge tube and stored at 4C, whereas the pellet was stored at -20C. 
Once the time course was completed samples were titrated (section 2.3.4) and 
processed for protein activity assays (section 2.7.3).  
A second 10 µl sample was also taken from each culture during the harvesting, to allow 
cell viability to be determined using 2% (w/v) trypan blue (Sigma-Aldrich). For each 
sample 1 µl 2% (w/v) trypan blue and 9 µl PBS was added, before placing into the 
wells of a glass haemocytometer and left to settle for 1 minute. Blue (dead) and non-
blue (alive) cells were counted under light microscope and cells were only counted if 
they lay within one of the five squares or touched the left-hand or top boundary lines.  
 
2.3.6 Purification of Baculovirus DNA 
 
2.3.6a Purification of large quantities of virus DNA using Caesium 
Chloride  
 
A 400 ml culture of Sf9 cells was seeded at a density of 5x105 cells/ml in a shaker 
culture and monitored until they had reach a density of 2x106 cells/ml. At this density, 
the culture was infected with virus at an MOI of 0.1 pfu/cell by direct addition of the 
virus to the culture. The cell suspension was harvested when all the cells showed 
cytopathic effect, approximately 4-6 days dpi. The cell suspension was centrifuged at 
4,000 rpm for 15 minutes at 4C (TY-JS 4.2 rotor, J6-MI Beckman centrifuge) to 
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remove any cells. The supernatant containing the virus was centrifuged at 24,000 rpm 
for 1 hour at 4C (SW40 Ti rotor, Optima LE-80K Beckman Ultracentrifuge) to pellet the 
BV. Two ml of 1x TE buffer (10mM Tris.Cl; pH 8.0; 1 mM EDTA) was added to the 
pellet and incubated overnight at 4C to aid resuspension of the pellet.  
The pellet was resuspended and loaded onto a 30/50% (w/v) sucrose step gradient in 
ultraclear tubes (25 x 89 mm Beckman). An overlay of liquid paraffin was added and 
samples were centrifuged at 24,000 rpm, 4C for 1 hour (SW40 Ti rotor, Optima LE-
80K Beckman Ultracentrifuge). After centrifugation, the BV-containing band was 
retrieved from the sucrose interface. The BVs were diluted with 10 volumes of 1x TE 
buffer, and centrifuged for 24,000 rpm for 1 hour at 4C (SW40 Ti rotor, Optima LE-80K 
Beckman Ultracentrifuge). The supernatant fraction was carefully removed and 
discarded and the pellet containing BV was re-suspended in 1 ml 1x TE buffer.  
The BV sample was incubated at 60C for 30 minutes with the addition of sarkosyl 
(final concentration 4% (w/v)) to release the DNA. The sample was then layered onto a 
5 ml cushion of 50% (w/w) caesium chloride containing 0.5 µg/ml ethidium bromide. An 
overlay of liquid paraffin was added and samples were centrifuged at 35,000 rpm, 20C 
for 1 hour (SW40 Ti rotor, Optima LE-80K Beckman Ultracentrifuge). The virus DNA 
band was harvested and ethidium bromide was extracted from the sample with water-
saturated butanol. The virus DNA was then dialysed against 500 ml TE stirred at 4C in 
the dark for 2-4 days. The TE was replaced every 24 hours and once the DNA was 
harvested, it was stored at 4C. The concentration and quality of the virus DNA was 
then determined by spectrophotometric measurements and restriction enzyme analysis 
(section 2.6.1).  
2.3.6b Purification of virus DNA from 35mm dishes 
 
Sf9 cells were seeded in 35mm tissue culture dishes at a density of 1x106 cells/dish 
and were incubated to attach at 28C for 1 hour. Cells were infected at an MOI of 5 
pfu/cell using 100 µl diluted in the relevant culture medium. After 1 hour incubation at 
room temperature, the inoculum was replaced with 2 ml of the relevant medium and the 
dishes were incubated at 28C for 2-3 days. Cells mock infected with medium were 
also included. The virus DNA purification technique used was described by King & 
Possee (1992). 
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Purification of virus DNA from BV 
After 2-3 dpi, the supernatant was harvested and cells removed by centrifugation at 
4,000 rpm for 5 minutes. The supernatant was transfered to a fresh 2 ml 
microcentrifuge tube and BV was pelleted by centrifugation at 13,000 rpm for 15 
minutes. The supernatant was carefully removed and the BV pellet was resuspended in 
100 µl 1x TE buffer. Two and half µl of both 10% (w/v) SDS and 20 mg/ml Proteinase K 
were added and the sample was incubated at 37C for 1 hour. The DNA was extracted 
twice by gently mixing with equal volumes of phenol/chloroform and once with 
chloroform. 0.1 volumes of 3M Sodium acetate and 2 volumes of 100% ethanol were 
added to the sample to precipitate the DNA overnight at -20C. The DNA was pelleted 
by centrifugation (13,000 rpm for 10 minutes) and the supernatant was carefully 
removed. The pellet was air-dried for 5 minutes before the addition of 20 µl 1x TE 
buffer. The sample was either placed overnight at 4C or heated at 65C for 15 minutes 
to aid resuspension of the DNA pellet. The sample was stored at 4C and used for 
restriction digest or PCR analyses.   
Purification of Intracellular virus DNA 
Using the same dish of infected cells, after 2-3 dpi, the cell monolayer was harvested 
and the cells were pelleted by centrifugation (3,000 rpm for 5 minutes). The 
supernatant was carefully removed and the pellet resuspended in 0.5 ml PBS. The 
cells were repelleted and resuspended in 250 µl TE buffer and 250 µl insect cell pellet 
lysis buffer (50 mM Tris pH 8.0, 5% (v/v) β-mercaptoethanol, 0.4% (w/v) SDS, 10 mM 
EDTA). After the addition of 12.5 µl 20 mg/ml Proteinase K and 2.5 µl RNAseA, the 
sample was incubated at 37C for 30 minutes. After this incubation, the DNA was 
subsequently extracted and precipitated using the method described above  
 
2.3.6c Purification of virus DNA using a Viral Nucleic Acid Kit 
 
An alternative method using the High Pure Viral Nucleic Acid Kit (Roche Applied 
Science) was also used to purify viral DNA from BV, which was carried out using the 
supplier’s instructions. 
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2.3.7 Virus infection of insect larvae 
 
The methodology described by King & Possee (1992) was used to propagate viruses 
and purify their occlusion bodies (OBs). Viral infection of the larvae was carried out in 
plastic tubs (8 cm diameter, 6 cm height) containing 22 ml of semi-artificial diet 
(modified Hoffmans Tobacco Hornworm diet; Hunter et al., 1984). A Gilson pipette was 
used to apply 200 l purified OBs (concentrations between 103 and 106 OBs/l) to the 
surface of the diet and evenly spread out across the diet using a plastic disposable 
spreader. After the inoculum had air dried at room temperature, 10 late-third or early 
fourth instar T. ni larvae were placed into each tub and approximately 2 cm slit placed 
in the lid to allow ventilation. The infected larvae were kept at room temperature in 
normal illumination.  
The diet plug method described by King & Possee (1992), was also used to infect 
larvae. Diet plugs approximately 1 mm2 were placed into 96-well micro titre plate, which 
had been inoculated with 1 l dilution of OBs (concentrations between 100 and 103 
OBs/l). An early third instar larvae was placed in each well and tissue paper spread 
with MilliQ water was placed over the wells before replacing the lid. The insects were 
incubated overnight at room temperature and those larvae that had consumed the 
contaminated diet were transferred to small individual plastic containers (poly-pots) 
using soft, blunt forceps. These poly-pots contained sufficient diet to support the larvae 
for the remainder of their feeding period. A control group of larvae that were treated 
identically but had 1 l of MilliQ water applied to each diet plug in place of the OB 
suspension 
 
2.3.8 BV injection in vivo 
 
Early fourth instar T. ni larvae were injected with 1 l BV (105 and 106 BV/l) in their 
haemocoels using a micro-applicator fitted with a syringe and a BD Microfine u100 
8mm/30G 0.3 ml needle (Westons Internet). Injected larvae were then incubated at 
room temperature in individual poly-pots and checked daily for signs of infection.  
 
2.3.9 Purification of OBs from virus-infected larvae 
 
The virus-infected larvae were stored at -20C and thawed at room temperature on the 
day of purification before purifying OBs using the method described by Harrap et al. 
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(1977). The larvae were placed into a stomacher bag with 5 ml 0.1% (w/v) SDS and 
macerated into a smooth paste using a p1000 Gilson tip to disrupt the insect. This 
extract was filtered into a 50ml conical flask through two layers of muslin and 0.5 ml of 
0.1% (w/v) SDS was used to wash any remaining extract through the muslin. The 
extract was then centrifuged at 4500 rpm, 20C for 30 minutes (TY-JS 4.2 rotor, J6-MI 
Beckman centrifuge). After the supernatant fraction had been carefully removed, the 
pellet was re-suspended in a small volume of 1x TE buffer.  
The extract was loaded onto a 50/60% (w/v) sucrose step gradient in ultraclear tubes 
(25 x 89 mm Beckman). An overlay of liquid paraffin was added and samples were 
centrifuged at 24,000 rpm, 4C for 1 hour (SW40 Ti rotor, Optima LE-80K Beckman 
Ultracentrifuge). After centrifugation, the purified OBs were retrieved from the sucrose 
interface. The OBs were diluted with 10 volumes of 1x TE buffer, and centrifuged for 
10,000 rpm for 30 minutes at 4C (SW40 Ti rotor, Optima LE-80K Beckman 
Ultracentrifuge). The pellet was re-suspended in 1-2 ml TE buffer, depending on size of 
pellet, and stored at 4C. 
  
2.3.9a Purification of OBs from single infected larvae 
 
The OBs from a single virus-infected larva were also purified using the following 
method.  The ‘V-shaped’ base was removed from a 0.5 ml microcentrifuge tube using a 
heated scalpel and melted onto two layers of muslim to form a filter. This modified 
microcentrifuge tube was placed into a 2 ml microcentrifuge tube and loaded with 
extract from a single larva, which had been vortexed in 500 l 1x TE buffer for 1 
minute. The filter was t centrifuged in a bench-top centrifuge at 13,000 rpm, 20C for 1 
minute. The filtrate was layered onto 300 l of 30% (w/v) sucrose, in a 1.5 ml 
microcentrifuge tube and centrifuged at 13,000 rpm for 5 minutes. The supernatant was 
removed and the pellet re-suspended in 150-300 l dH2O. 
 
2.3.10 Enumerating OBs from infected larvae 
 
A diluted sub-sample of the OB suspension was placed into the wells of a C-chip 
haemocytometer (Labtech) and left to settle for 10 minutes. OBs were counted under 
light microscope phase-contrast objective at X400 magnification, and the concentration 
of the original suspension was then calculated. 
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2.3.11 Bioassays 
 
Bioassays were carried out using third instar larvae inoculated with a range of OB 
doses. Individual larvae were incubated overnight with a diet plug inoculated with a 
defined number of OBs (100, 101 102 or 103 OBs). If the diet-plug had been eaten by the 
larvae after 24hpi, then they were transferred to fresh diet, incubated at room 
temperature and monitored four times a day for viral death. The highest OB dose (104 
OBs) was droplet fed to the larvae within a disposable plastic petri dish. Once the larva 
had finished feeding it was transferred to fresh diet, incubated at room temperature and 
also monitored four times a day.   
 
2.3.11a Statistical analysis of Bioassay data 
 
Bioassay data was analysed using chi-square analysis (Microsoft Office Excel 2007) 
and Probit analysis (PoloPlus, LeOra Software), which were used to compare oral 
infectivity between viruses. The values for lethal dose (LD50 and LD90) were determined 
by linear regression and two-tailed student t-test was used to analysis the survival 
times between viruses. 
 
2.4 Microscopy Methods 
 
2.4.1 Laser scanning confocal microscopy of fixed cells 
 
For confocal microscopy, TN368 cells were seeded at 2.5x106 cells per 35mm tissue 
culture dish, which contained a glass coverslip (No. 0 thickness 22 mm diameter, 
Scientific Laboratory Supplies Ltd). The cells were allowed to settle for 1 hour at 28C, 
before being infected at a MOI of 5 pfu/cell. Infections were carried out with virus 
diluted in the relevant culture medium, in a final volume of 100 µl. After 1 hour 
incubation at room temperature, the virus inoculum was replaced with 2 ml of the 
relevant medium and the dishes were incubated at 28C for the required time. Mock 
infected samples comprised cells treated identically with 100 µl of medium containing 
no virus. 
The TN368 cells growing on the coverslips were chemically fixed using 
paraformaldehyde (Thermo-Scientific) at the required time post-infection. This was 
carried out by first washing the cells once or twice with 2 ml of PBS before treating 
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them with 1 ml 4% (v/v) paraformaldehyde for 1 hour. The fixed samples were then 
washed with 1 ml PBS and stored at 4C in 2 ml PBS. 
Immunofluorescence staining was performed on the fixed samples by first washing 
them with 1 ml PBS, before permeabilising the cells with a 10 minutes treatment of 
PBS-BSA (PBS containing 1% (w/v) bovine serum albumin (Sigma-Aldrich)) containing 
0.1% (v/v) Triton X-100. The samples were then washed twice with 2 ml PBS and 
followed by two washes with 2 mls of PBS-BSA blocking solution. The samples were 
then incubated at room temperature with the primary antibody (Table 2.3) at the 
relevant dilution in 100 µl of PBS-BSA. After this incubation the samples were then 
washed three times with 2 ml of PBS-BSA, before treatment with the diluted secondary 
antibody (Table 2.3) in 100 µl of PBS-BSA for 45 minutes. Samples were then finally 
washed five times with 2 ml of PBS-BSA and mounted onto microscopy slides with 
Vectashield (Vector Laboratories), a glycerol-based mounting media containing the 
DNA stain 4’,6-diamidino-2-phenylindole (DAPI). The slides were then sealed with clear 
nail-vanish and stored protected from light at 4C.  
Table 2.3 Antibodies used for Laser scanning confocal microscopy 
Antibody target Antibody source 
species 
Working Dilution 
(Immuno-fluorescence) 
anit-6xHis-tag Mouse 1:1000 
anti-mouse IgG conjugated to 
TRITC 
Goat 1:64 
 
The samples were visualised within a month of staining on a confocal laser scanning 
microscopy (Zeiss LSM 510 META confocal system mounted on an Axio Imager-Z1 
upright microscope). The Zeiss LSM 510 image acquisition software was used to 
acquire the images and Zeiss LSM Image browser was used to label the images. 
2.4.2 Electron microscopy of OBs 
 
The OBs purified from a single virus-infected larva (section 2.3.9a), were used in the 
electron microscopy (EM) studies carried out in this thesis. The dH2O was removed 
from the OB pellets and replaced with the primary fixative (2% (w/v) paraformaldehyde, 
2% (v/v) glutaraldehyde solution in cacodylate buffer (0.1 M NaCl, 0.05 M cacodylate 
pH 7.5)). The samples were incubated at room temperature for 1.5 hour. The samples 
were washed four times for 10 minutes at room temperature in 1 ml cacodylate buffer. 
The secondary fixative (1% (w/v) aqueous Osmium Tetroxide) was then added and 
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samples incubated for 1 hour at room temperature. The samples were washed four 
times for 10 minutes at room temperature in 1 ml ultra-pure water. Samples were 
stained overnight at 4C in 500 µl 0.5% (w/v) aqueous uranyl acetate and following the 
incubation washed two times for 10 minutes at room temperature in 1 ml ultra-pure 
water. The samples were then dehydrated through a series of 20-100% ethanol 
washes, before being embedded in Spur resin (Taab Laboratories). Ultra thin sections 
were obtained using PT-PC PowerTome Ultramicrotomes (RMC) and subsequently 
stained with filtered 0.5% (w/v) aqueous uranyl acetate and lead citrate. The sections 
were then washed in ultra-pure water and dried, before images were obtained using a 
Hitachi H7650 electron microscope.   
 
2.5 Bacteria methods 
The Escherichia coli (E. coli) strains used within thesis are shown in Table 2.4 
Table 2.4 E. coli strains used in this thesis1 
Bacteria Name Strain 
DH5  
 
F- φ80lacZΔM15 Δ(lacZYA-argF) U169 
recA1 endA1 hsdR17 (rk-, mk+) phoA 
supE44 λ- thi-1 gyrA96 relA1 
DH10B F- mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacX74 recA1 endA1 
araD139 Δ (ara, leu)7697 galU galK λ- 
rpsL nupG /pMON14272 / pMON7124 
 
Top 10  
 
F- mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacΧ74 recA1 araD139 
Δ(ara-leu) 7697 galU galK rpsL (StrR) 
endA1 nupG λ- 
1
E. coli strains used in this study were purchased from Invitrogen 
 
2.5.1 Preparation of chemically competent E. coli cells 
 
A 10 ml Luria Broth (LB, 10g bactotryptone, 5g NaCl and 5g yeast extract in 1 litre of 
deionised water, sterilised by autoclaving) culture was set up by picking a single colony 
from a fresh plate of E. coli cells. This culture was incubated overnight at 37C with 
shaking (200 rpm). 1ml of this overnight culture was then used to inoculate 100 ml of 
LB, which was grown at 37C with shaking until it reached a cell density corresponding 
to 0.4-0.5 spectrophotometer reading at OD650. The culture was then chilled on ice for 
30 minutes, before the cells were pelleted by centrifugation in a pre-chilled rotor at 
4000 g for 15 minutes (TY-JS 4.2 rotor, J6-MI Beckman centrifuge). The cell pellet was 
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then resuspended in ice-cold 0.1 M CaCl2 and chilled on ice for 1 hour. The cells were 
then re-pelleted by centrifugation at 4000 g for 30 minutes (TY-JS 4.2 rotor, J6-MI 
Beckman centrifuge). This final pellet was resuspended in a small volume of ice-cold 
0.1 M CaCl2, 15% glycerol, to allow aliquots of 500 l into 0.2 ml microcentrifuge tube 
to be dispensed and stored at -70C. 
 
2.5.2 Preparation of chemically competent E. coli cells – Inoue method 
 
A 5 ml LB culture was set up by picking a single colony from a fresh plate of E. coli 
cells and this culture was incubated for 6-8 hours at 37C with shaking (200 rpm). 
Varying volumes of this culture was then used to inoculate three flasks containing 250 
ml of SOB media (20 g tryptone, 5 g yeast extract and 0.5 g NaCl in 1 litre of deionised 
water after pH adjusted to 7.0; sterilised by autoclaving). These starter cultures were 
then grown overnight at 18C with shaking. When one of the cultures had reached a 
cell density corresponding to 0.55 spectrophotometer reading at OD600, it was then 
chilled on ice for 30 minutes. Before the cells were pelleted by centrifugation in a pre-
chilled rotor at 2500 g for 10 minutes (TY-JS 4.2 rotor, J6-MI Beckman centrifuge). The 
cell pellet was then resuspended in 80 ml ice-cold Inoue buffer (55 mM MnCl2, 15 mM 
CaCl2, 250 mM KCl, 10 mM PIPES (pH 6.7)) and the cells were then re-pelleted by 
centrifugation. The final pellet was resuspended in 10 ml Inoue buffer and 750 µl 
DMSO. Aliquots of 500 l were dispensed into 0.2 ml microcentrifuge tube and flash 
frozen in either liquid nitrogen or ethanol dry-ice bath. These aliquots were then stored 
at -70C. 
 
2.5.3 Transformation of competent E. coli cells with plasmid DNA 
 
Competent E. coli cells (sections 2.5.1/2.5.2) were thawed on ice and 50 µl mixed with 
2-3 µl of a ligation reaction or 10 ng of vector DNA. This mixture was cooled on ice for 
15 minutes before being heat shocked for 45 seconds at 42C. One ml SOC media 
was then added to the mixture and incubated at 37C for 1 hour. Cell aliquots of 100 l 
were dispensed across separate plates of LB-agar containing the appropriate 
antibiotic(s) (Table 2.5) and spread across the surface using plastic disposable 
spreaders. The plates incubated at 37C overnight. 
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Table 2.5 Antibiotics used in bacteria cultures 
Antibiotic Stock  Working 
solution 
(Plasmids) 
Working 
solution 
(Bacmids) 
Ampicillin 50 mg/ml in dH2O 50 µg/ml N/A 
Kanamycin 30 mg/ml in dH2O 50 µg/ml 15 µg/ml 
Tetracycline 10 mg/ml in 75% (v/v) 
ethanol 
3 µg/ml N/A 
Chloramphenicol 30 mg/ml in ethanol N/A 15 µg/ml 
 
2.5.4 Preparation of electrocompetent E. coli cells containing pRedET 
 
A 10 ml LB culture containing Tetracycline (3 μg/ml; LB-Tet) was established by picking 
a single colony from a fresh plate of E. coli cells containing the pRedET plasmid (Gene 
Bridge). This culture was incubated overnight at 30C with shaking (200 rpm). Five ml 
of this overnight culture was used to inoculate 400 ml of LB-Tet, which was grown at 30
C with shaking until it reached a cell density corresponding to 0.3 spectrophotometer 
reading at OD600. Once at this density, 15 ml 10% (w/v) L-arabinose was added to the 
culture and placed at 37C with shaking for 1 hour. This induced the expression of 
recombination proteins from the pRedET vector. The cells were pelleted by 
centrifugation in a pre-chilled rotor at 4000 rpm for 15 minutes (TY-JS 4.2 rotor, J6-MI 
Beckman centrifuge). The cell pellet was resuspended in 200 ml of ice-cold dH2O and 
the cells were re-pelleted. After this the cell pellet was resuspended in 100 ml of ice-
cold dH2O and re-pelleted, this stage was repeated. The cell pellet was resuspended in 
15 ml ice-cold 10% (v/v) glycerol and re-pelleted. This final pellet was resuspended in a 
small volume of ice-cold 10% (v/v) glycerol, to allow aliquots of 500 l to be dispensed 
into 0.2 ml microcentrifuge tube and stored at -70C.  
The preparation of electrocompetent E. coli cells that did not harbour the pRedET 
vector was also carried out. In these preparations, the appropriate antibiotic was used 
and the cultures were grown at 37C with shaking until they reached a cell density 
corresponding to 0.4-0.5 spectrophotometer reading at OD600. Subsequent pelleting 
and washes with ice-cold dH2O were performed as described above. 
 
2.5.5 Electroporation of competent E. coli cells 
 
The competent E. coli cells (section 2.5.4) were thawed on ice and 40 µl mixed with 3-5 
µl PCR product or 1 ng of vector DNA. This mixture was added to a 1 mm cuvette 
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(Geneflow) and chilled on ice for 10 minutes prior to electroporation. Transformation 
was achieved using a Bio-Rad Gene Pulser II (BIO-RAD) or Electroporator 2510 
(Eppendoff) according to the manufacturers’ protocols. Immediately after 
transformation 1 ml SOC medium was added to the cuvette, to allow transfer of the 
cells from the cuvette to 15 ml tube. The cells were then incubated at 37C for 1 hour, 
after which 100 l cell aliquots were dispensed into separate plates of LB-agar 
containing the appropriate antibiotic(s) and spread across the surface using plastic 
disposable spreaders. The plates were incubated at 37C overnight. 
 
2.5.6 Plasmid DNA purification from E. coli cells 
 
Depending on the quantity of plasmid DNA required a QIAprep Spin Miniprep Kit, 
QIAGEN Plasmid Midi Kit or QIAGEN Plasmid Maxi Kit was used and the procedure 
carried out as described in the supplier’s instructions (QIAGEN).  
For bacmid DNA an adapted version of the Miniprep Kit QIAGEN protocol was used. 
Briefly, the bacterial culture was treated as described in the QIAGEN protocol but at 
step five the clear supernatant was transferred to a fresh tube containing 0.7 vol 
isopropanol, to precipitate the DNA. The sample was inverted to mix and centrifuged at 
13,000 rpm for 30 minutes at 4C (J-25.5 rotor, Avanti J-25i Beckman centrifuge). 
Immediately the supernatant was removed and 500 µl 70% (v/v) ethanol was added to 
the pellet before being centrifuged at 13,000 rpm for 5 minutes at 4C (J-25.5 rotor, 
Avanti J-25i Beckman centrifuge). This wash was repeated and the final pellet was left 
to air dry for 15 minutes. The bacmid DNA pellet was re-suspended in 30 l TE buffer. 
 
2.5.7 Purification of large quantities of bacmid DNA using caesium 
chloride 
 
For bacmid DNA, an adapted version of the Miniprep Kit QIAGEN protocol by R. D. 
Possee was used.  
A 5 ml LB culture containing chloramphenicol at 25 μg/ml (LB-Cm) was set up by 
picking a single colony from a fresh plate of E. coli cells. This culture was incubated 
overnight at 37C with shaking (200 rpm). 0.2 ml of this overnight culture was then 
used to inoculate 200 ml of LB-Cm, which was grown at 37C with shaking overnight. 
The cells were pelleted at 4200 rpm for 20 minutes at 4C (TY-JS 4.2 rotor, J6-MI 
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Beckman centrifuge). The supernatant was removed and the cell pellet resuspended in 
20 ml Qiagen buffer P1 (containing RNase A 100 μg/ml). 40 ml Qiagen Buffer P2 was 
added and the tube was inverted several times to gently mix the samples. Finally, 30 
ml chilled Qiagen Buffer P3 was added, the tube was mixed as before and incubated 
on ice for 20 minutes. The sample was then centrifuged at 4200 rpm for 30 minutes at 
4C (TY-JS 4.2 rotor, J6-MI Beckman centrifuge). The supernatant was filtered through 
Whatman paper to remove any remaining precipitate. The DNA was precipitated by the 
addition of 100 ml isopropanol. The sample was then centrifuged at 4200 rpm for 60 
minutes at 4C (TY-JS 4.2 rotor, J6-MI Beckman centrifuge). The supernatant was 
carefully removed and the pellet was gently resuspended in 5 ml 70% (v/v) ethanol. 
The sample was transferred to a 15 ml Oakridge tubes and centrifuged at 12,000 rpm 
for 10 minutes at 4C (J-25.5 rotor, Avanti J-25i Beckman centrifuge). The supernatant 
was carefully removed and the pellet allowed to air-dry for 5-10 minutes. 0.7 ml 1x TE 
buffer was added to the pellet and stored overnight at 4C to aid resuspension of the 
DNA pellet.  
The DNA pellet was re-suspended and layered onto a 5 ml cushion of 50 % (w/w) 
caesium chloride containing 0.5 µg/ml ethidium bromide. An overlay of liquid paraffin 
was added and samples were centrifuged at 35,000 rpm, 20C for 1 hour (SW40 Ti 
rotor, Optima LE-80K Beckman Ultracentrifuge). The bacmid DNA was harvested, 
loaded onto a second gradient and centrifuged again. The bacmid DNA was harvested 
and ethidium bromide was extracted from the sample with water saturated butanol. The 
bacmid DNA was dialysed against 500 ml TE stirring at 4C in the dark for 2-4 days. 
The TE was replaced every 24 hours and once the DNA was harvested, it was stored 
at 4C. The concentration and quality of the bacmid DNA was then determined by 
spectrophotometric measurements and restriction enzyme analysis (section 2.6.1).  
 
2.5.8 Red/ET recombination system 
 
The Red/ET recombination system (Gene Bridge) was used to generate deletion 
mutant bacmids. The supplier’s instructions were carried out with alterations given in 
sections 2.5.4 and 2.5.5. 
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2.5.9 Bacmid transfection of insect cells 
 
Sf9 cells were transfected with bacmid DNA (100 ng) alone or bacmid DNA (100 ng) 
plus plasmid DNA (500 ng) using the liposome-mediated transfection method 
(LipofectinTM, Invitrogen) as described by King & Possee (1992). Subsequent steps 
were performed as described in sections 2.3.3 and 2.3.3a.  
 
2.6 Molecular Biology Methods 
 
2.6.1 Restriction enzyme digestions of DNA 
 
Restriction endonucleases (RE) were purchased from New England Biolabs, apart from 
SrfI, which was purchased from Stratagene. The DNA (plasmid, bacmid and virus) 
concentration was determined spectrophotometrically and was digested using a variety 
of standard restriction enzymes methods as described in the supplier’s instructions. 
Digests were performed in 1.5 ml microcentrifuge tubes in a total volume of 25-50 µl 
and incubated at 37C for 1-4 hours.  
 
2.6.2 Dephosphorylation of DNA 
 
Following the purification of restriction enzyme digested vector DNA (section 2.6.1), 
Shrimp Alkaline Phosphatase (SAP, Promega) was added to the sample (1 U/µg DNA) 
along with Shrimp Alkaline Phosphatase buffer and incubated at 37C for 15-30 
minutes. After this incubation, the SAP was heat-inactivated at 65C for 15 minutes.  
 
2.6.3 Ligation of DNA 
 
Ligation reactions were carried out using 50 ng of plasmid vector DNA (SAP and non-
SAP treated) with varying concentrations of inserts, using molar ratios of vector DNA: 
insert DNA of 1:1, 1:3 and 3:1. Reactions were carried out using T4 DNA ligase (New 
England Biolabs) as described in the supplier’s instructions, at room temperature for 1 
hour. 
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2.6.4 Agarose gel electrophoresis 
 
Horizontal agarose gels were routinely carried out to allow the estimation of DNA 
concentrations and visualisation of restriction enzyme profiles. The concentration of 
High gelling temperature agarose (Lonza) varied from 0.6% to 1% (w/v) depending 
upon the sizes of the DNA fragments to be separated. Submerged gel electrophoresis 
was performed in 1x TAE buffer (Tris-Acetate 40 mM, EDTA 1 mM) containing 0.5 
g/ml ethidium bromide. Prior to electrophoresis, samples were mixed with 1:5 volumes 
of 5x loading buffer (40% sucrose, 5x TAE, 2.5% SDS, 0.1% bromophenol blue dye). 
Electrophoresis separations were performed at 25-100 volts (V) for 1 to 18 hours as 
required. Following electrophoresis, DNA was both visualised and documented using a 
UV transilluminator (Ingeneous system supplied by Syngene Bio imaging Ltd). 
 
2.6.5 Isolation of DNA from agarose gels 
 
The 1% (w/v) low gelling temperature agarose (Lonza) gels containing ethidium 
bromide (0.5 g/ml) were used to separate DNA fragments during electrophoresis in 1 
x TAE buffer at 50V. The DNA was visualised under UV light and the required 
fragments excised from the gel, using a sterile scalpel.  The DNA was purified from the 
gel using a QIAquick Gel Extraction Kit (QIAGEN), as described by the supplier.  
 
2.6.6 Polymerase chain reaction (PCR) 
 
Synthetic oligonucleotides were designed by the author and synthesised by Eurofins 
MWG Operon. They were supplied as freeze-dried pellets, which were re-suspended in 
dH2O to give a stock concentration of 100 pmol/μl and stored at –20C. 
Reactions were performed using a RoboCycler gradient 96 (Stratagene) PCR machine. 
The 50 l reaction mixture consisted of 0.8 pmol each of the forward and reverse 
primers, with approximately 10 ng of DNA, 100 nM dNTPs, 2.5 mM MgCl2 and 2.5 
Units DNA polymerase. Taq DNA polymerase and supplied buffer purchased from New 
England Biolabs was used for general PCR purposes. Expand DNA polymerase and 
supplied buffer purchased from Roche Applied Science was used when greater fidelity 
was required. All PCR amplifications included a negative control that contained MilliQ 
water in place of template DNA in the reaction mix. 5 l of each reaction was then 
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analysed by agarose gel electrophoresis (section 2.6.4), to identify a successful 
reaction.  
 
2.6.7 TOPO and pGEM-T cloning of PCR fragments. 
 
The PCR generated fragments with either Taq or Expand DNA polymerase were 
cloned into either the TOPO-TA vector (Invitrogen) or pGEM-T (Promega). The ligation 
reactions were carried out as described in the supplier’s instructions. 
 
2.6.8 DNA sequencing  
All DNA sequencing was outsourced to Geneservice, Oxford or CEH, Wallingford. The 
free software developed by Geospiza Inc, Finch TV (http://www.geospiza.Com 
/index.shtml) was used to visualise and analyze sequence data.  
 
2.6.9 Generation of Oligonucleotide fragments 
 
Reactions were performed using a RoboCycler gradient 96 (Stratagene) PCR machine. 
The 100 l reaction mixture consisted of 10 ul 10x T4 DNA ligase buffer (NEB), 70 µl 
dH2O and 10 µl each of the forward and reverse primers to give a final concentration of 
0.1 µg/µl:  
The reaction was placed at 95C for 3 minutes to denature the DNA. After 3 minutes, 
the heat block is switched off and allowed to cool to room temperature. This allows the 
primers to anneal and form the oligonucleotide fragment. 
After this the DNA was extracted twice by gently mixing with equal volumes of 
phenol/chloroform and once with chloroform. Ten µl 3M Sodium acetate and 200 µl 
100% ethanol were added to the sample to precipitate the DNA. The DNA was pelleted 
by centrifugation in bench centrifuge at 13,000 rpm for 5 minutes and washed twice in 
75% (v/v) ethanol. The pellet was air-dried for 5 minutes before being resuspended in 
40 µl 1x TE buffer and stored at -20C. The DNA concentration was determined 
spectrophotometrically and used in ligation reactions (section 2.6.3). 
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2.6.10 Mutagenesis 
 
Mutations were introduced into the AcMNPV pif1 sequence that resulted in either or 
both amino acids 96 (cgt to gcg) and 478 (cgc to gcg) to be changed from arginine to 
alanine. These mutations were synthesized by Advantagen Ltd and provided in 
pBluescript.  
 
2.7 Protein Analysis 
 
2.7.1 SDS-PAGE analysis of protein samples 
 
Protein samples were analysed by standard sodium dodecyl sulphate polyacryamide 
gel electrophoresis (SDS-PAGE) as described in Sambrook and Russell (2001). 
Samples to be run on a SDS-PAGE were first quantified using the Qubit system 
(Invitrogen) as described in the supplier’s instructions. After the quantification, 1/5th 
volume of 6X Laemmli SDS-PAGE loading buffer (250mM Tris-HCl ph 6.8, 10% (w/v) 
sodium dodecyl sulphate (SDS), 50% (v/v) glycerol, 0.05-0.5% (w/v) bromophenol blue 
and 25% (v/v) β-mercaptoethanol, which was added just before use) was added to the 
sample. The samples were boiled in a waterbath for 5 minutes and centrifuged to 
remove any insoluble matter (13,000 rpm, 5 minutes). Samples were run on 12% SDS-
PAGE gels using the mini-PROTEAN vertical gel electrophoresis system (Bio-Rad). 
The SDS-PAGE gels were either Coomassie stained or blotted onto nitrocellulose 
membranes (Section 2.7.2). 
For Coomassie staining, the gels were placed in 0.25% (w/v) Coomassie Brilliant Blue 
R-250 dissolved in; 50% (v/v) methanol, 10% (v/v) glacial acetic acid, for 4 or more 
hours. The gels were destained for 2 or more hours using 30% (v/v) methanol, 10% 
(v/v) glacial acetic acid. Images of the gels were taken using a digital camera, before 
they were dried between two sheets of cellophane using small amount of gel drying 
buffer (40% (v/v) methanol, 10% (v/v) glycerol, 7.5% glacial acetic acid) and plastic 
frame system (Promega).  
 
2.7.2 Western blot analysis of proteins 
 
Proteins were transferred from the SDS-PAGE (section 2.7.1) onto nitrocellulose 
membrane using the Trans-Blot SD semi-dry transfer cell system (Bio-Rad) as 
instructed by the manufacturer. Once the proteins had been transferred, the membrane 
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was washed in blocking buffer (PBS-T (PBS, 0.1% (v/v) Tween 20) with 5% (w/v) 
skimmed milk powder) for 1 hour at room temperature with rotation. The membranes 
were incubated for another hour rotating in 5-10 ml blocking buffer containing the 
primary antibody (Table 2.6) at the desired concentration. Membranes were washed 
four times for 15 minutes at room temperature with rotation in 10 ml PBS-T. The 
membranes were subsequently incubated for 1 hour, rotating in 10 ml blocking buffer 
containing the alkaline phosphatase conjugated secondary antibody (Table 2.6) at the 
desired concentration. Membranes were washed four times for 15 minutes at room 
temperature, with rotation in 10 ml PBS-T. 10 ml alkaline phosphatase buffer (100mM 
Tris-HCl pH 9.5, 100 mM NaCl, 5mM MgCl2) containing 66 µl Nitro blue tetrazolium 
(stock concentration at 50 mg/ml in 70% (v/v) DMF) and 33 µl 5-Bromo-4-chloro-3-
indolyl phosphate p-toluidine salt (stock concentration at 50 mg/ml in dH2O) was added 
to the membranes to visualise any bound alkaline phosphatase conjugated antibody. 
The development was stopped by washing the membrane with dH2O three times and 
leaving it to air-dry.  
Table 2.6 Antibodies used for Westerm blotting 
Antibody target Antibody source 
species 
Working Dilution 
(Western blotting) 
anit-6xHis-tag Mouse 1:1000 
Anti-VP39 (AcMNPV) Mouse 1:500 
Anti-uPA (Urokinase) Mouse 1:1000 
anti-mouse IgG conjugated to 
alkaline phosphatase 
Goat 1:30,000 
 
2.7.3 Enzyme activity assays 
 
Samples from the time course studies (section 2.3.5) were harvested from shaker 
cultures and the cells were pelleted by centrifugation in a bench centrifuge at 6,000 
rpm for 5 minutes. The supernatant fractions were carefully removed to 1 ml 
microcentrifuge tubes and stored at 4C, whereas the cell pellets were stored at -20C 
until used in the activity assays. 
 
2.7.3a β-galactosidase activity assay 
 
The cell pellets and 2x assay buffer (200 mM sodium phosphate buffer (pH 7.3), 2 mM 
MgCl2, 100 mM β-mercaptoethanol, 1.33 mg/ml ONPG) were thawed at room 
temperature on the day of the assay. The cell pellets were resuspended in 100µl of 
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Reporter Lysis Buffer (RLB, Promega) and incubated at room temperature for 15 
minutes. The samples were then vortexed briefly and cell debris was pelleted by 
centrifugation in bench centrifuge at 13,000 rpm for 2 minutes. Supernatants were 
carefully transferred to new 0.5 ml microcentrifuge tubes and serial log dilutions (10-3 to 
10-5) were set up for each sample to be tested in RLB. Triplicate 90 µl of each dilution 
were then added to separate wells in a 96 well plate along with 90 µl of 2x assay 
buffer. A negative control 90 µl RLB and known standards were also performed. The 
reaction was incubated at 37C for 30 minutes and stopped after this incubation by the 
addition of 300µl 1M Sodium carbonate. The absorbance of each well at 420 nm was 
then read using am ELx808 ultra microplate reader (Biotek). The standards were used 
to plot a standard curve to allow the conversion of the samples from wavelength 
readings into β-galactosidase activity after the removal of the negative control value.  
 
2.7.3b Urokinase activity assay 
 
Urokinase activity assay was performed on time course study samples using uPA 
activity assay kit, which was carried out using the supplier’s instructions (Millipore). 
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3.1 Introduction 
 
Baculoviruses are found in two forms. The budded virus (BV) form buds from infected 
cells and is involved in spreading the infection between cells and tissues in the host 
larvae. The initial infection of larvae and subsequent horizontal transmission of 
baculoviruses between hosts is mediated by the oral route using the second form, the 
occlusion-derived viruses (ODVs), which are found embedded in polyhedra. Both the BV 
and ODV forms contain nucleocapsids (NC) that are comprised of many similar proteins, 
however, the genome within these nucleocapsids is identical for both forms. The 
differences between the BV and ODV become apparent when the membrane envelopes 
are examined, showing variation in both protein and lipid content as described in Chapter 
1 (section 1.3.12).  In the exploitation of baculoviruses (largely AcMNPV) as expression 
vectors (section 1.4), only the BV form of the virus is required for propagation of 
recombinant viruses in cell culture.  It could be considered that production of ODV in 
recombinant virus-infected cells is a waste of limited cellular resources that might 
otherwise be directed into either BV or recombinant protein synthesis. One of the longer 
term aims of this project is to identify and delete ODV-specific genes to abrogate or at 
least limit ODV production and determine, if in doing so, the yield of recombinant protein 
can be increased. 
The first stage, however, was to identify putative ODV genes that could be deleted from 
the virus genome without affecting the ability of the virus to replicate in cell culture. 
 
3.2 Structural proteins of the occlusion derived virus  
 
The ODV envelope contains a wide range of viral proteins and is more diverse than the 
BV envelope. These proteins are transported to the ODV envelope by unique 
mechanisms and are mostly non-glycosylated. Eight putative gene deletion targets were 
selected for further study (Table 3.1) from the data collected on ODV proteins (Table 3.2). 
Recent proteomic investigations and reviews of the baculovirus ODV have been published 
(Braunagel et al., 2003; Slack and Arif, 2007; Rohrmann, 2011) and together with 
information from publications on specific ODV proteins, Table 3.2 was compiled showing 
all known structural proteins of the ODV.   
The target genes were selected because they encoded structural components of the ODV 
that were not found in the BV (using the literature available at the start of this thesis) and 
thus were predicted to have no effect on BV production in cell culture. The targeted genes 
have been listed in Table 3.1 and are individually reviewed in the following sections. 
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Table 3.1 Target structural proteins of the AcMNPV occlusion-derived virus 
orf Name 
Predicted  
aa 
Proposed 
ODV 
localization  Comments mass(kDa) 
46 ODV-E66 79 704 Envelope 
Interacts with ODV-E25 and possibly involved in 
ODV capsid envelopment – Deletion mutant had no 
effect on BV production.  
79 12.1 kDa 12.2 104 Nucleocapsid 
Very similar to UvrC intron encoded nucleases, 
bacterial protein involved in DNA repair after UV 
damage  
88 CG30 30.1 264 Nucleosome 
Possibly a ubiquitin ligase due to it being a ring 
finger protein which could catalyze the ubiquitination 
and destruction of p53 – but experimental work was 
inconclusive for CG30 ubiquitin ligase activity. 
Deletion mutants produced more BV and were more 
infectious orally. 
96 ODV-E28 19.8 173 Envelope 
One of the 31 core baculovirus genes, Located to 
the ODV envelope and essential for oral infection 
109 ODV-EC43 44.8 390 Nucleocapsid 
Located both to the ODV nucleocapsid and 
envelope. 
148 ODV-E56 40.9 376 Envelope 
Essential for oral infection and Over expression 
causes a major decrease in envelopment of ODV.  
22 PIF2 43.8 382 Envelope 
Essential for oral infection – binding to the midgut 
cells  
115 PIF3 23 204 Envelope 
Essential for oral infection – not involved in 
binding/fusion to the midgut cells – possibly plays a 
role in translocation of ODV capsid along the 
microvillus 
 
Notes: The table was constructed from four sources (Ayres et al., 1994; Braunagel et al., 2003; Slack & Arif, 2007; 
Rohrmann, 2011).     
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orf Name Alt Name Left Dir Right 
Predicted  
aa pI Motifs 
Proposed ODV 
localization  Comments References MW (kDa) 
14 lef-1   10513 <- 11311 30.8 266 8.8 DNA Bind Nucleosome 
One of the six core baculovirus replication proteins – functions as a primase, allowing DNA 
replication of the lagging strand (Slack & Arif, 2007) 
49 PCNA ETL 39643 <- 40498 28.6 285 5.2 DNA Bind Nucleosome 
DNA replication factor/involved in repair of UV damaged DNA/promote cell cycle shifts into S 
phase – Non-essential but enhances infectivity.  (Slack & Arif, 2007) 
58 6.8 kDa   47574 <- 47745 6.8 57 9.8 Nuclear Nucleosome     
65 DNA pol   52329 <- 55281 114.3 984 8.6 DNA Bind Nucleosome DNA polymerase - One of the six core baculovirus replication proteins (Slack & Arif, 2007) 
66 Desmoplakin 93 kDa 55292 -> 57716 93.9 808 5.3 Topoisomerase Nucleosome 
possibly involved in mediating supercoiling of viral DNA and shows some homology to Type 
I topoisomerases.   (Slack & Arif, 2007) 
67 lef-3   57721 <- 58876 44.6 385 5.1 DNA Bind Nucleosome 
One of the six core baculovirus replication proteins, binds to single stranded DNA, P143 and 
IE-1 (Slack & Arif, 2007) 
70 HCF-1   60110 -> 60980 34.4 290 9.2 Zincfing Nucleosome Required for DNA replication in T. ni and allows oral infection of T. ni larvae. (Slack & Arif, 2007) 
77 VLF-1   63813 <- 64950 44.4 379 9.2 Nuclear Nucleosome 
essential for virus replication, also associated with BV nucleocapsid, during nucleocapsid 
assembly may possibly play a role in processing of the viral genome.  (Slack & Arif, 2007) 
86 PNK/PNL   72131 <- 74213 80.8 694 8.8 NTPBind Nucleosome 
Non-essential - Possibly involved in RNA splicing IE-0, which effects host specificity through 
ratio of IE-0/IE-1 (Slack & Arif, 2007) 
88 cg30   74737 <- 75529 30.1 264 8.8 LeucineZip Nucleosome 
Possibly a ubiquitin ligase due to it being a ring finger protein which could catalyze the 
ubiuitination and destruction of p53 – but experimental work was inconclusive for CG30 
ubiquitin ligase activity. Deletion mutants produced more BV and were more orally 
infections. 
(Thiem and Miller, 
1989) 
92 p33   78699 <- 79476 30.9 259 8.2 p53 binding Nucleosome 
Possibly involved in preventing apoptosis/cell cycle progression due to binding to p53 which 
is involved in apoptosis and cell cycle regulation.  (Slack & Arif, 2007) 
95 helicase p143 80694 <- 84357 143.2 1221 8.4 DNA Bind Nucleosome 
One of the six core baculovirus replication proteins, involved in separating viral DNA during 
DNA replication.  (Slack & Arif, 2007) 
100 p6.9 
basic protein, 
VP12 86712 <- 86877 6.9 55 12.3 Nuclear Nucleosome 
Interacts with DNA through positively charged arginine residues, enabling condensation of 
DNA into nucleocapsid. Interaction believed to be control through phospholation.  (Slack & Arif, 2007) 
133 Alk-exo AN 112560 -> 113817 48.3 419 8.9 DNA Bind Nucleosome 
Alkaline exonuclease – possibly involved in removing aberrant DNA structures from 
condensing DNA, also shown to bind to complex with LEF-3 (Slack & Arif, 2007) 
Table 3.2 Potential structural proteins of the occlusion-derived virus 
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orf Name Alt Name Left Dir Right 
Predicted  
aa pI Motifs 
Proposed ODV 
localization  Comments References MW (kDa) 
147 IE-1   127198 -> 128944 66.9 582 6.1 DNA Bind Nucleosome 
One of the six core baculovirus replication proteins and transcriptional activator of viral 
genes, could possibly be the main reason why IE-1 is found in ODVs to begin transcription 
of early viral genes after unpackaging of the viral genome in the nucleus 
(Kawasaki et al., 
2004) 
89 vp39 capsid 75534 <- 76575 38.9 347 6.2   Capsid Main Structural Protein of Nucleocapsid (Slack & Arif, 2007) 
129 p24 
capsid 
protein 109900 -> 110494 22.1 198 5.8   Capsid Found also in the BV capsid, SpltNPV's P24 believed to be homodimer in ODV   (Slack & Arif, 2007) 
9 p78/83 
ORF1629, 
83/87 5287 <- 6916 60.7 543 5.8 LeucineZip Capsid Base 
Phosphoprotein, nucleates actin polymerisation – possibly involved in translocation into 
nucleus after infection  (Slack & Arif, 2007) 
5 12.4 kDa ORF 4 2779 -> 3106 12.4 109 9.1   Nucleocapsid     
30 54.6 kDa ORF 15 24315 <- 25704 54.7 463 7.6   Nucleocapsid     
39 p43   31078 <- 32167 43.5 363 9.8   Nucleocapsid     
54 vp1054   45222 -> 46317 42.1 365 8.2   Nucleocapsid 
Essential protein which is required for capsid assembly through arrangement of VP39 
monomers   (Slack & Arif, 2007) 
59 8.2 kDa   47882 <- 48089 8.2 69 9.4   Nucleocapsid 
strong homology to ChaB, an E. Coli protein involved in divalent cation transport – possibly 
role for orf59 is Zn2+ transport into capsid which inhibits phospholation of p6.9    (Slack & Arif, 2007) 
74 30.5 kDa   62311 <- 63106 30.6 265 5   Nucleocapsid     
79 12.1 kDa   65290 <- 65602 12.2 104 10.3   Nucleocapsid 
Very similar to UvrC intronencoded nucleases, bacterial protein involved in DNA repair after 
UV damage    
101 BV/ODV-C42 p40 86921 <- 88004 41.5 361 8.2   Nucleocapsid Yeast two-hybrid experiments show interactions with p78/83 and ODV-EC27 
 (Braunagel et al., 
2001) 
102 13.1 kDa   88026 <- 88392 13.3 122 5.3   Nucleocapsid 
Possibly involved in shifting the cell cycle – shows some similarities to Never In Mitosis gene 
A which is a protein involved in cell cycle regulation.    (Slack & Arif, 2007) 
104 vp80 p87 89564 -> 91637 79.9 691 5.4   Nucleocapsid Structural protein only found in NPVs (Slack & Arif, 2007) 
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orf Name Alt Name Left Dir Right 
Predicted  
aa pI Motifs 
Proposed ODV 
localization  Comments References MW (kDa) 
109 ODV-EC43 44.8 kDa 94721 <- 95891 44.8 390 8.5   Nucleocapsid Located both to the nucleocapsid and envelope of ODVs (Fang et al., 2003) 
114 49 kDa   97886 <- 99158 49.3 424 6.9   Nucleocapsid     
132 25 kDa   111873 -> 112530 25.1 219 8.5   Nucleocapsid     
142 49 kDa   123632 -> 125063 55.4 477 8.7   Nucleocapsid Essential for BV production - Required for ODV envelopment and subsequent 
(McCarthy et al., 
2008) 
80 gp41   65607 <- 66834 45.4 409 8.2 O-glyc  Tegument 
Temperature sensitive mutant – prevented nucleocapsids exit from the nucleus therefore 
effected BV production  
(Braunagel and 
Summers, 2007) 
144 ODV-EC27   125357 -> 126227 33.5 290 6 Cyclin Tegument 
Effects cell cycle, by binding to cyclin dependent kinases – binds to cycle kinase 2 which 
causes G2/M phase arrest.   
(Belyavskyi et al., 
1998) 
16 BV/ODV-E26 ORF 1, DA26 13092 -> 13767 25.9 225 10.1   Envelope 
Lacks transmembrane domain - associates with FP25K which possibly gives them a role in 
BV/ODV envelope proteins trafficking (Burks et al., 2007) 
22 Pif2 ORF 6/8 17301 -> 18447 43.8 382 5.1 Transmembrane Envelope 
ORFs 6/8 joined as a larger coding region - Essential for oral infection – binding to the 
midgut cells  (Pijlman et al., 2003) 
23 F-protein ORF 9, ENV 18513 -> 20583 79.9 690 5.3 Transmembrane Envelope 
Fusion protein - BV envelope with host endosomal membranes releasing nucleocapsids for 
initial infection - Accelerates mortality of host 
(Braunagel & 
Summers, 2007) 
46 ODV-E66   36718 -> 38830 79 704 6.3 Transmembrane Envelope 
Interacts with ODV-E25 and possibly involved in ODV capsid envelopment – Deletion 
mutant had no effect on BV production.  (Hong et al., 1997) 
61 FP25K FP protein 48513 <- 49155 22.2 214 9.1   Envelope 
Also found in BV – associates with BV/ODV-E26 which possibly gives them a role in 
BV/ODV envelope proteins trafficking. (Wu et al., 2005) 
83 VP91 p95, p91, p96 67884 -> 70425 96.2 847 4.6 Transmembrane Envelope 
Possibly involved in cross linking virion envelope with nucleocapsid through covalent bonds 
to unknown nucleocapsid protein(s). Also found in BV. 
(Braunagel & 
Summers, 2007) 
94 ODV-E25 p25 79971 -> 80655 25.5 228 5.9 Transmembrane Envelope 
Found also in BV, but more abundant in ODVs – Interacts with ODV-E66 and possibly 
involved in ODV capsid envelopment 
(Hong et al., 1997; Li 
et al., 2006) 
96 ODV-E28 Pif4 84346 -> 84865 19.8 173 4.8 Transmembrane Envelope 
One of the 31 core baculovirus genes, Located to the ODV envelope and essential for oral 
infection (Fang et al., 2009) 
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orf Name Alt Name Left Dir Right 
Predicted  
aa pI Motifs 
Proposed ODV 
localization  Comments References MW (kDa) 
115 Pif3   99182 <- 99794 23 204 4.9 Transmembrane Envelope 
Essential for oral infection – not involved in binding/fusion to the midgut cells – possibly 
plays around in translocation of ODV capsid along the microvillus (Ohkawa et al., 2005) 
119 Pif1   100699 -> 102289 59.8 530 5.6 Transmembrane Envelope Essential for oral infection – binding to the midgut cells  (Kikhno et al., 2002) 
138 p74 Pif-0 119135 <- 121070 73.9 645 4.9 Transmembrane Envelope 
Essential for oral infection, binds to 30kDa insect midgut receptor protein and the central 
transmembrane domain possibly involved in membrane fusion after trysin cleavage. 
(Faulkner et al., 1997; 
Haas-Stapleton et al., 
2004) 
143 ODV-E18   125153 -> 125339 6.6 62 12 Transmembrane Envelope 
Shown to be strongly associated homodimer – produces a chimeric fusion protein or a 
heterodimer called ODV-E35 with ODV-EC27 – Essential for BV production.  
(McCarthy and 
Theilmann, 2008) 
145 11k protein   126299 -> 126530 8.9 77 4.6 Transmembrane Envelope 
Enhances oral infectivity – associated to ORF150 another 11k protein – Also incorporated 
into BV  (Lapointe et al., 2004) 
148 ODV-E56   129008 <- 130136 40.9 376 5.1 Transmembrane Envelope 
Essential for oral infection and Over expression causes a major decrease in envelopment of 
ODV. 
 (Braunagel et al., 
1996; Theilmann et 
al., 1996; Rashidan et 
al., 2002) 
 
150 11k protein   130456 -> 130753 11.2 99 4.6 Transmembrane Envelope 
Enhances oral infectivity – sometimes associated to ORF145 another 11k protein – Possibly 
involved in release of ODVs from OB protein matrix. - Also incorporated into BV  
 (Lapointe et al., 
2004) 
The table was constructed from four key sources (Ayres et al., 1994; Braunagel et al., 2003; Slack & Arif, 2007; Rohrmann, 2011) to create a list of 48 ODV-associated proteins. The putative functions of many of these proteins has been 
analysed in the literature and the results summarised in the comments column. The left and right columns define the end positions of the ORF on AcMNPV genome, Dir column indicates the direction of the transcript(s) from that ORF, aa 
column is the number of amino acids encoded by the ORF from the first ATG codon and ‘pI’ column is the isoelectric point of the protein expressed from the ORF.      
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3.2.1 Occlusion-derived virus structural protein: ODV-E66 
 
The odv-e66 is located in the HindIII E fragment of AcMNPV genome at 36718-38830bp 
(Ayres et al., 1994). Sequence analysis indicated that odv-e66 is 2112 bp and encodes a 
protein of 704 aa with a predicted molecular mass of 79kDa. Alignment of the ODV-E66 
peptide sequence with its homologues in other Type I and II alphabaculovirus shows that 
it is highly conserved among Type I and shares 29% amino acid sequence identity with 
Type II.  From the alignments in Figure 3.1, it can be seen that both the C- and N-termini 
of ODV-E66 Type I and Type II demonstrated large variation, as shown by the shift in the 
transmembrane domain between these homologues.  However, the central domain of 
ODV-E66 shows more conservation with the Type II alphabaculovirus showing ~45% 
amino acid sequence identity compared to an overall ~29% amino acid sequence identity. 
AcMNPV ODV-E66 also shares ~47% amino acid sequence identity when aligned with 
homologues from the betabaculoviruses. In all three alignments, the N-termini of ODV-
E66 homologues show large variation compared to the rest of the peptide sequence.  This 
could suggest that the active part of ODV-E66 is either within the central domain or C-
terminus of ODV-E66 with the N-terminus important in anchoring ODV-E66.  A 
transmembrane region was identified by TMPRED at the EXPASY server and ODV-E66 
also contains an inner nuclear membrane sorting motif (INM-SM) (Braunagel and 
Summers, 2007). The protein has 13 potential N-linked glycosylation consensus 
sequences (Asn-Xaa-Ser/Thr), however, only eight of them were predicted to be 
glycosylated by NetNGlyc 1.0 Server at CBS (Center for biological sequence analysis).  
The N-terminal amino acid sequence is highly hydrophobic and it has been demonstrated 
that the protein is membrane bound at this terminus to the ODV envelope (Hong et al., 
1997). It was demonstrated that 23 amino acids at the N-terminus of ODV-E66 were 
sufficient to transport and localise fusion proteins to discrete locations within the nucleus. 
The results from this study also suggested that ODV envelope proteins could be 
transported back from the endoplasmic reticulum to the nucleus through the outer and 
inner nuclear membrane (Hong et al., 1997). The transportation of ODV-E66 is believed to 
be mediated by another viral protein FP25K, due to deletion mutants of FP25K failing to 
translocate ODV-E66 to inner nuclear membrane vesicles (Rosas-Acosta et al., 2001). 
Internal transmembrane motifs, which are not conserved in position and do not have high 
transmembrane probability scores, are found in some ODV-E66 homologues. ODV-E66 is 
found in all lepidopteran baculoviruses, along with another envelope protein ODV-E25. It 
has been demonstrated by yeast two hybrid and immunoprecipitation experiments that 
these two proteins interact at the exposed C-terminal regions (Braunagel et al., 1999). 
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The same study using the previous technique also showed that ODV-E66 binds to the 
major capsid protein VP39; suggesting strongly that both ODV-E66 and ODV-E25 are 
closely oriented on the inner side of the ODV envelope (Braunagel et al., 1999). Further 
support for this was shown when ODV-E25 remained associated with the nucleocapsid 
and was not completely released from the ODV by NP-40 detergent (Russell and 
Rohrmann, 1997). This could suggest that ODV-E66 and ODV-E25 are involved in ODV 
capsid envelopment. Therefore, if ODV-E66 is oriented inside then no effect on ODV 
attachment or fusion to the midgut would be expected (Russell and Rohrmann, 1997). 
However, evidence against this role has been shown because ODV-E66 can be cleaved 
by trypsins in ODV preparations, and this would indicate that ODV-E66 is exposed at the 
surface (Hong et al., 1994). 
Interestingly, however, yeast two hybrid and immunoprecipitation experiments carried out 
on samples from mutant virus infections that expressed ODV-E66 lacking its N-terminus 
(∆NE66), demonstrated that ∆NE66 interacted with α-adaptin. In Drosophila melanogaster 
midgut plasma membrane, α-adaptin is a marker for endocytosis (Dornan et al., 1997), 
therefore, if this interaction is functionally important, ODV-E66 could function during 
primary infection as a recognition factor for ODV and midgut cells (Braunagel and 
Summers, 2007). During a random screening for peptides that bound to brush border 
membrane vesicles derived from the midgut of Heliothis virescens, two peptides that have 
similarity to ODV-E66 were identified. It was then shown that ODV-E66 could bind to 
whole midgut tissues of H. virescens and during competitive assays between one of these 
peptides identified HV1 and purified AcMNPV ODV a decrease in mortality of the larva 
was seen at lower doses and increased in survival times at the highest doses. Therefore 
this result suggests that ODV-E66 is located on the surface of the ODV envelope and may 
play a role in larva midgut epithelium infection (Sparks et al., 2011b). 
Recently Xiang et al. (2011) constructed deletion mutant virus that did not express the N-
terminal of ODV-E66 and demonstrated that this deletion mutant virus had no affect on BV 
production. However, the LD50 for this deletion mutant virus was 10 times higher than the 
rescued or parental viruses when larva were infected orally, suggesting that ODV-E66 is 
not essential for viral replication but plays an important role in the oral infectivity of 
AcMNPV. A truncated form of ODV-E66 has recently been shown to have enzyme activity 
to catalyze the breakdown of chondroitin sulphate. This linear polysaccharide molecule 
influences development, organ morphogenesis, inflammation and infection by interacting 
with and regulating cytokines and growth signal transductions (Sugiura et al., 2011). 
However, further study is required to understand the role of this enzyme activity in the 
baculovirus replication cycle. 
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3.3.2 Occlusion-derived virus structural protein: ORF79 
 
The orf79 is located between 65290-65602bp on the AcMNPV genome and produces a 
protein of 104 amino acids with a predicted molecular mass of 12.2 kDa, which is believed 
to be associated with the ODV nucleocapsid (Braunagel et al., 2003). However, analysis 
of the promoter sequence of orf79 showed no transcriptional start site motif that is 
normally associated with baculovirus genes upstream of the predicted translational start 
codon.  This could suggest that orf79 is expressed from the gp41 promoter by read 
through. The function of orf79 is unknown but it shares strong homology to a bacterial 
UvrC intron-encoded endonuclease, which is involved in DNA repair after UV damage 
(Aravind et al., 1999). The UvrC intron-encoded endonucleases make incisions on either 
side of the DNA lesion enabling repair of the damaged DNA (Aravind et al., 1999). In the 
bacterial system, the nucleases form part of a complex with ABC-type UvrA ATPases and 
UvrB helicases (Lin et al., 1992; Lin and Sancar, 1992). Therefore this suggests that orf79 
could be a member of the UvrC superfamily of endonucleases and could play a role in UV 
damage repair of the baculovirus genome. It is possible that AcMNPV could have 
acquired orf79 from a bacteria or another insect virus, as there is an orf79 homologue in 
the insect iridovirus type 6 (Rohrmann, 2011). 
 
Figure 3.2 presents alignments of the ORF79 peptide sequence with its homologues in 
alphabaculovirus Type I, which show that ORF79 is highly conserved. ORF79 has also 
been aligned with homologues from two enterobacteria, Yersinia pseudotuberculosis and 
Dickeya zeae, and another invertebrate virus, Trichoplusia ni ascovirus. This alignment 
demonstrated the high similarity between these proteins, which supports the theory that 
ORF79 may have been acquired from bacteria (Rohrmann, 2011). No signal peptide 
sequence was predicted from the ORF79 amino acid sequence using SIGNALP and no 
transmembrane region was identified by TMPRED at the EXPASY server. ORF79 has no 
potential N-linked glycosylation consensus sequences (Asn-Xaa-Ser/Thr) and none were 
predicted to be glycosylated by NetNGlyc 1.0 Server at CBS, thus further supporting the 
theory that orf79 was gained from bacteria, as glycosylation does not occur in bacteria.  
Chapter 3 
 
65 
 
 
 
 
 
 
 
 
Figure 3.1 Sequence alignments of Type I and Type II ODV-E66 Sequences 
 
The sequence alignments of type I and type II alphabaculoviruses ODV-E66 sequences were shaded using the GeneDoc software package to highlight the conserved 
amino acid sequences; (Conserved mode: X, 100%, 80% X, 60% X). Potential transmembrane domains and a signal peptide have been indicated by  and possible N-
glycosylated sites have been indicated with  . AcMNPV ODVE66 sequence was also aligned against betabaculovirus ODV-E66 homologues to demonstrate the 
conserved amino acids between ODV-E66 alphabaculovirus and betabaculovirus. 
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Figure 3.2 Sequence alignments of ORF79 Sequences 
The sequence alignments of type I alphabaculoviruses ORF79 sequences were shaded using the GeneDoc software package to highlight the conserved amino acid sequences; 
(Conserved mode: X, 100%, 80% X, 60% X). ORF79 was also aligned against enterobacteria; Yersinia pseudotuberculosis and Dickeya zeae and another invertebrate infecting virus; 
Trichoplusia ni ascovirus to show the conserved sequences between these species. The Endonuclease region is highlighted by  .  
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3.2.3 Occlusion-derived virus structural protein: CG30 
 
The cg30 is located in the HindIII C fragment of AcMNPV genome at coordinates 74737-
75529bp (Ayres et al., 1994). Sequence analysis indicated that cg30 is 792 bp and 
encodes a protein of 264 aa with a predicted molecular mass of 30.1 kDa. Figure 3.3 
shows the alignments of the CG30 peptide sequence with its homologues in other type I 
and II alphabaculovirus, showing it shares ~34% amino acid sequence identity with Type I 
and only ~14% with Type II.  No signal peptide sequence was predicted from the CG30 
amino acid sequence using SIGNALP and no transmembrane region was identified by 
TMPRED at the EXPASY server either. CG30 has two potential N-linked glycosylation 
consensus sequences (Asn-Xaa-Ser/Thr), however, only one of them was predicted to be 
glycosylated by NetNGlyc 1.0 Server at CBS. 
The location of CG30 is most likely to be inside the nucleocapsid bound to the viral 
genome because CG30 contains two DNA binding motifs, comprising  a zinc ring finger 
motif (C3HC4) and a leucine zipper motif at the C-terminus and N-terminus, respectively 
(Thiem and Miller, 1989). The cg30 is only found in NPV and all homologues of cg30 are 
located downstream of, and in the same direction as, vp39, which encodes the major 
capsid protein VP39. It has been suggested that cg30 may be transcribed from the vp39 
late promoter and that the bicistronic mRNA produced can translate both CG30 and VP39 
(Blissard et al., 1989; Thiem and Miller, 1989; Lu and Iatrou, 1996). However, cg30 
contains its own early promoter and there is no evidence currently available that any 
bicistronic mRNA is produced. However, from the available information on baculovirus 
bicistronic translation and the fact that only 2bp separate the end of vp39 and the 
beginning of cg30, it is highly likely that CG30 is expressed at the same time as VP39 but 
in smaller amounts (Chang and Blissard, 1997).   
The AcMNPV genome expresses a number of viral proteins that contain ring finger motifs, 
however, CG30 is the only one located to the ODV. Imai et al. (2003) hypothesized that 
these ring finger motif proteins were ubiquitin ligases that could possibly be involved in the 
ubiquitination and destruction of cellular p53. The targeting and degradation of p53 to shift 
the cell cycle into the DNA replication phase using virus encoded ubiquitin ligases has 
already been described for other viruses such as herpesviruses and adeno-associated 
viruses (Weger et al., 2002; Boutell and Everett, 2003). However, tests for ubiquitin ligase 
activity for CG30 were inconclusive (Imai et al., 2003). 
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Figure 3.3 Sequence alignments of Type I and Type II CG30 Sequences 
The sequence alignments of type I and type II alphabaculoviruses CG30 sequences were shaded using the GeneDoc software package to highlight the conserved amino acid 
sequences; (Conserved mode: X, 100%, 80% X, 60% X). Zinc finger region is indicated by , Acidic region is indicated by  and Leucine Zipper region is indicated by . 
Type II alphabaculovirus 
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A cg30 deletion mutant virus was shown to be slightly more infectious orally and produced 
more BV than the parental virus. This showed that CG30 was nonessential for viral 
infection and, in fact, seemed to be limiting the production of BV and OB, permitting the 
authors to conclude that CG30 might have some long term evolutionary benefit (Passarelli 
and Miller, 1994). The CG30 contains a central acidic domain that suggests it could play a 
role in transcriptional activation; however, there is no evidence to date to support this 
theory (Thiem and Miller, 1989; Passarelli and Miller, 1994). 
 
3.3.4 Occlusion-derived virus structural protein: ODV-E28 
 
The odv-e28 is located in the HindIII H fragment of AcMNPV genome at coordinates 
84346-84867bp (Ayres et al., 1994). Sequence analysis indicated that odv-e28 is 519 bp 
and encodes a protein of 173 aa with a predicted molecular mass of 19.8 kDa. Figure 3.4 
shows the alignments of the ODV-E28 peptide sequence with its homologues in other 
Type I and II alphabaculovirus, showing it is highly conserved among Type I and shares 
~53% amino acid sequence identity with Type II. A transmembrane region was identified 
by TMPRED at the EXPASY server and the protein was predicted to contain an INM-SM 
(Braunagel and Summers, 2007). ODV-E28 has three potential N-linked glycosylation 
consensus sequences (Asn-Xaa-Ser/Thr) with only two of them being indicated by 
NetNGlyc 1.0 Server at CBS to be glycosylated. ODV-E28 could also contain two potential 
O-linked glycosylation sites as predicted by NetOGlyc 3.1 Server at CBS and as indicated 
in Figure 3.4. However, it should be noted that the scores for these O-linked glycosylation 
sites were only just over the threshold of 0.5 at 0.510 and 0.526. 
The odv-e28 is one of the 31 core genes conserved among all baculoviruses sequenced 
to date. The ODV-E28 demonstrates similarities with other ODV envelope proteins at the 
N-terminal region. Most of the core genes have been assigned roles related to DNA 
replication, gene expression, packaging and assembly or per os infection. The ODV-E28 
homologue in Bombyx mori nucleopolyhedrovirus (BmNPV) is ORF79, encoding Bm79 a 
28 kDa protein that was located to the ODV envelope, and represented the first 
characterization of ODV-E28 (Xu et al., 2006). Recently, ODV-E28 has been shown to be 
involved in per os infection and it has been suggested to be part of the per os infectivity 
factor family; pif4 (Fang et al., 2009). The ODV-E28 is transcribed from a late promoter 
located 141 nucleotides upstream of a start codon within helicase and produces a protein 
with predicted molecular mass of 19.8 kDa. The ODV-E28 has a highly hydrophobic 
transmembrane signal peptide, which strongly supports its proposed location in the ODV 
envelope (Fang et al., 2009). 
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 Type II alphabaculovirus 
Figure 3.4 Sequence alignments of Type I and Type II ODV-E28 Sequences 
 
The sequence alignments of type I and type II alphabaculoviruses ODV-E28 sequences were shaded using the GeneDoc software package to highlight the conserved amino acid 
sequences; (Conserved mode: X, 100%, 80% X, 60% X). Potential transmembrane domains and a signal peptide have been indicated by  and possible N-glycosylated sites have 
been indicated with   and possible O-glycosylated sites have been indicated with . 
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3.3.5 Occlusion-derived virus structural protein: ODV-EC43 
 
The odv-ec43 is located in the HindIII A1 fragment of AcMNPV genome at coordinates 
94721-95891bp (Ayres et al., 1994). Sequence analysis indicated that odv-ec43 is 1170 
bp and encodes a protein of 390 aa with a predicted molecular mass of 44.8 kDa. Figure 
3.5 illustrates the alignments of the ODV-EC43 peptide sequence with its homologues in 
other Type I and II alphabaculovirus, showing it is highly conserved among Type I and 
shares about 50% amino acid sequence identity with Type II.  The region between 310 
and 324 amino acids of ODV-EC43, that is not highly conserved among Type I 
alphabaculovirus, is missing in Type II alphabaculovirus, suggesting that this sequence 
may be redundant and not necessary for ODV-EC43 function. No signal peptide sequence 
was predicted using SIGNALP and no transmembrane region was identified by TMPRED 
at the EXPASY server. ODV-EC43 has three potential N-linked glycosylation consensus 
sequences (Asn-Xaa-Ser/Thr) as indicated by NetNGlyc 1.0 Server at CBS, however only 
one of them was predicted to actually be glycosylated.  
The ODV-EC43 is another one of the 30 conserved genes among baculoviruses, but its 
function is unknown. Some ODV-EC43 homologues contain transmembrane domain 
motifs. The ODV-EC43 homologue in Helicoverpa armigera single nucleocapsid 
nucleopolyhedrovirus (HaSNPV) is ORF94, encoding Ha94 that was located to both the 
ODV envelope and the nucleocapsid (Fang et al., 2003). The ODV-EC43 has been 
detected in the AcMNPV ODV; but was not specifically located to any fraction of the ODV 
in the study (Braunagel et al., 2003). However, the fact that ha94 is located to both the 
envelope and nucleocapsid of ODV, does suggest that AcMNPV ODV-EC43 is located to 
both these locations. Interestingly ODV-EC43 appears to be under the control of both an 
early and late promoter, whereas Ha94 is only under control of a late promoter and was 
expressed from 24hpi (Fang et al., 2003). If the early promoter is active in AcMNPV, this 
could suggest that ODV-EC43 plays an earlier role in AcMNPV infection that has not been 
observed in HaSNPV. More recently, Lin et al. (2009) demonstrated, using electron 
microscopy, that deletion of odv-ec43 from AcMNPV blocked nucleocapsid formation that 
resulted in the abrogation of BV and ODV production but had no affect on viral DNA 
replication, as shown by qPCR analysis. 
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Figure 3.5 Sequence alignments of Type I and Type II ODV-EC43 Sequences 
 
The sequence alignments of type I and type II alphabaculoviruses ODV-EC43 sequences were shaded using the GeneDoc software package to highlight the conserved amino acid 
sequences; (Conserved mode: X, 100%, 80% X, 60% X). Possible N-glycosylated sites have been indicated with  . 
Type II alphabaculovirus 
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3.3.6 Occlusion-derived virus structural protein: ODV-E56 
 
The ODV-E56 was characterised simultaneously in two baculoviruses: OpMNPV 
(Theilmann et al., 1996) and AcMNPV (Braunagel et al., 1996). The OpMNPV ODV-E56 
migrated in SDS-PAGE as 46 and 43 kDa proteins (Theilmann et al., 1996), whereas the 
AcMNPV ODV-E56 migrated as 67 and 56 kDa proteins (Braunagel et al., 1996). The 
genome sequence predicts that the size of these proteins, for both OpMNPV and 
AcMNPV, is around 41 kDa, suggesting that both homologues are post-translationally 
modified. However, Braunagel et al. (1996) showed that N-glycosylation did not account 
for the differences and Theilmann et al. (1996) put forward the idea that the multiple forms 
observed may be due to proteolytic cleavage. Both studies demonstrated that ODV-E56 
was exclusively associated with the ODV envelope (Braunagel et al., 1996; Theilmann et 
al., 1996).  
Figure 3.6 depicts the alignments of the ODV-E56 peptide sequence with its homologues 
in other Type I and II alphabaculovirus, showing it is highly conserved among Type I 
examples and shares ~35% amino acid sequence identity with Type II. AcMNPV ODV-
E56 also shares ~42% amino acid sequence identity when aligned with homologues from 
betabaculoviruses. A transmembrane region was identified by TMPRED at the EXPASY 
server but no signal peptide sequence was predicted using SIGNALP. ODV-E56 has four 
potential N-linked glycosylation consensus sequences (Asn-Xaa-Ser/Thr), although only 
two of them were predicted to be glycosylated by NetNGlyc 1.0 Server at CBS. ODVE56 
could also contain potential O-linked glycosylation sites predicted by NetOGlyc 3.1 Server 
at CBS, interestingly all these O-linked glycosylation sites are predicted at the C-terminal 
of ODV-E56 shown in Figure 3.6.  
Unlike the other ODV envelope proteins, ODV-E56 shows a strong transmembrane motif 
at its C-terminus that has been proven to be required for the translocation of ODVE56 into 
the nucleus and localization into the ODV envelope (Braunagel et al., 1996). The ODV-
E56 transmembrane domain prediction is similar to P74, suggesting that ODV-E56 is 
exposed on the surface of ODV.  Additionally, ODVE56 contains transmembrane domain 
in its central region.  
An ODV-E56 deletion mutant virus was used to demonstrate that ODV-E56 has no effect 
on BV production, ODV assembly or occlusion; although no bioassay data was presented 
(Braunagel et al., 1996). However, this study used a virus with a disrupted, rather than 
deleted, odv-e56 and attempts to generate a complete odv-e56 deletion mutant virus were 
unsuccessful. It was demonstrated in the same study that over expression of ODV-E56, 
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under control of the polh promoter, had a major effect on ODV maturation, decreasing 
envelopment of ODV to near undetectable levels. But there was no affect on either ODV 
envelope protein transport to microvesicles, the quantity of microvesicles or their 
association with nucleocapsids. This suggests that ODV-E56 plays a role in ODV 
morphogenesis (Braunagel and Summers 2007). However, more recently it has been 
shown that ODV-E56 is essential for oral infection of Heliothis virescens larva, supporting 
the suggestion that ODV-E56 is exposed on the surface of ODV (Sparks et al., 2011a).  
The results from this study suggest that ODV-E56 does not play a role in binding or fusion 
of the ODV to the midgut but instead at a critical point before or after this event, prompting 
the authors to recommend that ODV-E56 should be renamed PIF5 (Sparks et al., 2011a).  
 
3.2.7 Occlusion-derived virus structural proteins: PIF2 & PIF3 
 
The per os infectivity factor (PIF) family contains proteins that are essential for oral 
infection of lepidopteran larval hosts by AcMNPV. To date, the PIF family consists of P74, 
PIF1, PIF2, PIF3 and PIF4 that are all core genes conserved among all sequenced 
baculoviruses. The two of interest in this study are PIF2 and PIF3 that have already been 
demonstrated to be members of the per os infectivity factor family (Pijlman et al., 2003; 
Ohkawa et al., 2005).  
PIF2 was first characterized in Spodoptera exigua multiple nucleopolyhedrovirus 
(SeMNPV) as ORF35 (Pijlman et al., 2003) using a per os bioassay functional genomics 
approach that identified proteins that were non-essential for replication of the virus in 
insect cell culture but essential for oral infection. The AcMNPV homologue for PIF2 is 
ORF22 that produces a 44 kDa protein, which contains a highly conserved hydrophobic 
N-terminal transmembrane motif. This serves to anchor PIF2 to the ODV envelope and is 
similar to the inner nuclear membrane sorting motif of ODV-E66 and ODV-E25 (Hong et 
al., 1997; Braunagel et al., 2004). The AcMNPV PIF2 has been located to the ODV, 
whereas SeMNPV PIF2 has yet to be established as part of the ODV (Braunagel et al., 
2003).   
Figure 3.7 shows the alignments of the PIF2 peptide sequence with its homologues in 
other Type I and II alphabaculovirus, showing it is highly conserved among both Type I 
and Type II. AcMNPV PIF2 is also highly conserved among homologues from 
betabaculoviruses, as shown in Figure 3.8. A transmembrane region was identified by 
TMPRED at the EXPASY server and it contains an INM-SM (Braunagel and Summers, 
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2007). PIF2 has seven potential N-linked glycosylation consensus sequences (Asn-Xaa-
Ser/Thr), all of which are predicted by NetNGlyc 1.0 Server at CBS to be glycosylated.  
PIF3 was more recently described by Ohkawa et al. (2005) as a 23 kDa protein encoded 
by AcMNPV ORF115 that is essential for oral infection. Like PIF2, PIF3 contains an N-
terminal transmembrane domain that most likely anchors the protein to the ODV 
envelope. However, unlike PIF2, PIF3 was not identified as a component of the AcMNPV 
ODV during protein composition analysis that could suggest the relative levels of each of 
these PIF proteins differs (Braunagel et al., 2003). 
The alignments of PIF3 peptide sequence with its homologues in other Type I and II 
alphabaculovirus can be seen in Figure 3.9 PIF3 is shown to be highly conserved among 
Type I but only shares ~30% amino acid sequence identity with Type II. From the 
alignments in Figure 3.10 it can be seen that the region after the transmembrane domain 
in both Type I and II alphabaculovirus shows variation compared to the rest of the peptide 
sequence. AcMNPV PIF3 also shares ~31% amino acid sequence identity when aligned 
with homologues from betabaculoviruses, as shown in Figure 3.10. A transmembrane 
region was identified by TMPRED at the EXPASY and PIF3 contains an INM-SM 
(Braunagel and Summers 2007). PIF3 has two potential N-linked glycosylation consensus 
sequences (Asn-Xaa-Ser/Thr), all of which are predicted by NetNGlyc 1.0 Server at CBS 
to be glycosylated. 
It has been shown that PIF2 and PIF3 along with two other conserved PIF proteins; PIF1 
and P74 form a stable complex on the surface of the ODV, which is essential for the early 
stages of baculovirus oral infection (Peng et al., 2010). However, the roles of PIF2 and 
PIF3 in oral infection differ because the former is involved in mediating specific binding to 
primary midgut cells. Whereas PIF3 deletion mutants showed similar ODV binding levels 
as wild type virus, during binding and fusion assays, so this protein must be involved in a 
critical event in early primary infection; deletion mutants being unable to infect larva 
through the oral route (Ohkawa et al., 2005). It was suggested by Ohkawa et al. (2005) 
that PIF3 may be involved in the translocation of the ODV capsids along the microvillus of 
the midgut cells. Alternatively it could interact with cytoskeletal elements aiding transport 
of the ODV, if it is located on the inside of the ODV envelope (Slack and Arif, 2007). 
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Figure 3.6 Sequence alignments of Type I and Type II ODV-E56 Sequences 
 
The sequence alignments of type I and type II alphabaculoviruses ODV-E56 sequences were shaded using the GeneDoc software package to highlight the conserved 
amino acid sequences; (Conserved mode: X, 100%, 80% X, 60% X). Potential transmembrane domain and signal peptide have been indicated by  and possible N-
glycosylated sites have been indicated with   and possible O-glycosylated sites have been indicated with . AcMNPV ODV-E56 sequence was also aligned against 
betabaculovirus ODV-E56 homologues to demonstrate the conserved amino acids between ODV-E56 alphabaculovirus and betabaculovirus. 
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Type I alphabaculovirus 
Figure 3.7 Sequence alignments of Type I and Type II PIF2 Sequences 
 
The sequence alignments of type I and type II alphabaculoviruses PIF2 sequences were shaded using the GeneDoc software package to 
highlight the conserved amino acid sequences; (Conserved mode: X, 100%, 80% X, 60% X). Potential transmembrane domain and signal 
peptide have been indicated by  and possible N-glycosylated sites have been indicated with . AcMNPV PIF2 sequence was also aligned 
against betabaculovirus PIF2 homologues to demonstrate the conserved amino acids between PIF2 alphabaculovirus and betabaculovirus 
see Figure 3.8. 
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Figure 3.8 Sequence alignment of PIF2 Sequence against betabaculovirus homologue 
 
The sequence alignment for AcMNPV PIF2 was carried out against betabaculovirus homologues and shaded using the GeneDoc software package to highlight the conserved amino 
acid sequences; (Conserved mode: X, 100%, 80% X, 60% X).  
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Figure 3.9 Sequence alignments of Type I and Type II PIF3 Sequences 
 
The sequence alignments of type I and type II alphabaculoviruses PIF3 sequences were shaded using the GeneDoc software package to highlight the conserved amino acid 
sequences; (Conserved mode: X, 100%, 80% X, 60% X). Potential transmembrane domain and signal peptide have been indicated by  and possible N-glycosylated sites have 
been indicated with . AcMNPV PIF3 sequence was also aligned against betabaculovirus PIF3 homologues to demonstrate the conserved amino acids between PIF3 
alphabaculovirus and betabaculovirus see Figure 3.10. 
Type II alphabaculovirus 
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Figure 3.10 Sequence alignment of PIF3 Sequence against betabaculovirus homologue 
 
The sequence alignment for AcMNPV PIF3 was carried out against betabaculovirus homologues and shaded using the GeneDoc software package to highlight the conserved amino 
acid sequences; (Conserved mode: X, 100%, 80% X, 60% X).  
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3.3 Conclusion 
 
The first stage of this thesis was to select genes based on the literature that were 
structural components of the ODV, which were not found in BV and possibly would have 
no effect on BV production in cell culture. From this bioinformatic review conducted at the 
time Table 3.2 was compiled showing all known structural proteins of the ODV, eight 
genes were selected for further study; odv-ec43, orf79, odv-e28, pif2, pif3, odv-e66, cg30 
and odv-e56. This chapter goes on to individually review each of these selected genes 
using the current literature and this information was used to inform the interpretation of the 
results found in later chapters of this thesis.  
The alignments undertaken in this chapter showed that all of these selected genes were 
highly conserved among Type I alphabaculovirus, however the percentage of amino acid 
sequence identity varied from 14% (cg30) to 53% (odv-e28) when aligned with 
homologues from Type II alphabaculovirus. Several of the selected genes; pif2, pif3, odv-
e66 and odv-e56 had homologues in betabaculoviruses and the variation in amino acid 
sequence identity varied from 51% (pif2) to 31% (pif3). The alignments have also shown 
highly conserved regions or regions showing high variation, these could indicate either the 
functional region of the protein or regions that are not essential for function, respectively. 
For example, in all three alignments performed on ODV-E66 homologues the N-termini 
showed large variation when compared to the rest of the peptide sequence. 
The initial research allowed the target sequence to be selected for each gene that would 
be deleted using the Red/ET recombination system, so that no neighbouring genes’ 
transcription would be disrupted from the deletions carried out in Chapter 4. Further 
chapters of this thesis go on to explain the results gained from these deletion mutant 
viruses and how they compare with the literature as presented within this chapter.  
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4.1 Introduction 
 
Baculovirus ODV is comprised of a nucleocapsid wrapped in a membrane envelope that 
contains a number of viral proteins. A bioinformatic approach (Chapter 3) was undertaken 
to identify proteins that were ODV specific and had no direct association with BV structure 
or production according to the literature. Therefore, in principle the genes for these 
proteins could be deleted from the virus genome without affecting its ability to replicate in 
cell culture. The immediate aim of this research was to elucidate the roles of these 
selected proteins on the baculovirus replication cycle with specific regard to ODV 
production and packaging into the OB. The long term goal was to identify specific ODV 
gene deletions that could be used to abrogate ODV production in recombinant 
baculovirus-infected insect cells and reduce the wasted cellular resources that produce 
unnecessary ODV.  To investigate the immediate aim, a system for deleting baculovirus 
genes was required to allow the rapid construction of virus mutants that could be 
characterized for any defects in ODV production.  
Some methods utilized in the 1970’s for studying virus gene function involved the use of 
chemicals such as N-methyl-N'-nitro-N-nitrosoguanidine or 5-bromodeoxyuridine to 
mutate randomly viral DNA and produce temperature sensitive mutants (Timbury, 1971; 
Brown et al., 1979). This proved to be a very successful approach, especially for herpes 
simplex virus (HSV) where marker rescue allowed temperature sensitive mutations to be 
physically mapped (Stow et al., 1978; Chartrand et al., 1981). This permitted physical 
maps of HSV-coded proteins and functions to be constructed along with analysis from 
polypeptide profile and restriction enzyme generated fragments from the marker rescue 
(Stow et al., 1978). Therefore this approach was a powerful tool enabling the 
understanding of the functional organization of viral genomes and the role of certain 
products in virus replication. In the case of baculovirus, this approach allowed the 
functional discovery of a number of gene products such as late expression factors (lef) 4 
and 8, which were both shown to play a role in late and very late gene expression 
(Carstens et al., 1994; Shikata et al., 1998). However, this approach relies on random 
mutagenesis that requires large amounts of screening and isolation of temperature 
sensitive mutants.  
The production of random mutations in virus genomes was suited to an era in which full 
virus genome sequences were unavailable. The sequencing of many virus genomes from 
the 1980’s onwards opened the way to conduct more targeted mutations to virus 
genomes, rather than relying on the production of random mutants. Methods were 
developed that allowed the direct insertion of a marker into the viral DNA resulting in the 
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complete deletion or simple disruption of the target gene. Mackett et al. (1982) 
demonstrated a method that allowed the selection of thymidine kinase-negative 
recombinants from a wild-type Vaccinia virus background after the disruption of the 
thymidine kinase gene by insertion of foreign DNA from a plasmid transfer vector (Mackett 
et al., 1982). This discovery permitted vaccines to be constructed by the insertion of 
sequences encoding antigens from other viruses into infectious Vaccinia virus. For 
example, candidate vaccines for hepatitis B virus (Smith et al., 1983b) and influenza virus 
(Smith et al., 1983c). The most common approach involved the construction of a plasmid 
transfer vector containing the gene under study, which could be manipulated in vitro and 
in bacteria. The target gene was then modified by insertion of a marker sequence (e.g. β-
galactosidase), which could be selected subsequently in the host cell of the virus. The 
parental virus and transfer vector were then introduced into the host to permit homologous 
recombination between the two molecules (Figure 4.1).  
For baculoviruses, the first examples of the use of this system were the independent 
studies conducted by Smith et al. (1983a) and Pennock et al. (1984) to derive expression 
vectors. Smith et al. (1983a) used a transfer vector containing beta interferon to delete the 
AcMNPV polyhedrin gene (polh) and thus produce a virus lacking the ability to make 
polyhedra. This polyhedrin-negative phenotype could then be selected by observing 
plaques with a microscope. Pennock et al. (1984) used the β-galactosidase gene (lacZ) as 
a selectable marker so that blue plaques formed in the presence of X-gal could be 
isolated. This method was also used by Ohkawa (1997) to construct 150 Bombyx mori 
NPV mutants. Each mutant had a large fragment of DNA removed from each ORF and 
replaced with a lacZ reporter cassette. These viral mutants were then screened for those 
that were viable in cell culture but unable to infect larvae orally and lead to the 
identification of a third pif gene, pif3 (Ohkawa et al., 2005). 
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Figure 4.1 Illustration of the method used to disrupt a target gene.  
 
The transfer vector carrying the target gene is modified by the direct insertion of lacZ (marker) into 
the transfer vector causing disruption of the target gene. Viral DNA and modified transfer vector are 
introduced into the host cells to allow homologous recombination to occur and finally the deletion 
mutant virus is selected for using the marker.  
 
Although directed mutation of virus sequences in the host cell has proved an efficient way 
to generate mutants to study protein function, it is impossible to produce deletions in 
essential genes and recover viable virus for investigation.  It is also necessary to construct 
a plasmid transfer vector with each modified virus gene prior to making the virus mutant 
via homologous recombination in insect cells.  Finally, the process of recombination 
between a virus genome and a plasmid transfer vector is not 100% efficient, so a mixed 
population of viruses must be purified further by subsequent rounds of plaque purification. 
With some genes it was necessary to undertake 15-20 sequential plaque assays to obtain 
a genetically homogeneous recombinant virus (R.D. Possee, personal communication).  
The recovery of recombinant viruses can be enhanced if the baculovirus DNA is linearised 
with a restriction enzyme at the point of marker gene insertion but this is rarely possible 
due to the size of these genomes. For example, AcMNPV is about 134 kbp and has two 
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restriction enzyme sites AvrII and FseI that only digest it once. Kitts et al. (1990) 
introduced a Bsu361 site into the polh locus of AcMNPV so that the virus genome could 
be linearized, which improved the recovery of recombinant viruses in subsequent tests to 
30%. However, while this approach was useful as a tool for making recombinant viruses 
as expression vectors, it has little application in deriving virus mutants to study gene 
function. 
The introduction of yeast and bacterial vectors for maintaining large circular plasmids in 
these hosts has enabled the development of new approaches for generating baculovirus 
gene mutants (Patel et al., 1992; Luckow et al., 1993). The yeast system has not 
progressed beyond an experimental technique for making recombinant viruses, although it 
was used to generate lef2 and lef8 deletion mutants (R.D. Possee, personal 
communication).  The yeast system can also cause chimerism, rearrangements and 
deletions in the viral genome during the manipulation (Luckow et al., 1993; Kim et al., 
1996). Therefore the yeast system is mainly used for inserting genes encoding 
recombinant proteins into the baculovirus genome at either the p10 or polh locus to allow 
expression of these sequences in either insect cell culture or larvae. 
The bacterial system is based on a low copy number plasmid or bacterial artificial 
chromosomes (BAC), which was originally developed for cloning large sections of human 
genome to aid in mapping and sequencing of the human genome (Shizuya et al., 1992). 
The BAC is based on the E. coli F factor, which means the replication of the BAC is strictly 
controlled, resulting in only one copy per bacteria cell (Kim et al., 1996). Baculovirus 
genomes were first maintained in bacteria by Luckow et al. (1993) who developed a 
transposition system for inserting foreign genes into AcMNPV that avoided the need to do 
plaque purification of recombinant viruses. While this system is of little direct use in 
making modifications to other regions of the AcMNPV genome, it established the principle 
that infectious baculovirus genomes could be recovered from bacteria and used 
subsequently to transfect insect cells. When this is allied with the Red/ET recombination 
BAC-based system used for manipulation of large DNA molecules (Zhang et al., 1998), it 
provided an extremely convenient method for modifying any target sequence in the 
baculovirus genome.   
4.1.1 Red/ET recombination system 
 
The Red/ET recombination system uses homologous recombination in E. coli, which 
allows specific and accurate exchange of genetic material between two DNA molecules. 
This exchange occurs through homologous regions that are stretches of DNA shared by 
the two DNA molecules, which allows this system to specifically alter any location on the 
Chapter 4 
 
98 
 
selected DNA molecule. The core of the Red/ET recombination system comprises two 
phage encoded proteins; RecE and RecT, which function via a double-strand, break-
repair mechanism. They were first shown in 1998 to mediate homologous recombination 
between the antibiotic marker kanamycin that contained homologous arms and circular 
DNA maintained within E. coli. Using this method it was shown that homologous arms as 
short as 42bp could successfully be used to integrate the kanamycin resistance gene into 
the circular DNA (Zhang et al., 1998). However, the efficiency of the homologous 
recombination in the Red/ET system has been increased three-fold by replacing the recE 
and recT with their respective functional counterparts of phage lambda redα and redβ. 
Using these coupled proteins allows this system to directly insert linear double-stranded 
DNA into high copy number plasmids, large episomes, BACs and the E. coli chromosome 
itself (Muyrers et al., 2000). 
The RecE/RecT or Redα/Redβ proteins naturally function as double-stranded repair 
proteins during DNA breakage caused by damaging reagents. The RecE and Redα are 5’- 
3’ exonucleases that digest one of the 5’ ends of the linear double-stranded DNA, leaving 
a single-stranded 3’ extension, which is then bound and coated by RecT or Redβ. This 
protein-nucleic acid filament aligns with homologous DNA and allows recombination to 
occur between the two DNA molecules (Zhang et al., 1998; Muyrers et al., 1999). In the 
Red/ET recombination system these proteins are expressed from a single plasmid; 
pRedET, which was developed in A. Francis Stewarts laboratory at the European 
Molecular Biology Laboratory (EMBL). The Redα/Redβ proteins play the key role in 
homologous recombination in the Red/ET recombination system, however, several other 
proteins are produced from the pRedET that optimize the system allowing more controlled 
and efficient homologous recombination.  
 
Figure 4.2 pRedET plasmid 
Map of the Red/ET expression plasmid pRedET 
showing all the genes involved in the Red/ET 
recombination system (From the Gene Bridge 
BAC Modification Kit manual). 
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The pRedET contains both redα and redβ along with a third λ phage gene; gam (Figure 
4.2). The Gam protein assists the recombination by inhibiting RecBCD exonuclease 
activity of the E. coli, which prevents digestion of the linear double-stranded DNA 
fragment. All of the λ phage genes along with recA are under the control of the pBAD 
promoter, forming an operon that is arabinose inducible. The E. coli RecA protein is 
involved in the recombination process by aiding the protein-nucleic acid filaments binding 
to the homologous DNA. The araC produces a protein that is involved in transcriptional 
regulation of the pBAD promoter and forms a complex with L-arabinose which allows 
transcription to begin. The AraC forms a dimer in the absence of L-arabinose or presence 
of glucose that blocks the transcription from the pBAD promoter. The temperature 
sensitive RepA is required for plasmid DNA replication and the partitioning of plasmids to 
daughter cells at division. Therefore the plasmid is maintained at 30°C in liquid culture but 
due to the heat sensitive nature of RepA the plasmid copy number drops at temperatures 
above 37°C. This regulation of pRedET copy number along with the controlling elements 
of key homologous recombination genes allows the timing of the recombination event to 
be selectable, thereby decreasing the risk of unwanted intra-molecular rearrangement 
(Muyrers et al., 1999). 
For baculovirus, homologous recombination in E. coli has proven a most useful tool 
enabling the deletion mutants to be rapidly created and tested. McCarthy and Theilmann 
(2008) used homologous recombination in E. coli to replace odv-e18 with a zeocin gene 
resistance cassette. Using this knockout they demonstrated that odv-e18 is essential for 
mediating budded virus production (McCarthy and Theilmann, 2008). McCarthy et al. 
(2008) used a similar method to replaced ORF 142 a structural component of AcMNPV 
BV and ODV nucleocapsids with a zeocin gene resistance cassette. Using this knockout 
demonstrated that ORF 142 is required for budded virus production, nucleocapsid 
envelopment to form ODV and their subsequent occlusion (McCarthy et al., 2008).  
Recently, Xiang et al. (2011) used homologous recombination in E. coli to construct an 
odve66 deletion mutant virus and showed that this virus had no affect on viral replication 
but oral infectivity of this deletion mutant virus was 10 times lower than either a rescued or 
parental virus. This strongly indicates that ODVE66 plays an important role in oral 
infectivity of AcMNPV.  
In this chapter, the aim was to use the Red/ET system to delete the eight ODV genes 
identified in Chapter 3, to produce eight mutant viruses for further characterisation in later 
chapters. 
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4.2 Construction of parental bacmid (AcBacPAK5lacZ/BACpol) 
 
The AcBacPAK5lacZ/BACpol was constructed to provide a virus for this research that 
included a complete baculovirus genome containing a BAC replicon allowing the virus 
genome to be maintained in E. coli along with a lacZ reporter gene. The lacZ would allow 
expression tests to be carried out in insect cells to observe any effects subsequent gene 
deletions could have on recombinant protein expression under the control of the polh 
promoter. The deletion mutant viruses could also be linearised due to a unique Bsu361 
site within lacZ allowing insertion of the polh or other recombinant genes at the polh locus. 
Also during the isolation of recombinant baculoviruses, the beta-galactosidease produced 
could serve as a selective maker for the parental virus.  
The parental virus for the construction of AcBacPAK5lacZ/BACpol was BacPAK5 (Kitts and 
Possee, 1993). A transfer plasmid was constructed using the commercially available 
pBacPAK8 (Clontech) into which the lacZ gene and BAC replicon were sub-cloned (Figure 
4.3, panel A) and as described in methods (section 2.6).  
Insect Sf9 cells were co-tranfected with pBacPAK8-lacZ/BAC and Bsu361 linearised 
BacPAK5 DNA, which had been purified from BacPAK5 BVs as described in methods 
(section 2.3.6a), to derive the bacmid AcBacPAK5lacZ/BACpol (Figure 4.3, panel B). 
BacPAK5 DNA contains two Bsu361 sites that flank the polh; one of these sites is located 
in the essential gene orf1629. This produces a selection marker in which only those 
viruses that are rescued with a transfer plasmid that restores the whole of orf1629 will be 
viable in insect cells. Recombination between BacPAK5 and pBacPAK8-lacZ/BAC should 
knock-out the polh and result in a virus (AcBacPAK5lacZ/BACpol) whose only difference 
from AcMNPV is the presence of lacZ and BAC in place of the polh.  
The resulting recombinant virus was plaque-purified for three rounds, which were required 
to generate polyhedrin-negative and lacZ-positive plaques (plaques that turned blue when 
stained with X-gal) (data not shown). The virus amplified to titres of 8.9x107 pfu/ml and 
infected cells turned blue in the presence of X-gal (data not shown) suggesting that the 
virus was replicating normally in insect cells. No polyhedra were visible under the 
microscope (data not shown). Virus DNA was isolated from BV and restriction digest 
profiles were used to first confirm the successful recombination event with insertion of 
lacZ and BAC at the polh locus and, second, to ensure that the rest of the virus genome 
restriction profile was unaffected by the recombination process (Figure 4.4). The HindIII 
restriction fragment pattern of the new AcBacPAK5lacZ/BACpol virus (Figure 4.4, lane 3) 
was compared to the pattern of the parental BacPAK5 (Figure 4.4, lane 2). The insertion 
of the lacZ fragment and BAC replicon into the polh locus to produce 
Chapter 4 
 
101 
 
AcBacPAK5lacZ/BACpol resulted in a 150bp size decrease to fragment F due to the loss of 
the HindIII site in the polh and the small addition from lacZ fragment, producing a new 
fragment of 8829bp (Figure 4.4, panel A, lane 3). A second new fragment with an 
approximate size of 9400bp appeared due to the HindIII site located in both the lacZ 
fragment and BAC replicon (Figure 4.4, panel B). These results confirmed that both the 
lacZ and BAC had been correctly inserted into the polh locus of AcBacPAK5lacZ/BACpol. 
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Figure 4.3 Illustration of the formation of AcBacPAK5lacZ/BACpol 
 
(A) The lacZ fragment was subcloned from pCH110 into the BamHI site of pBacPAK8. This 
insertion resulted in a fusion of BamHI and BglII sites at the 5’ end of lacZ but left the BamHI site at 
the 3’ end intact and available for subsequent insertion of the BAC replicon from pBluescript-BAC 
to form pBacPAK8-lacZ/BAC. 
 
(B) Sf9 Cells co-tranfected with pBacPAK8-lacZ/BAC and Bsu361 linearised BacPAK5 DNA, to 
form AcBacPAK5lacZ/BAC
pol
. AcBacPAK5lacZ/BAC
pol
 was isolated from parental background 
using plaque purification, polyhedrin negative and lacZ positive plaques were selected for further 
study.   
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Figure 4.4 HindIII restriction enzyme analysis of AcBacPAK5lacZ/BACpol virus 
 
Sf9 cells were cotransfected with pBacPAK8-lacZ/BAC and Bsu361-linearised BacPAK5 virus 
DNA. The resulting BV was used to isolate virus DNA that was validated by restriction enzyme 
(HindIII) analysis in a 0.6% agarose gel (A). Lanes 1 and 4, NEB log2 marker in Kbp; lane 2, 
BacPAK5 DNA; lane 3, AcBacPAK5lacZ/BAC
pol
 DNA. (B) Alternations to the HindIII F fragment of 
AcBacPAK5lacZ/BAC
pol 
shown due to the replacement of polyhedrin with lacZ/BAC replicon. 
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Viral DNA purified from AcBacPAK5lacZ/BACpol BV was electroporated into DH5 E. coli, 
as described in Methods (section 2.5.5) to facilitate the use of the Red/ET recombination 
system to delete ODV genes from AcBacPAK5lacZ/BACpol.   
Thus all the experimental data indicated that pBacPAK8-lacZ/BAC and BacPAK5 had 
been used successfully to generate AcBacPAK5lacZ/BACpol. (1) The restriction profile 
matched the expected shift in restriction fragment sizes resulting from the introduction of 
two HindIII sites flanking the inserted lacZ and BAC. (2) The virus could replicate in cell 
culture and successfully produce β-galactosidase, but not polyhedra. (3) The viral DNA 
could be maintained in E. coli, which grew in the presence of chloramphenicol due to the 
BAC located in the viral DNA. 
 
4.3 Construction of the kanamycin gene cassette with AcMNPV flanking 
sequences and production of ODV deletion mutant bacmids 
 
In order to delete the required AcMNPV ODV genes from the bacmid 
AcBacPAK5lacZ/BACpol, it was necessary to construct a neomycin selection cassette 
(Neo cassette) flanked by relevant ODV sequences that would allow kanamycin selection. 
The kanamycin resistance gene fragment supplied with the Red/ET recombination system 
was amplified using primers with regions flanking the selected ODV genes (Figure 4.5). 
The flanking regions were designed to remove as much coding region from the selected 
ODV gene without disrupting neighbouring gene expression using the bioinformatics data 
(Chapter 3). In most cases portions of the ODV coding region remain because of the 
overlapping nature of the genes within the AcMNPV genome (Ayres et al., 1994). The 
primers used and their locations on the AcMNPV genome are shown in Table 4.1, for 
specific information on each of the individual deletions refer to their own sections within 
this thesis. 
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Figure 4.5 Schematic showing the construction of the kanamycin resistance gene 
cassette with AcMNPV flanking arms. 
 
Primers were designed with flanking regions to the selected target ODV genes and kanamycin 
binding sites to allow PCR to amplify a modified kanamycin cassette with homologous arms, which 
could be used with the Red/ET recombination system to remove the target sequence from the 
AcMNPV bacmid AcBacPAK5lacZ/BAC
pol
. 
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Table 4.1 Sequence of ODV primers and their location on the AcMNPV genome 
        
orf  Name Primer 5' - 3' Primer Sequence                                                                                     5' end  
22 PIF2 ACC1 ACATTTTGAATATTTAATTCAACAACTAAGTAATGGCAAT*GCCCGGGC*neo-F 17311 
    ACC2 GACGTAACATTTAAATGACTTATTGTTTGTGTTATCACAA*GCCCGGGC*neo-R 18489 
46 ODV-E66 ACC5 TATTAATAATAAGCAACATTCGACATGTCTATCGTATTGA*GCCCGGGC*neo-F 36684 
    ACC6 ACAGTCAGTCTTTTGAATATCACATTCTCCCTAAATATAA*GCCCGGGC*neo-R 38882 
96 ODV-E28 ACC9 GCACGTTTTTCAAAAAAAATTGTAAAATGTTGTCAATCAT*GCCCGGGC*neo-F 84524 
    ACC10 CTATATACGCGTTATTCGGCCAACAAATCCACGTAGCCAT*GCCCGGGC*neo-R 84742 
115 PIF3 ACC13 AAAGCGCGTACTTGCTCATGTTGACAGAATCTCTTACATT*GCCCGGGC*neo-F 99301 
    ACC14 GTGCGTCACACCACGCTTTTCACACTCAGTTAAGACGATC*GCCCGGGC*neo-R 99836 
148 ODV-E56 ACC17 AATTAATTATACATATATTTTATATTATTTTTGTCTTTTA*GCCCGGGC*neo-F 128958 
    ACC18 CCTTTACTGTGATATATTTATTAAATAAGTTTGCTTTAAA*GCCCGGGC*neo-R 130188 
88 CG30 ACC21 ATATTATTACATTAAAGTAGAATGTTATGTAAACAGTTAA*GCCCGGGC*neo-F 74687 
    ACC22 GTGTTGCAGGCGAAGCAGGTGGAGGAATAGCCGTCTAAAA*GCCCGGGC*neo-R 75581 
79 12.1 kDa ACC25 TGGTTGCCCAACCGATAGTAGGGCACGTCCAAATTCATGT*GCCCGGGC*neo-F 65392 
    ACC26 ACGCCACTCGGCCGAACACGAAAGGGCGCACTGCATAATC*GCCCGGGC*neo-R 65644 
109 ODV-EC43 ACC29 GATATAATGTCGGCCGCCGTCGGTTTCATGATGTGCTTAA*GCCCGGGC*neo-F 94731 
    ACC30 AATAATCTAAAGTCTAATGAAGTAAGACATATACATCACG*GCCCGGGC*neo-R 95943 
Notes: The orf column contains the orf number for the corresponding gene indicated in the name column. The Primer columns show the label given to each primer along with the sequence for each primer; 
the black text is the region selected for homologues recombination, SrfI restriction site is shown by *GCCCGGGC* and the neo-F (TGGACAGCAAGCGAACCGGAATTGC) or neo-R 
(TCAGAAGAACTCGTCAAGAAGGCG) indicates where the primer will bind to the kanamycin fragment (Gene Bridge) to allow amplification. The 5' end column displays the 5' end position on AcMNPV 
genome for each of the primers.  
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The eight modified kanamycin resistance gene fragments were then used to electroporate 
Red/ET recombination competent E. coli containing the AcMNPV bacmid 
AcBacPAK5lacZ/BACpol. Kanamycin-resistant colonies were picked and the deletion 
mutant bacmids were analysed by PCR and restriction digests to verify that the required 
gene had been deleted. As an example, Figure 4.6 illustrates how the Red/ET 
recombination system was used to delete pif2 from AcBacPAK5lacZ/BACpol.  
 
Figure 4.6 Schematic of the construction of AcBacPAK5lacZ/BACpol∆pif2 bacmid. 
 
Most of the pif2 ORF was deleted by the insertion of the kanamycin resistance gene between 
positions 17351 and 18449 bp in the AcMNPV genome via homologous recombination in E. coli 
using the Red/ET recombination system.  
 
However, the PCR and RE digest data indicated that the initial attempts to delete the 
target ODV genes from AcBacPAK5lacZ/BACpol using the Red/ET recombination were 
unsuccessful. PCR showed the continued presence of the target ODV gene within the 
bacmid DNA after the selection process. As an example, E. coli colonies that should have 
contained AcBacPAK5lacZ/BACpol genomes with a deletion in cg30 (∆cg30) appeared to 
show both the presence of AcBacPAK5lacZ/BACpol∆cg30 and AcBacPAK5lacZ/BACpol, as 
evidenced by the clear amplification of both kanamycin/cg30 (1210 bp) and cg30 (1058 
bp) fragments (Figure 4.7, lanes 3-9). This result was supported by lack of DNA 
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amplification in the negative control (H2O) (Figure 4.7, lane 2) and only amplification of the 
1058bp cg30 fragment in the positive control (AcBacPAK5lacZ/BACpol) (Figure 4.7, lane 
2).  
 
 
Figure 4.7 PCR analysis of AcBacPAK5lacZ/BACpol∆cg30 DNA 
 
DNA was isolated from putative colonies containing AcBacPAK5lacZ/BAC
pol
∆cg30 and analysed by 
PCR using primers 121 bp upstream and 110 bp downstream of the cg30 locus and Taq DNA 
polymerase (lanes 3-9).  A negative (water-only) control is shown in lane 1 and the parental bacmid 
AcBacPAK5lacZ/BAC
pol
 as a positive control (lane 2). NEB log2 Marker (Kbp) shown in lane 10 
with arrows indicating 1.2 Kbp and 1.0 Kbp sizes. 
 
Similar results were observed when screening the other seven targeted ODV genes, 
indicating that the Red/ET recombination system wasn’t working correctly; something that 
had not occurred previously when constructing deletion mutant viruses (R.D. Possee, 
personal communication). 
Further attempts to delete the target ODV genes from AcBacPAK5lacZ/BACpol using the 
Red/ET recombination system described above were undertaken. After several attempts 
two of the target genes (pif2 and odv-ec43) were successfully deleted from 
AcBacPAK5lacZ/BACpol. The resultant deletion bacmids were designated 
AcBacPAK5lacZ/BACpol∆pif2 (∆pif2) and AcBacPAK5lacZ/BACpol∆odv-ec43 (∆odv-ec43). 
Figure 4.8 shows that for ∆pif2 most clones showed only one DNA fragment with the 
correct size (1210 bp) amplified using primers flanking pif2 (lanes 4-7, 9-13 and 15). 
Similar PCR results were obtain for ∆odv-ec43 clones (data not shown). The integrity of 
these two deletion mutants was further characterised by RE digestion, as described in 
Figure 4.9. 
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Figure 4.8 PCR analysis of AcBacPAK5lacZ/BACpol∆pif2 DNA 
 
DNA was isolated from putative colonies containing AcBacPAK5lacZ/BAC
pol
∆pif2 and analysed by 
PCR using primers 82 bp upstream and 120 bp downstream of the pif2 locus (lanes 4-15). A 
negative (water-only) control is shown in lane 2 and the parental bacmid AcBacPAK5lacZ/BAC
pol
 
as a positive control (lane 3, 1348bp). NEB log2 Marker (Kbp) shown in lane 1 and 16. 
 
Restriction enzyme digest profiles of ∆pif2 and ∆odv-ec43 (Figure 4.9 A) were used to 
confirm that the rest of the virus genome was unaffected by the recombination process. 
The HindIII restriction fragment pattern of the deletion mutant bacmids ∆pif2 and ∆odv-
ec43 were compared to the pattern of the parental virus. The predicted alteration in the 
fragment pattern for each deletion can be seen in Figure 4.9 B and these alterations 
matched the profiles obtained for each of the deletion mutant bacmids in Figure 4.9 A. 
The gel electrophoresis image in Figure 4.9 A also showed that the rest of the deletion 
mutant bacmid profile fit the parental bacmid genome as expected, and that no random 
mutations had occurred that could be detected using this restriction enzyme.  
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Figure 4.9 HindIII restriction enzyme analyses of AcBacPAK5lacZ/BACpol∆pif2 and 
AcBacPAK5lacZ/BACpol∆odv-ec43 bacmids. 
 
DNA was isolated from E. coli containing either AcBacPAK5lacZ/BAC
pol
∆pif2 or 
AcBacPAK5lacZ/BAC
pol
∆odv-ec43 and validated by restriction enzyme (HindIII) analysis in a 0.6% 
agarose gel. Panel A, Lane 1 NEB log2 marker in Kbp; lane 2, AcBacPAK5lacZ/BAC
pol
; lanes 3-6, 
AcBacPAK5lacZ/BAC
pol
∆pif2 and lanes 7-9; AcBacPAK5lacZ/BAC
pol
∆odv-ec43. Panel B contains a 
table displaying the alterations predicted in the HindIII restriction profile caused by the deletion of 
the target gene and insertion of the kanamycin fragment.      
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orf 
 
 
Name 
 
 
Gene size (bp) 
 
Fragment 
Location 
Original 
Fragment  
Size (bp) 
Expected 
Fragment  
Size (bp) 
 
 
Lane(s) 
22 PIF2 1149 D 10001 9803 3-6 
109 ODV-EC43 1173 A1 15293 15515 7-9 
 
A 
B 
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4.4 Deletion of the remaining six AcMNPV ODV genes using 
AcBAC∆chitinase as the parental bacmid DNA 
 
In order to try and overcome the unresolved problems with AcBacPAK5lacZ/BACpol and 
Red/ET system (4.3), an alternative bacmid (AcBAC∆chitinase) was used to delete the 
remaining six AcMNPV ODV genes; odv-e66, orf79, cg30, odv-e28, pif3 and odv-e56. 
This bacmid contains a copy of the AcMNPV genome minus the chitinase gene (R.D 
Possee, personal communication).  The chitinase gene is non-essential for virus 
replication in cell culture and plays a role in host liquefaction (Hawtin et al., 1997).  
Importantly, it did not contain a copy of the lacZ, which may have compromised the 
original Red/ET experimental design. The changing of the bacmid proved successful and 
all the six remaining deletion mutant viruses were successfully constructed, using 
essentially the same methodology as previously described (4.3; data not shown).  
The integrity of these six deletion mutants was further characterised by RE digestion, as 
described in section 4.3. The HindIII restriction fragment pattern of the deletion mutant 
bacmids were compared with the pattern of the parental bacmid (Figure 4.10). The 
expected alteration in the fragment pattern for each deletion can be seen in Table 4.2 and 
these alterations matched the profiles obtained for each of the deletion mutant bacmids in 
Figure 4.10. The gel electrophoresis image in Figure 4.10 also shows that the rest of the 
deletion mutant bacmid profile fit the parental bacmid genome as expected, and that no 
random mutations had occurred that could be detected using this restriction enzyme. A 
summary list of the deletion mutant bacmids constructed in 4.3 and this section, along 
with their abbreviations used further in this thesis, is shown in Table 4.3.  
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Figure 4.10 HindIII restriction enzyme analyses of deletion mutant bacmids. 
 
DNA was isolated from E. coli for each of the six deletion mutant bacmids and validated by 
restriction enzyme (HindIII) analysis in a 0.6% agarose gel. Lanes 12 NEB log2 marker in Kbp; lane 
1, AcBAC∆chitinase; lane 2, AcBAC∆chitinase∆odv-e66; lane 3, AcBAC∆chitinase∆odv-e28; lane 
4, AcBAC∆chitinase∆pif3; lane 5, AcBAC∆chitinase∆odv-e56; lanes 6-7, AcBAC∆chitinase∆cg30 
and lanes 8-11, AcBAC∆chitinase∆orf79.  
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Table 4.2: The predicted alterations to the banding pattern of HindIII-digested 
parental bacmid. 
orf Name Gene size (bp) 
Fragment 
Location 
Original 
Fragment  
Size (bp) 
Expected 
Fragment  
Size (bp) 
 
 
Lane(s) 
46 ODV-E66 2099 E 9916 8768 2 
96 ODV-E28 479 H 5502 5974 3 
115 PIF3 615 A1 15293 15629 4 
148 ODV-E56 1131 G/F  8397/8979 17196 5 
88 CG30 795 C 11704 11860 6-7 
79 12.1 kDa 315 B 21769 22405 8-11 
 
 
Table 4.3: Summary of deletion mutant bacmids. 
orf Gene 
 
Name 
Short form 
bacmid name 
Short form 
virus name1 
22 PIF2 AcBacPAK5lacZ/BACpol∆pif2 ∆pif2 Ac∆pif2 
109 ODV-EC43 AcBacPAK5lacZ/BACpol∆odv-ec43 ∆odv-ec43 Ac∆odv-ec43 
46 ODV-E66 AcBAC∆chitinase∆odv-e66 ∆odv-e66 Ac∆odv-e66 
79 12.1 kDa AcBAC∆chitinase∆orf79 ∆orf79 Ac∆orf79 
88 CG30 AcBAC∆chitinase∆cg30 ∆cg30 Ac∆cg30 
96 ODV-E28 AcBAC∆chitinase∆odv-e28 ∆odv-e28 Ac∆odv-e28 
115 PIF3 AcBAC∆chitinase∆pif3 ∆pif3 Ac∆pif3 
148 ODV-E56 AcBAC∆chitinase∆odv-e56 ∆odv-e56 Ac∆odv-e56 
1
This name is used for virus recovered after transfection of Sf9 cells with bacmid DNA. 
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4.5 Recovery of virus after transfection of Sf9 cells with deletion bacmids 
 
Having confirmed that the eight deletion bacmids were genetically correct, the next stage 
was to test whether viable virus could be recovered when insect cells were transfected 
with the deletion mutant bacmid DNA. Bacmid DNA was purified from multiple E. coli 
colonies of each of the eight deletion bacmids (referred to as clones) and Sf9 cells were 
transfected as described in methods (section 2.3.3). Five of the deletion mutant viruses; 
Ac∆pif2, Ac∆odv-e66, Ac∆cg30, Ac∆pif3 and Ac∆odv-e56 were able to successfully 
replicate in the Sf9 cells and produce visible virus cytopathic effects as determined from 
microscopic observations during virus amplification (data not shown). The viruses 
recovered from transfected Sf9 cells were designated “Ac” to distinguish them from the 
bacmid DNA isolated from E. coli (Table 4.3). However, cells transfected with ∆orf79, 
∆odv-e28 or ∆odv-ec43 showed no obvious signs of viral infection (data not shown). Virus 
DNA was purified from the BV harvested from these infections and the modified gene 
locus in each of the deletion mutant viruses was amplified using primers specific for each 
gene (Table 4.4). For each virus clone, PCR was used to (1) confirm the deletion of the 
target ODV gene, (2) confirm the absence of parental virus (AcBacPAK5lacZ/BACpol or 
AcBAC∆chitinase) and (3) make the final selection of deletion mutant virus clone where 
multiple clones had been analysed (Figure 4.10).  
Primers designed to ~110 bp upstream and ~120 bp downstream for each of the target 
gene loci were used in a PCR using Taq DNA polymerase to amplify the locus to allow the 
determination of the kanamycin insert. The insertion of kanamycin into the target locus 
would result in the amplification of a 1210bp fragment with any difference in this product 
size indicating the presence of the original gene. Primers were also designed internally for 
each of the target loci and these would produce a product of about ~200 bp if the gene 
was still present.  
Figure 4.11 shows the results of the PCR; all the gels were set up with negative (H2O) and 
positive (parental viral DNA) controls and as expected these showed either no 
amplification (negative control) or amplification of bands suggesting the target gene was 
present (positive control). The target gene was not detected in any of the samples tested 
for the Ac∆cg30, Ac∆odv-e66, Ac∆pif3 and Ac∆odv-e56 viruses (Figure 4.11 B, E, and D 
respectively). One of the Ac∆pif2 viruses does indicate the presence of pif2 (Figure 4.11 
A, lane 13). There were no products generated for the Ac∆orf79 virus samples with either 
internal or external primers (Figure 4.11 B). The Ac∆odv-e28 results suggested the 
presence of both AcBAC∆chitinase∆odv-e28 and AcBAC∆chitinase, as evidenced by the 
clear amplification of both kanamycin/odv-e28 (1210 bp) and odv-e28 (715bp) fragments 
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(Figure 4.11 A, lane 18). The presence of odv-e28 was confirmed by the amplification of a 
214 bp internal fragment (Figure 4.11 A, lane 21). 
For Ac∆odv-ec43, two lanes both contain a single band of 1365 bp indicating that odv-
ec43 is present in those samples (Figure 4.11 C, lanes 4 and 7). Two other lanes contain 
fragment sizes indicating that both odv-ec43 and the kanamycin resistance fragment 
(1143 bp) are present in these samples of Ac∆odv-ec43 (Figure 4.11 C, lanes 15 and 16). 
The presence of odv-ec43 was confirmed further using the internal primers giving the 
correct size band of 273 bp in three of the samples (Figure 4.11 C, lanes 22, 30 and 31). 
All other lanes indicated that neither odv-ec43 nor the kanamycin resistance fragment was 
present in those samples. 
The selection of a single deletion mutant virus clone for further study was only necessary 
for Ac∆pif2 and Ac∆cg30, due to these two deletion mutant viruses having more than one 
cloned analysed in this section. For both of these deletion mutant viruses, the first clone 
was chosen; Ac∆pif2 (Figure 4.11 A, lanes 4 and 11) and Ac∆cg30 (Figure 4.11 B, lanes 4 
and 10). 
 
Following this initial characterisation, it was possible to divide the eight deletion mutant 
viruses into three clusters for further study: 
1. The three mutant viruses that did not appear to replicate in insect cells (Ac∆odv-
ec43, Ac∆orf79 and Ac∆odv-e28).  These are further characterised in 4.6 
2. The mutant viruses that contain deletions in non pif genes (Ac∆odv-e66, Ac∆cg30 
and Ac∆odv-e56).  These will be further characterised in Chapter 5. 
3. The mutant viruses that contain deletions in pif genes (Ac∆pif2 and Ac∆pif3).  
These are further characterised in Chapter 6. 
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Table 4.4 Sequence of external and internal primers for each target gene.  
orf  Name Primer  5' - 3' Primer Sequence                                                            
22 pif2 External ACC3 AGGCATTAAGCCCGAATTGT 
     ACC4 CAGCTTTACACCGTCCATGA 
  Internal ACC37 ATATGCGATAACCCGTCTGC 
   ACC38 AGGGGATTAAGCGGATTAACA   
46 odv-e66 External ACC7 GAATCGGTGTTGGCGTCTAT 
     ACC8 CGTGATTTGTACGCGTTAGC 
  Internal ACC35 CCGATTGGTACCATTTCACA 
   ACC36 CCTTGAGTCACGTACGGAAA 
96 odv-e28 External ACC11 TCCTGTTCGCGTGTTTCTAA 
     ACC12 AGTGACTCTTTCACCCATTGC 
  Internal ACC33 TTTGGCGCGTATGTACAGATT 
   ACC34 TGGCATATATTCCCGTCTCG 
115 pif3 External ACC15 AGCGTAATTCACGTTGTCGTT 
     ACC16 TCAGATGCATGACGGTAAAAA 
  Internal ACC39 GTACGTGCTCACGCATGTTT 
   ACC40 GCACATTAACGAGTTGGAAGC 
148 odv-e56 External ACC19 ACGTTTGCGGAACAAAAACT 
     ACC20 TCTCGCCCAGAATCTAAAGC 
  Internal ACC41 GACCCAAGTCGCCAACTAAA 
   ACC42 CACCGGCGGAAGTTATTATG    
88 cg30 External ACC23 CGACACAAATAATTGGCATCA 
     ACC24 ACTTTTTGCGCAACGACTTTA 
  Internal ACC45 TTGCGTAATCGTCATTGAGC 
   ACC46 GCAGAAGACAACAACGCAAA 
79 12.1 kDa External ACC27 TCGCTAAATTGTTGCGGTTC 
     ACC28 TTACAACAAGGACGCCAACG 
  Internal ACC43 AGTGGTTTGGCTTTGATGAGA 
   ACC44 TGTACATTCTGCGGCAAGAC 
109 odv-ec43 External ACC31 GTTGTGGGCTTGGATGATGT 
   ACC32 ATTACAATTACGTGCCCGACA 
  Internal ACC47 GTCCACAACCGTTTGGCTAT 
   ACC48 AATCTGGAAACGTCCACCAT 
 
Notes: The orf column contains the orf number for the corresponding gene indicated in the name column. The Primer 
columns indicates whether the primer is external or internal to the target gene and the label given to each primer along with 
the sequence for each primer.  
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Figure 4.11 PCR analysis of deletion mutant virus DNA 
DNA was isolated from BV for each of the eight deletion mutant viruses and analysed by PCR 
using both external and internal primers. Marker used NEB Log2 Marker, Negative (water-only) and 
Positive control (AcBAC∆chitinase or AcBacPAK5lacZ/BAC
pol
) found in first two lanes in each 
primer set followed by samples using either external primers (external) or internal primers 
(internal). 
(A) PCR results from Ac∆pif2 clones using ACC3/ACC4 external primers and ACC37/ ACC38 
internal primers and from Ac∆odv-e28 clone using ACC11/ACC12 external primers and 
ACC33/ACC34 internal primers. 
(B) PCR results from Ac∆cg30 clones using ACC23/ACC24 external primers and ACC45/ACC46 
internal primers and from Ac∆orf79 clone using ACC27/ACC28 external primers and 
ACC43/ACC44 internal primers.  
(C) PCR results from Ac∆odv-ec43 clones using ACC31/ACC32 external primers and 
ACC47/ACC48 internal primers.  
(D) PCR results from Ac∆pif3 clone using ACC15/ACC16 external primers and ACC39/ACC40 
internal primers and from Ac∆odv-e56 clone using ACC19/ACC20 external primers and 
ACC40/ACC41 internal primers.  
(E) PCR results from Ac∆odv-e66 clone using ACC7/ACC8 external primers and ACC35/ACC36 
internal primers. 
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4.6 Characterization of Ac∆odv-ec43, Ac∆orf79 and Ac∆odv-e28 
 
4.6.1 Ac∆odv-ec43 
 
As described in Chapter 3, odv-ec43 is one of the 31 conserved baculovirus genes and 
although it has not been characterized, its homologue in HaSNPV, ORF94, encodes a 
protein that has been localized to the ODV envelope and nucleocapsids. The Red/ET 
system was successfully used to produce a deletion mutant bacmid (∆odv-ec43) in which 
the majority of the coding region of odv-ec43 was removed and replaced with a 
kanamycin resistance gene, leaving ~50bp of odv-ec43 at the 5’ end to ensure that the 
orf108 promoter was unaffected by the deletion as summarized in Figure 4.12.   
 
 
Figure 4.12 Schematic of the construction of AcBacPAK5lacZ/BACpol∆odv-ec43 
bacmid. 
 
The odv-ec43 ORF was mostly deleted by the insertion of kanamycin resistance gene between 
94771 and 95893 bp on the AcMNPV genome via homologous recombination in E. coli using the 
Red/ET recombination system.  
 
However, initial attempts to amplify the virus (Ac∆odv-ec43) following transfection of Sf9 
cells with ∆odv-ec43 proved unsuccessful with no signs of viral infection detected as 
determined by microscopic observation. However, on further investigation of ∆odv-ec43- 
transfected insect cells stained with X-gal at 72 hours post-tranfection, it became apparent 
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that the primary transfected cells were showing a blue coloration suggesting that β-
galactosidase was being produced from the viral genome. Only individual cells turned blue 
further suggesting that the virus was not able to spread to neighboring cells. This 
indicated that ODV-EC43 may be essential for BV production but not for DNA replication 
or gene expression. Another possibility was that the deletion in odv-ec43 had affected 
neighboring genes despite the precautions taken to avoid this (Chapter 3), preventing the 
recovery of a fully replication-competent virus. Therefore the next stage of this study was 
to investigate whether the deletion of odv-ec43 could be rescued by the deleted gene at 
its native locus or at the polh locus. Rescue at the native locus would indicate whether the 
observed phenotype was attributable to the odv-ec43 gene and rescue at the polh locus 
would indicate whether any of the neighboring genes had been affected by the deletion; if 
the rescue at the polh locus failed to restore virus infectivity it would indicate that 
neighboring genes may have been affected by the deletion and a new strategy will be 
required. 
The odv-ec43 coding region was amplified using specific primers and AcMNPV DNA as 
template with proof reading polymerase (Expand, Roche). The amplified gene fragment 
was then inserted into a Topo vector and sequenced. The gene fragment was then 
removed from the Topo vector and inserted into either pOET3 (Oxford Expression 
Technologies ltd) or pBAC5 (Novagen) to allow rescue of this gene at the polh locus 
under the control of two different promoters; the late p6.9 promoter (pOET3) and early and 
late gp64 promoter (pBAC5). Figure 4.13 details the cloning strategy using protocols 
described in methods (section 2.6). These promoters were chosen to reflect the natural 
expression of this gene at its own locus as odv-ec43 is under control of both early and late 
promoters (Lin et al., 2009). Both constructs were confirmed by RE mapping (data not 
shown). 
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Figure 4.13 Insertion of baculovirus genes into pOET3 and pBAC5 
 
The baculovirus transfer vectors were constructed using standard classical cloning techniques. The 
target gene was amplified by PCR using Expand DNA polymerase and inserted into the invitrogen 
Topo vector, where its sequence was confirmed by DNA sequencing. The target gene was 
subcloned from the Topo vector into the BamHI and XhoI sites of both pOET3 and pBAC5, and this 
insertion resulted in a recirculation of both pOET3 and pBAC5. These baculovirus transfer vectors 
would allow insertion of the target gene under the control of either p6.9 promoter (pOET3) or gp64 
promoter (pBAC5) into the baculovirus genome at the polh locus through homologues 
recombination in insect cells.  
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Insect Sf9 cells were cotransfected with pOET3-odv-ec43 or pBAC5-odv-ec43 and ∆odv-
ec43 bacmid DNA purified from E. coli and linearised by restriction enzyme digestion with 
Bsu361. The ∆odv-ec43 contains a single Bsu361 site located within the lacZ at the polh 
locus. These cotransfections rescue the target gene at the polh locus.  
For the rescue to occur at the odv-ec43 locus, the ∆odv-ec43 bacmid DNA purified from 
E. coli was linearised by restriction enzyme digestion with SrfI and Sf9 cells were 
cotransfected with the Topo vector containing the target gene, odv-ec43. The ∆odv-ec43 
bacmid contain two SrfI sites flanking the kanamycin insert. Due to the Ac∆odv-ec43 virus 
being unable to replicate in cell culture, only those viruses that are rescued with a transfer 
plasmid that restores infectivity will be viable in insect cells. 
The resulting rescue viruses were harvested from the culture media of transfected Sf9 
cells. Viability was assessed by the formation of plaques caused by cell death due to viral 
infection in a standard plaque assay (Table 4.5). The viability results demonstrated that 
rescue of odv-ec43 at either its own locus or the polh locus restored infectivity of Ac∆odv-
ec43, suggesting the deletion of odv-ec43 caused Ac∆odv-ec43 to be non-infectious.  
 
Table 4.5: Summary of results from Ac∆odv-ec43 rescue experiments. 
 Bacmids  
Plasmids AcBacPAK5lacZ/BAC
pol
 ∆odv-ec43 
Rescue with pOET3- odv-ec43 Infectious Infectious 
Rescue with pBAC5- odv-ec43 Infectious Infectious 
Rescue with pOET3  Infectious Non-infectious 
Rescue with pBAC5 Infectious Non-infectious 
Rescue at own locus - odv-ec43 N/A Infectious 
 
4.4.2 Ac∆odv-e28 and Ac∆orf79 
 
The odv-e28 is one of the 31 core genes conserved among all baculoviruses sequenced. 
Most of these core genes have been related to DNA replication, gene expression, 
packaging and assembly or per os infection. Recently odv-e28 has been shown to be 
involved in per os infection and has been suggested to be part of the per os infectivity 
factor family; pif4 (Fang et al., 2009). The odv-e28 is transcribed from a late promoter 
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located 141 nucleotides upsteam of a start codon within helicase and produces protein 
with a predicted molecular weight of 19.8 kDa. The odv-e28 has a highly hydrophobic 
transmembrane signal peptide which strongly supports its proposed location in the ODV 
envelope. 
The orf79 produces a protein of 104 amino acid with a predicted molecular weight of 12.2 
kDa and is believed to be associated with the ODV nucleocapsid (Braunagel et al., 2003). 
However, analysis of the promoter sequence of orf79 showed no transcriptional start site 
motif normally associated with baculovirus genes upstream of the predicted start codon. 
This could suggest that orf79 is expressed from gp41 promoter by read through. The 
function of orf79 is unknown but it shares strong homology to an endonuclease in a 
number of bacteria; UvrC intronencoded nucleases which are involved in DNA repair after 
UV damage (Aravind et al., 1999). Therefore, this suggests that orf79 could be a member 
of the UvrC superfamily of endonucleases and might play a role in UV damage repair of 
the baculovirus genome.  
The Red/ET system was successfully used to produce both these individual deletion 
mutant bacmids (∆odv-e28 and ∆orf79). In ∆odv-e28 part of the odv-e28 coding region 
was removed and replaced with a kanamycin resistance gene, leaving 218bp of odv-e28 
at the 5’ end to ensure that helicase promoter was unaffected and 165bp at the 3’ end to 
ensure orf97 promoter was also unaffected by the deletion as summarized in Figure 4.14 
A. In the case ∆orf79, the majority of the orf79 coding region was removed and replaced 
with a kanamycin resistance gene, leaving 142bp of orf79 at the 5’ end to ensure that 
orf78 promoter was unaffected by the deletion as summarized in Figure 4.14 B.   
Attempts to recover Ac∆orf79 and Ac∆odv-e28 after transfection of insect Sf9 cells with 
bacmid DNA had proved unsuccessful (section 4.5) and no signs of virus infection were 
observed. Therefore the same procedure that was used to investigate whether the 
deletion of odv-ec43 was the cause of its observed effects on virus replication was 
undertaken here for both ∆orf79 and ∆odv-e28. Briefly, this involved constructing transfer 
vectors to allow the rescue of the deleted gene at either its own locus or the polh locus 
(Figure 4.13), as this would indicate whether any of the neighboring genes had been 
affected by the deletion. However, at the cotransfection stage the deletion mutant virus 
DNA was linearised with AvrII instead of Bsu361 due to the differences in the parental 
genome, both ∆orf79 and ∆odv-e28 contain a single AvrII site in the essential gene 
orf1629. The resulting rescue viruses were recovered from transfected Sf9 cells. Viability 
was assessed by the formation of plaques due to viral infection. The results demonstrated 
for both Ac∆orf79 and Ac∆odv-e28 that only rescuing the target gene at its own locus 
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could restore the infectivity of these deletion mutant viruses (Table 4.6). No plaques were 
obtained with attempts to rescue the viruses at the polh gene locus. 
To investigate whether the deletion of orf79 had affected the late promoter of orf78 (Figure 
4.14), orf78 was cloned into pOET3 using the same method shown in Figure 4.13. This 
would allow the placement of orf78 at the polh locus of Ac∆orf79 under control of the p6.9 
promoter and the resulting virus was tested for viability by plaque assay. The results 
showed that the placement of orf78 at the polh locus was unable to rescue the infectivity 
of the ∆orf79 virus suggesting that both orf78 and orf79 could be essential for viral 
replication (Table 4.6).  
 
Table 4.6: Summary of results from Ac∆orf79 and Ac∆odv-e28 rescue experiments. 
 Bacmids   
Plasmids AcBAC∆chitinase ∆orf79 ∆odv-e28 
Rescue with pOET3-orf79 Infectious Non-Infectious N/A 
Rescue with pBAC5-orf79 Infectious Non-Infectious N/A 
Rescue at own locus – orf79 N/A Infectious N/A 
Rescue with pOET3- odv-e28 Infectious N/A Non-Infectious 
Rescue with pBAC5- odv-e28 Infectious N/A Non-Infectious 
Rescue at own locus - odv-e28 N/A N/A Infectious 
Rescue with pOET3 Infectious Non-Infectious Non-Infectious 
Rescue with pBAC5 Infectious Non-Infectious Non-Infectious 
Rescue with pOET3-orf78 Infectious Non-Infectious N/A 
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Figure 4.14 Schematic of the construction of (A) AcBAC∆chitinase∆odv-e28 and (B) 
AcBAC∆chitinase∆orf79   
 
The ORFs odv-e28 and orf79 were mostly deleted by the insertion of kanamycin resistance gene 
between 84564-84702 bp and 65432-65604 bp positions respectively on AcMNPV genome via 
homologous recombination in E. coli using the Red/ET recombination system.  
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4.5 Discussion 
 
In this chapter the Red/ET recombination system was successfully used to create several 
viruses with mutations of specific genes. These deletion mutants were classified into three 
groups; those that did not appear to replicate in insect cells (Ac∆odv-ec43, Ac∆orf79 and 
Ac∆odv-e28), those containing deletions in known pif genes (Ac∆pif2 and Ac∆pif3) and 
those that replicated in insect cells and were not part of the pif family (Ac∆odv-e66, 
Ac∆cg30 and Ac∆odv-e56).  In spite of earlier experiences in our laboratory with the 
Red/ET recombination system where it was used to modify the AcMNPV genome, in this 
study some initial problems were encountered deleting the coding regions of interest.  
These difficulties necessitated the use of two different parental bacmids.   
 
4.5.1 Construction of deletion mutant viruses 
 
The first AcMNPV bacmid (AcBacPAK5lacZ/BACpol) used as a target for gene modification 
contained a low copy number bac replicon at the polh locus.  It also had a copy of the lacZ 
coding region under polh promoter control in tandem with this bacterial element.  All other 
genes in the virus were left unchanged prior to the attempts with Red/ET recombination to 
modify the gene targets.  Several experiments to insert a kanamycin gene resistance 
cassette into AcBacPAK5lacZ/BACpol only yielded two mutants (Ac∆pif2 and Ac∆odv-
ec43). A key reason for using AcBacPAK5lacZ/BACpol was the addition of lacZ to the virus 
genome so that subsequent experiments on viable virus mutants could analyse any effect 
on polh promoter activity and accompanying protein production.   
However, other AcMNPV bacmids have been used with Red/ET recombination to modify 
virus genes without reported problems (McCarthy et al., 2008; McCarthy and Theilmann, 
2008; Fang et al., 2009). The only significant difference between the bacmid used in this 
study and others was the lacZ coding region incorporated as a reporter.  This suggested 
that AcBacPAK5lacZ/BACpol might produce beta-galactosidase protein in the bacterial 
host that could inhibit the Red/ET recombination process. There is evidence that the polh 
promoter is active in E. coli (Lewin et al., 2005), which might result in low levels of active 
enzyme. Furthermore, the original source of the lacZ cassette inserted into 
AcBacPAK5lacZ/BACpol was pCH110.  This was originally constructed as an expression 
vector for both prokaryotic and eukaryotic cells with E. coli gpt and SV40 early promoters.  
Although it has never been tested in our laboratory, it is very likely that the gpt promoter 
remains active in the lacZ gene cassette to facilitate beta-galactosidase production in the 
host cell of the bacmid. However, it is unclear how the presence of the beta-galactosidase 
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could affect the homologous recombination process.  In experiments to investigate the 
feedback of L-arabinose on AraC novel activation of its native operon lacZ was used in a 
fusion with araC (Cass and Wilcox, 1988). This suggests that the presence of β-
galactosidase in the current studies on AcMNPV gene modification wouldn’t affect the 
expression of the proteins required for homologous recombination or directly affect the 
homologous recombination process between the bacmid and kanamycin cassette.  
Another possibility could be that the E. coli containing AcBacPAK5lacZ/BACpol is in fact 
harboring two copies of the bacmid or a single bacmid that has two copies of 
BacPAK5lacZ. The latter is more likely due to the BAC being based on the E. coli F factor 
which means its  replication is strictly controlled resulting in only one copy per bacterial 
cell (Kim et al., 1996). The BAC is capable of maintaining DNA fragments of > 300 kb 
(Shizuya et al., 1992), which would easily accept a duplicated AcMNPV genome (ca. 134 
kbp; Ayres et al., 1994). The results from the PCR analysis of DNA samples believed to 
be AcBacPAK5lacZ/BACpol∆cg30 clearly showed two bands after amplification of the cg30 
locus, which was consistent with the presence of the native virus gene and the insertion of 
the kanamycin gene (Figure 4.7). This does provide some supporting evidence for the 
idea of two cg30 loci in the bacterial cell.  Possibly quantitative PCR could be used to 
determine relative gene copy numbers in the bacterial cells. If all genes encoded by the 
baculoviruses were equimolar then this would suggest that both cg30 and the locus with 
the kanamycin cassette were contained within a single genome. If other virus genes, such 
as lef-8 or dnapol were found to be twice the copy number of the kanamycin cassette this 
would suggest two copies of the bacmid in the bacterial host cell.  
At this point in the study, given the uncertainties of using AcBacPAK5lacZ/BACpol for 
construction of AcMNPV gene deletion mutants, it was decided to use an alternative 
bacmid, AcBAC∆chitinase. While this did not have the lacZ coding region, it had been 
used previously in other experiments to construct AcMNPV gene deletion mutants (R.D. 
Possee, personal communication) and was used successfully in this study also. The 
problems encountered with AcBacPAK5lacZ/BACpol are still to be resolved, but were 
eventually considered to be outside the scope of the current project. 
 
4.5.2 Analysis of the deletion mutant virus; Ac∆odv-ec43 
 
The deletion of odv-ec43 in ∆odv-ec43 abolished the infectivity of BV in cell culture. 
However, transfection of ∆odv-ec43 DNA into cell cultures demonstrated that transcription 
and translation of viral factors was occurring in transfected cells, demonstrated by staining 
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of the cell monolayer with X-gal that turns the infected cells blue due to the presence of β-
galactosidase produced from the viral genome. The β-galactosidase is under the control 
of the very late polh promoter and this would require all the earlier viral expression factors 
to be successfully expressed. This strongly suggested that the deletion of odv-ec43 did 
not affect viral transcription and translation of the genome but instead maybe essential for 
BV assembly. This evidence is preliminary, but could be supported by further studies to 
measure virus DNA replication and gene expression using quantitative PCR and qRT-
PCR respectively. A good control virus to use for these studies would be AcMNPV where 
gp64 has been deleted, which would limit virus replication to cells initially transfected with 
bacmid DNA. The lack of virus encoded GP64, the major BV envelope protein, would 
prevent infectious virus production. 
The infectivity of the ∆odv-ec43 was rescued by insertion of odv-ec43 at either its own 
locus or the polh locus; this confirmed that the deletion of odv-ec43 was the cause of the 
observed effects and not due to bystander effects on neighboring genes. These results 
are consistent with other studies reported recently. Lin et al., 2009 demonstrated using 
electron microscopy that deletion of odv-ec43 blocked nucleocapsid formation, which 
subsequently inhibited  synthesis of BV and ODV but had no affect on viral DNA 
replication as measured by qPCR (Lin et al., 2009).  The conclusion that odv-ec43 is an 
essential virus gene product required for both BV and ODV particle formation lead to the 
conclusion that it was not a suitable gene to be deleted from the AcMNPV genome to 
enhance its attributes as an expression vector. It was therefore not considered further in 
work plans in this project.   
 
4.5.3 Analysis of the deletion mutant virus; Ac∆odv-e28 
 
The deletion of odv-e28 in ∆odv-e28 abolished the infectivity of BV in cell culture; however 
rescue of odv-e28 at the polh locus did not restore the infectivity of ∆odv-e28 suggesting 
the cause of this loss of infectivity was not due to the deletion of odv-e28. The infectivity of 
∆odv-e28 could be restored if the gene was rescued at its own locus, which suggests that 
one or both the neighboring genes had been affected by the deletion. Figure 4.14 shows a 
schematic representation of the deleted region in the ∆odv-e28 and it can be seen that the 
deletion could affect both of the neighboring gene promoters. The neighboring genes of 
odv-e28 are helicase and orf97. It is most likely that the helicase early promoter (CGTGC) 
has been affected by the deletion being too close to the promoter and thus preventing the 
binding of key protein(s) involved in DNA transcription. Also there is some doubt about the 
authenticity of orf97 since this orf only encodes a 55 aa protein with a predicated mass of 
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6.5kDa. Related viruses such as BmNPV or RoNPV lack this orf, which may suggest it is 
non functional and simply an artifact of the original bioinformatic analysis (Ayres et al., 
1994). Helicase is one of the core baculovirus genes and deletion of this gene is lethal for 
virus replication. Fang et al. (2009) also demonstrated that a similar deletion of odv-e28 
was non viable due to the flanking genes being interrupted, and was not a consequence 
of the changes to the target gene itself. However, they continued their work using insertion 
of a zeocin cassette into odv-e28 to delete it and showed that this had no effect on viral 
replication in cell culture but the ∆odv-e28 virus was unable to infect Trichoplusia ni larvae 
orally. These results suggest that odv-e28 encodes a new per os infectivity factor (Fang et 
al., 2009).  They also supported the idea of deleting the gene from AcMNPV expression 
vectors to minimise both the size of the virus genome and decrease 
transcription/translation load very late in virus infection.   
Ideally, when designing virus gene deletion experiments it would be advisable to have a 
thorough knowledge of gene transcription and termination in the regions flanking the 
target to avoid bystander effects on neighbouring sequences.  Primer extension could be 
used to map transcription start sites, although the more modern technique of 5’ RACE 
analysis could also be used. For transcription termination studies, simply sequencing the 
3’ ends of mRNAs via cDNA synthesis and cloning would be efficient.   
 
4.5.4 Analysis of the deletion mutant virus; Ac∆orf79 
 
The deletion of orf79 from AcMNPV to produce ∆orf79 yielded similar results to the 
deletion of odv-e28: Ac∆orf79 wasn’t viable and rescue of orf79 at the polh locus didn’t 
restore viability to the ∆orf79 virus,whereas rescue at its own locus did restore viability. 
The flanking genes of orf79 are orf78 and gp41 (Figure 4.14). It is apparent that the late 
promoter of orf78 could have been disrupted by the deletion of orf79. The orf78 may be an 
essential gene as homologues are found in all lepidopteran NPVs and GVs. However, the 
∆orf79 virus remained non-viable after the insertion of orf78 at the polh locus in Ac∆orf79. 
This suggests that both orf78 and orf79 are required by the virus to replicate and produce 
viral progeny. This could be tested by constructing a transfer vector to insert both orf78 
and orf79 into the ∆orf79 virus at the polh locus. This rescue virus would confirm whether 
or not both orf78 and orf79 are indeed essential genes. It would also rule out that the 
expression of gp41 had been interrupted, which could cause the loss of infectivity seen in 
∆orf79 as gp41 is an essential gene required for the transport of nucleocapsids from the 
nucleus (Olszewski and Miller, 1997). 
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4.5.5 Conclusion 
 
In this chapter several deletion mutant viruses were constructed and three of them were 
analysed further, namely Ac∆orf79, Ac∆odv-e28 and Ac∆odv-ec43, which were non-
infectious in insect cell culture. The results from this work demonstrated the possibility that 
orf79, orf78 and odv-ec43 are all essential genes. However, it also indicated that odv-
ec43 most likely does not play a role in viral DNA replication or translation of the viral 
genome but in processing of the BV particle. The odv-e28 was initially believed to be 
essential but the results confirmed this was incorrect and suggested that an essential 
neighboring gene had been interrupted instead. Overall, the results show that deleting 
genes from a virus genome such as AcMNPV, where ORFs and promoters over lap, can 
cause unseen problems even when such factors are taken into account. A better strategy 
for analyzing virus gene function might be first to delete the coding region of interest by 
insertion of a marker such as kanamycin selectable in E. coli essentially as was done in 
this study. If this modification proved lethal for virus replication, a gene rescue could be 
attempted using a modified version of the target sequences in which the putative 
translation initiation codon was mutated to a non functional triplet. Such an approach 
would overcome bystander effects on flanking genes unless the ATG sequence itself was 
involved in a regulatory role for upstream or downstream genes. 
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5.1 Introduction 
 
The Red/ET recombination system was successfully used to generate eight recombinant 
viruses with deletions in specific genes. Three of these viruses, Ac∆orf79, Ac∆odv-ec43 
and Ac∆odv-e28, which did not appear to replicate in insect cells have already been 
discussed in Chapter 4, section 5. Those deletion mutant viruses that did appear to 
replicate in insect cells and were not classified as pifs at the start of this project are further 
investigated in this chapter. Each of the targets; odv-e66, cg30 and odv-e56 will be briefly 
introduced along with information on the deletion of each gene (More information for each 
of the targets can be found in Chapter 3). Then experimental work to elucidate the roles of 
these selected proteins within the baculovirus replication cycle with specific regard to ODV 
production and packaging into the OB will be discussed. 
 
5.2 Characterisation of odv-e66, cg30 and odv-e56 
 
5.2.1 odv-e66 
 
The odv-e66 is 2112 bp gene that encodes a predicted ~79 kDa protein and is found in all 
lepidopteran baculoviruses. ODV-E66 is bound at the highly hydrophobic N-terminal to the 
ODV envelope and experiments have shown that ODV-E66 interacts with another viral 
envelope protein ODV-E25, at their exposed C-terminal regions (Braunagel et al., 1999).  
 
5.2.2 cg30 
 
The cg30 is 792 bp gene that encodes a predicted ~30.1 kDa protein and is only found 
NPV. Interestingly, all cg30 homologues are located downstream and in the same 
direction as vp39, which encodes the major capsid protein. CG30 contains two DNA 
binding motifs, zinc ring finger motif (C3HC4) and leucine zipper motif at the C-terminal 
and N-terminal, respectively (Thiem and Miller, 1989). This suggests that CG30 is located 
to the inside of the nucleocapsids bound to the viral genome.  
 
5.2.3 odv-e56 
 
The odv-e56 is 1128 bp gene that encodes a predicted ~40.9 kDa protein. ODV-E56 is 
bound at the C-terminal to the ODV envelope, which is unlike most other ODV envelope 
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proteins that are bound at their N-terminal (Braunagel et al., 1996; Theilmann et al., 
1996). 
 
5.3 Amplification of deletion mutant viruses for analysis 
 
The Red/ET recombination system was successfully used to produce deletion mutant 
bacmids (∆odv-e66, ∆cg30 and ∆odv-e56) in which the majority of the coding region of 
each of the target genes was removed and replaced with a kanamycin resistance gene 
(Figure 5.1). For a more detailed explanation of the method used to create these deletion 
mutant bacmids; Red/ET recombination system and methods used to confirm the 
deletions see Chapter 4. As also described in Chapter 4, the bacmid DNA was used to 
transfect Sf9 cells to recover infectious budded virus and the virus recovered from these 
infections was designated Ac∆odv-e66, Ac∆cg30 and Ac∆odv-e56, to distinguish them 
from the bacmid DNAs. 
Each recombinant virus and the parental control virus AcBACΔchitinase was amplified to 
a working stock in Sf9 cells and was titrated by plaque-assay so that the experiments 
described in the later sections of this chapter could be carried out using known 
multiplicities of infection (MOI). The deletion mutant viruses amplified to titres of 4.2x107 
(Ac∆cg30), 3.5x107 (Ac∆odv-e66) and 2.8x107 pfu/ml (Ac∆odv-e56) whereas 
AcBACΔchitinase amplified to titre of 8.3x107 pfu/ml.  
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Figure 5.1 Schematic of the construction of ∆odv-e66, ∆cg30 and ∆odv-e56 
bacmids. 
 
The odv-e66 (A), cg30 (B) and odv-e56 (C) ORFs were almost completely deleted by the insertion 
of a DNA fragment containing a kanamycin resistance gene between nucleotides 36734-38830 (A), 
74737-75529 (B) and 129008-130136 (C) relative to the AcMNPV genome via homologous 
recombination in E. coli using the Red/ET recombination system as described in Chapter 4.  
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5.4 Temporal analysis of virus replication in Ac∆odv-e66, Ac∆cg30, Ac∆odv-
e56 and AcBAC∆chitinase-infected Sf9 cells. 
 
5.4.1 Cell Viability 
 
Triplicate Sf9 suspension cultures were infected (MOI = 5 pfu/cell) with AcBAC∆chitinase, 
Ac∆odv-e66, Ac∆cg30 or Ac∆odv-e56 and incubated for 120 hours. Over this period, 
mock-infected cells remained >90% viable as judged by trypan blue staining. Up to 24hpi, 
the viability of all the virus-infected cells remained comparable (about 95%) to the mock-
infected Sf9 cultures, except for the initial reading (73% viable) for Ac∆odv-e66 at 0hpi 
(Figure 5.2). By 48hpi, the viability of all the virus-infected cells had declined compared to 
the control cells with AcBAC∆chitinase-infected cells showing the greatest decrease. 
However, a two-tailed student t-test showed no significant difference (P>0.05) between 
the cell viabilities of the deletion mutant viruses-infected cells compared to that of 
AcBAC∆chitinase-infected cells at this time point. The decrease in all the virus-infected 
cell viabilities continued until the last sample was taken at 120hpi.   
At 120hpi, the viability of AcBAC∆chitinase-infected Sf9 cells had decreased to 
approximately 19%. The viabilities of Ac∆odv-e66-, Ac∆cg30- and Ac∆odv-e56-infected 
cells had decreased to 27%, 24% and 36%, respectively, by the end of the experiment 
(Figure 5.2). A two-tailed student t-test showed a significant difference (P<0.05) in the 
virus-infected cell viability at 120hpi between the parental virus, AcBAC∆chitinase, and the 
two deletion mutant viruses, Ac∆odv-e66 and Ac∆odv-e56. However, there was no 
significant difference (P>0.05) between the cell viabilities at 120hpi for AcBAC∆chitinase 
and Ac∆cg30 using the same statistical test. However, despite these temporal differences, 
Analysis of variance (Anova) statistical analysis demonstrated that there was no 
significant difference between any of the virus infected cell viabilities across the time 
course study (P>0.05). 
 
5.4.2 Budded Virus Production  
 
The experiment to determine virus-infected cell viability described above (5.4.1) was 
accompanied by a study of budded virus production by AcBAC∆chitinase, Ac∆odv-e66, 
Ac∆cg30 or Ac∆odv-e56 over the same 120 hour time course (Figure 5.3). The infectious 
virus titres for each time point were obtained using the plaque assay method (methods 
section 2.3.4a). All the viruses displayed a typical eclipse phase decrease in titre between 
0hpi and 12hpi. By 24hpi, however, all viruses had produced greater than background 
levels of budded virus, although the increase for Ac∆odv-e56 was modest (3.5x106 
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pfu/ml). In subsequent time points, the parental AcBAC∆chitinase exceeded infectious 
virus production by the three virus gene mutants, which attained lower rates of increase, 
although all mutants amplified to titres in excess of 107 pfu/ml. The final budded virus titres 
at 120hpi were: AcBAC∆chitinase (7.15x107 pfu/ml), Ac∆odv-e66 (1.87x107 pfu/ml), 
Ac∆cg30 (2.97x107 pfu/ml) and Ac∆odv-e56 (1.52x107 pfu/ml). A two-tailed student t-test 
showed significant differences (P<0.05) between these titres for the parental virus, 
compared to the three deletion mutant viruses, suggesting that budded virus production 
had been compromised in each of the virus mutants. Anova statistical analysis further 
demonstrated that there was a significant difference (P<0.05) between Ac∆odv-e56 BV 
production kinetics and that of AcBAC∆chitinase, which was not shown for the other two 
deletion mutant viruses (Ac∆cg30 or Ac∆odv-e66, P>0.05).  
The final virus titres in this time course study were similar to those obtained when the 
viruses were amplified using a low moi 0.1 to produce working stocks (Section 5.3; 
Ac∆odv-e66 (3.5x107 pfu/ml), Ac∆cg30 (4.2x107 pfu/ml) and Ac∆odv-e56 (2.8x107 
pfu/ml)). Therefore, confirming the earlier indication that BV production had been affected 
in all three of these deletion mutant viruses.  
Earlier work on AcMNPV with a deletion in CG30 demonstrated an increase in budded 
virus production when compared to its parental virus (Passarelli and Miller, 1994). 
However, the results reported in Figure 5.3 showed that Ac∆cg30 was deficient in budded 
virus production compared to the unmodified virus. Since vp39 neighbours cg30 (Figure 
5.1), it is possible that the modifications made in the current study disrupted normal VP39 
production. This was tested by analysing VP39 steady state levels in virus-infected cells 
(section 5.5). 
 
5.5 Western blot analysis of VP39 production in Ac∆cg30-infected Sf9 cells 
 
To investigate whether or not VP39 expression had been compromised in Ac∆cg30-
infected cells, Western blots were used to analyse the production of the protein at various 
times after infection in mutant, parental and wild-type AcMNPV-infected cells.  
Triplicate 35mm dishes containing 2x106 Sf9 cells were infected with, AcMNPV, 
AcBAC∆chitinase or Ac∆cg30 using an MOI of 5 pfu/cell. Dishes were harvested every 
24hpi until 96hpi and the protein content of each cell lysate was determined using Quabit 
(Qiagen). Protein samples (15µg) were fractionated using 12% SDS PAGE and 
transferred to nitrocellulose membranes using electroblotting. Western blot analysis (see 
method section 2.7.2) was then performed using antibody to VP39 (Figure 5.4).  
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Figure 5.2 Cell viability of Ac∆odv-e66, Ac∆cg30 or Ac∆odv-e56-infected Sf9 cells. 
 
The viability of triplicate cultures of AcBAC∆chitinase-, Ac∆odv-e66-, Ac∆cg30- or Ac∆odv-e56-
infected Sf9 cells (MOI = 5 pfu/cell) were assessed over 120 hours. Cell viability was determined 
by trypan blue staining as described in methods (section 2.3.5). Standard error bars are shown. 
N=3. 
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Figure 5.3 Kinetics of budded virus production for Ac∆odv-e66, Ac∆cg30 or 
Ac∆odv-e56. 
 
Culture medium from the Sf9 cell cultures infected with AcBAC∆chitinase, Ac∆odv-e66, Ac∆cg30 or 
Ac∆odv-e56 (as described in Figure 5.2) were assayed using plaque titration to determine their 
budded virus content.  Standard error bars are shown for each time point of the 120 hour time 
course. N=3. 
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Figure 5.4 Western blot analysis of AcMNPV, AcBAC∆chitinase and Ac∆cg30 
infected Sf9 cells 
Triplicate total cell lysates from Sf9 cells infected with AcMNPV, AcBAC∆chitinase, or Ac∆cg30 
(MOI = 5 pfu/cell) were collected throughout a time course and 15µg of protein was fractionated 
using 12% SDS PAGE, transferred to a nitrocellulose membrane and probed with antibody to VP39 
as described in methods.A: 24hpi, B: 48hpi, C: 72hpi D: 96hpi. Arrow indicates the predicted band 
for VP39 and M indicates mock infected cell lysate samples.  
 
This demonstrated that a protein of the predicted size (38.9 kDa) was present in cells 
infected with each virus at 24, 48, 72 and 96hpi. However, there were some important 
differences between the samples. The temporal expression of VP39 by Ac∆cg30 closely 
matched that of its parental virus (AcBAC∆chitinase). Interestingly, the expression of 
VP39 by AcMNPV differed to that of Ac∆cg30 and AcBAC∆chitinase, with production of 
two VP39-specific protein bands with estimated molecular weights of 36 and 34 kDa. 
These were more prominent in AcMNPV-infected cells at 48hpi than in cells infected with 
the other two viruses. By 72hpi, AcBAC∆chitinase and Ac∆cg30-infected cells had 
approximately equal ratios of full length and lower molecular weight VP39. At 96hpi, the 
final time point analysed, all three virus-infected cell samples contained more of the lower 
molecular weight proteins. Overall, Ac∆cg30-infected cells also appeared to have lower 
levels of VP39 than the other two viruses at 96hpi in each of the triplicate samples. 
Comparing the relative amounts of VP39 bands on the Western blots was not very 
accurate due the unevenness in running of the SDS PAGE. For example, 
AcBAC∆chitinase VP39 bands in all the Western blot images shown in Figure 5.4 seem 
darker but this could be solely due to compression of these bands and not the amount of 
VP39 present. To obtain a more accurate and quantitative estimate for the expression of 
VP39 for each of these viruses at the chosen time points, a programme from Syngene 
known as Gene tool was used to semi-quantity the VP39 bands. Briefly, Gene tool 
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analyses the Western blot images by comparing band intensity and volume to each other, 
after this a value of 100 was given to the highest intensity band to allow an easier 
comparison between bands. In this case, the third AcBAC∆chitinase sample at 48hpi 
(Figure 5.4 B) was the highest intensity and all the other bands were compared to this 
band and given a value. The second AcMNPV sample at 72hpi (Figure 5.4 C) was 
excluded from this analysis due to the miss formation of the band This process was 
repeated three times and the mean value for each time point was determined (Figure 5.5).  
 
Figure 5.5 Semi-quantification of VP39 production in AcMNPV-, AcBAC∆chitinase- 
and Ac∆cg30-infected Sf9 cells 
 
The Western blot images in Figure 5.4 were analysed using Gene tools to determine relative VP39 
levels for each of the viruses at a given time point with standard error bars, grouped by viruses. All 
values are relative to the third AcBAC∆chitinase 48 hour time-point band in Figure 5.4 panel B, 
which was arbitrarily set at 100. 
 
The AcMNPV relative VP39 expression profile differs to that seen for AcBAC∆chitinase 
and Ac∆cg30 after 24hpi, most likely due to the earlier prominence of the other two VP39-
specific protein bands seen for AcMNPV (Figure 5.4). The Kruskal-Wallis test was used to 
compare the AcBAC∆chitinase values given for each time point to those of AcMNPV and 
significant difference was seen (P<0.05), suggesting the deletion of chitinase effected the 
expression profile of VP39.  
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When the Ac∆cg30 relative VP39 expression profile was compared to that of 
AcBAC∆chitinase, a decrease in VP39 level was seen at all time points tested here. 
However, Anova statistical analysis demonstrated no significant difference (P>0.05) when 
Ac∆cg30 values were compared to those of AcBAC∆chitinase. Therefore, the statistical 
analysis confirmed that there were no significant differences between the levels of VP39 
in the parental or cg30 deletion mutant virus at the time points examined here and thus 
this cannot account for the differences in BV titres observed between these viruses 
(Figure 5.3). 
The effects of the cg30 deletion on virus replication in insect cell culture will be discussed 
in the final sections of this chapter. The next part of this chapter focuses on the effects the 
deletion mutant viruses could potentially have on ODV production and occlusion into 
polyhedra. However, this work required the polyhedrin gene to be restored to these 
viruses to allow the occlusion of ODV.  
 
5.6 Restoration of polh into AcBAC∆chitinase, Ac∆odv-e66, Ac∆cg30 and 
Ac∆odv-e56 
 
The reinsertion of polh was carried out by cotransfecting insect Sf9 cells with a transfer 
plasmid containing the EcoRI I fragment of the AcMNPV that includes the polyhedrin orf 
(obtained from Prof R Possee) and bacmid DNA from each of the four mutants that had 
been purified from E.coli and linearised by restriction digestion with AvrII. Each of the virus 
deletion mutants and AcBAC∆chitinase contain a single AvrII site located within the 
essential gene orf1629. This produces a selection marker in which only those viruses that 
are rescued with a transfer plasmid that restores the whole of orf1629 will be viable in 
insect cells. A double cross-over recombination event between any of these bacmids and 
pAcEI-I should remove the BAC and result in a virus with a restored polyhedrin gene in 
place of the BAC (Figure 5.6). 
The resulting viruses were plaque-purified for several rounds until only polyhedrin-positive 
plaques were generated, as observed using a microscope (data not shown). The viruses 
were amplified to titres comparable to the original polyhedrin-negative viruses, suggesting 
that they were replicating normally in insect cells (See Figure 5.6 for virus names and 
titres). The next stage was to purify the OB from these polyhedrin-positive viruses to allow 
further experimental work to be carried on ODV.  
The BV produced by each of these polyhedrin-positive viruses was injected into the 
hemocoels of separate groups of 50 fourth instar T. ni larvae. Each larva received 1x105 
BVs to ensure 100% mortality for Ac∆chitinasePol+. The three viruses, Ac∆odv-e66Pol+, 
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Ac∆cg30Pol+ and Ac∆odv-e56Pol+ all produced similar levels of mortality to that of 
AcBAC∆chitinase (data not shown). The OBs were then purified from the larvae using two 
different methods involving sucrose gradients. The first method purified OB from individual 
larvae, which were treated with no SDS for electron microscopy (EM) imaging (methods 
section 2.3.9a). The second method purified OB from approximately 40 larvae using SDS 
and high speed centrifugation for bioassays (methods section 2.3.9). 
A
B 
Target Virus name 
 
Short form virus 
name 
Short form for 
polyhedrin 
positive virus 
 
Virus titre 
(pfu/ml) 
Parental AcBAC∆chitinase AcBAC∆chitinase Ac∆chitinase
Pol+
 7.9x10
7 
 
ODV-E66 AcBAC∆chitinase/odv-e66 Ac∆cg30 Ac∆cg30
Pol+
 4.5x10
7
  
CG30 AcBAC∆chitinase/cg30 Ac∆odv-e56 Ac∆odv-e56
Pol+
 3.5x10
7
  
ODV-E56 AcBAC∆chitinase/odv-e56 Ac∆odv-e66 Ac∆odv-e66
Pol+
 3.7x10
7
  
 
Figure 5.6 The restoration of the polyhedrin gene in AcBAC∆chitinase ∆odv-e66, 
∆cg30 and ∆odv-e56 bacmids. 
The BAC was completely deleted from AcBAC∆chitinase and the deletion mutant viruses by the 
insertion of the polyhedrin gene via homologous recombination in Sf9 insect cells between pAcEI-I 
and virus genomes (A). (B) Table showing summary of deletion mutant viruses with updated 
abbreviated names for polyhedrin-positive viruses and the titres obtained when these viruses were 
amplified in Sf9 cells. 
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5.7 Bioassays for Ac∆chitinasePol+, Ac∆odv-e66Pol+, Ac∆cg30Pol+ and Ac∆odv-
e56Pol+ 
 
To examine the effect of Ac∆odv-e66Pol+, Ac∆cg30Pol+ and Ac∆odv-e56Pol+ on viral infection 
in vivo, OBs from the deletion mutant viruses and Ac∆chitinasePol+ were purified from 
infected larvae and counted using a haemocytometer. They were assayed by oral 
infection in third instar T. ni larvae at a range of doses to determine their LD50, LD90 and 
survival time for each virus. Duplicate bioassays were set up as described in methods 
section 2.3.11 and the results are summarised in Table 5.1. 
Table 5.1 Infectivity of Ac∆odv-e66Pol+, Ac∆cg30Pol+ and Ac∆odv-e56Pol+ occlusion 
bodies  
 
Lethal dose (OB/larva)
Experiment 1 Experiment 2 Survival Time
Virus LD50 LD90 P LD50 LD90 P hpi±SE P
AcMNPV 33.5 1137.2 48.2 1704.2 167.3±7.6
Ac∆chitinasePol+ 30.2 1289.8 0.3947 48.5 1823.2 0.3879 166.4±5.9 0.931
Ac∆odv-e66Pol+ 415.3 78276.1 0.0062 195 4764.3 0.0001 155.1±8.5 0.267
Ac∆cg30
Pol+
7.5 939.1 0.0393 7.5 539.9 0.0005 160.8±3.6 0.423
Ac∆odv-e56Pol+ 2.6x1010 8.9x1018 0.0060 164.5±6.5 0.875  
 
The lethal dose (LD50 and LD90) values in Table 5.1 were determined by linear regression 
analysis; values above 10,000 OBs were extrapolated. Chi-square analysis was used to 
determine the P value for Ac∆chitinasePol+ compared to AcMNPV. In both bioassays no 
significant difference was seen between the infectivity of OBs from these two viruses. 
However, when each of the deletion mutant viruses were compared to Ac∆chitinasePol+ 
using the same chi-square analysis, a statistically significant difference was seen between 
the infectivity of OBs produced from larva infected with Ac∆chitinasePol+ compared to 
Ac∆odv-e66Pol+, Ac∆cg30Pol+ and Ac∆odv-e56Pol+ OBs. This significant difference was seen 
in both of the bioassays for Ac∆odv-e66Pol+ and Ac∆cg30Pol+.  
The oral infectivity of these viruses was also compared using Probit analysis (PoloPlus, 
LeOra Software). This further confirmed the results above suggesting the three deletion 
mutant viruses oral infectivity was significantly different to that of Ac∆chitinasePol+. 
However, the Probit analysis did suggest that the relative potency of Ac∆chitinasePol+ and 
Ac∆cg30Pol+ OBs were the same.  
The survival times in hpi was only carried out in the first bioassay. A student t-test was 
used to compare survival times between viruses to determine their P values. The survival 
times for Ac∆chitinasePol+ were compared to those for AcMNPV and demonstrated no 
significant difference between these two viruses. The survival times for Ac∆chitinasePol+ 
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were then compared to each of the survival times from the deletion mutant viruses using 
the student t-test and no significant difference was determined. This observation is 
confirmed by Figure 5.7 that demonstrates the majority of virus infected larva at the top 
dose (104 OBs/larva) died in a narrow window between 5.5-9.5 days post infection for all 
of the viruses even for Ac∆odv-e66Pol+ (61%), and Ac∆odv-e56Pol+ (21%), which didn’t 
cause 100% mortality at their top dose.  
The effects of these deletions on oral infection was investigated and differences have 
been observed compared to the parental virus; Ac∆chitinasePol+. These differences 
suggest that deletion of either odv-e66 or odv-e56 has a negative effect on oral infectivity 
of OBs, whereas the deletion of cg30 seems to increase oral infectivity of OBs. However, 
none of the deletions effected the replication of the virus within the host shown by no 
differences between the survival times of the deletion mutant viruses compared to their 
parental virus. The next stage was to determine whether or not these effects could have 
been caused by defects in ODV production or occlusion by examining purified OBs under 
EM. 
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Figure 5.7 Mortality of AcMNPV, Ac∆chitinasePol+, Ac∆odv-e66Pol+, Ac∆cg30Pol+ and 
Ac∆odv-e56Pol+ infected larvae 
 
The mortality rate of AcMNPV, Ac∆chitinase
Pol+
, Ac∆odv-e66
Pol+
, Ac∆cg30
Pol+
 and Ac∆odv-e56
Pol+ 
infected larvae at the top dose (10
4 
OBs/larva) were assessed until all larvae had succumb to viral 
infection or pupated.  
 
 
Chapter 5 
 
149 
 
5.8 Electron microscopic analysis of Ac∆chitinasePol+, Ac∆odv-e66Pol+, 
Ac∆cg30Pol+ and Ac∆odv-e56Pol+ OBs 
 
The OBs purified from Ac∆chitinasePol+, Ac∆odv-e66Pol+, Ac∆cg30Pol+ and Ac∆odv-e56Pol+ 
infected larvae were then prepared for EM imaging. This involved the samples being fixed, 
stained, dehydrated and then embedded in resin. Once the resin had set, ultrathin 
sections were produced using a microtome and these sections were then restained to 
increase imaging detail (methods section 2.4.2). The OB images taken on the EM (Hitachi 
H7650) for the deletion mutant viruses and Ac∆chitinasePol+ are shown in Figure 5.8.  
The sections through Ac∆chitinasePol+  polyhedra show that the ODVs contain multiple 
nucleocapsids and are embedded in polyhedrin with each OB surrounded by the 
polyhedron envelope (PE), which is evident as a dark outline (Figure 5.8, panel A). The 
OB sections from Ac∆odv-e66Pol+ appear structurally similar to those from Ac∆chitinasePol+ 
suggesting no differences in ODV production or occlusion that can be seen by EM (Figure 
5.8, panel B).  
However, the OBs from Ac∆cg30Pol+ show the loss of the PE, as indicated by red arrows in 
Figure 5.8, panel C. These OBs also seem to have started to degrade and release ODV, 
as indicated by the ‘empty pockets’ left behind. The OBs from Ac∆odv-e56Pol+ also look 
structurally similar to those from Ac∆chitinasePol+ suggesting no difference in the ODV 
production or occlusion that can be seen by EM. However, these OBs appear to be 
associated with another, unidentified, protein even after the purification process. This 
protein appears to be wrapped around the Ac∆odv-e56Pol+ OBs and is indicated by blue 
arrows in Figure 5.8, panel D. In the last image (Figure 5.8, panel D4), two Ac∆odv-e56Pol+ 
OBs are clearly linked together by this protein. A possible candidate for this protein is P10 
as it is known to associate with polyhedra during their formation (Lee et al., 1996; 
Patmanidi et al., 2003; Carpentier et al., 2008). 
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Figure 5.8 Electron microscopy of purified OBs from Ac∆chitinasePol+, Ac∆odv-e66Pol+, Ac∆cg30Pol+ and Ac∆odv-e56Pol+ infected larva. 
 
A selection of EM images which are representative of those obtained after fixing, staining and sectioning OBs from each of the deletion mutant viruses and 
Ac∆chitinase
pol+
 are shown. Red arrows in Ac∆cg30
Pol+
 images (C1-C4) indicate loss of the polyhedral envelope protein and blue arrows in Ac∆odv-e56
Pol+ 
images (D1-
D4) indicate an unidentified protein wrapped around Ac∆odv-e56
Pol+ 
OBs. Scale bars represent 100 nm. 
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5.9 Discussion 
 
In this chapter three viruses, Ac∆odv-e66, Ac∆cg30 and Ac∆odv-e56, which were able to 
replicate in insect cell culture but not initially classified as part of the pif family, were 
examined, particularly with regard to any effect on ODV production or packaging into the 
OB.  
 
5.9.1 Ac∆odv-e66 
 
The effect of odv-e66 deletion on BV production and cell viability in Sf9 cells was 
examined in a time course experiment. These results showed that both the viability of the 
Ac∆odv-e66-infected cells (27%) and BV titre (1.87x107 pfu/ml) were significantly different 
to those of AcBAC∆chitinase at 120hpi (19% and 7.15x107 pfu/ml). This suggests that the 
deletion of odv-e66 has affected both these aspects of viral replication It is likely that the 
improvement in virus-infected cell viability at 120hpi is a consequence of the decrease in 
BV production by Ac∆odv-e66. It would be interesting to continue the sampling of virus-
infected cell cultures to later time points to determine if BV production reaches the levels 
seen for the parental virus and if virus-infected cell viability also decreases further. 
This result conflicts with a current publication on deletion mutant of odv-e66 that 
demonstrated no effect on BV production (Xiang et al., 2011). In their study, BV 
production kinetics were analysed after the transfection of Sf9 cells with bacmid DNA 
instead of a virus stocks that had been accurately titrated prior to the experiment, as was 
carried out in this thesis. Transfection of insect cells with baculovirus DNA (e.g., bacmids) 
rarely produces a synchronous infection. This has the result that there will be multiple 
rounds of virus replication as cells initially escaping transfection with DNA become 
infected with virus in secondary rounds of replication.  
It was demonstrated that the deletion of odv-e66 affected per os infectivity of OBs fed to 
third instar T. ni larvae. However, different results were seen in two independent 
bioassays. In the first bioassay there was approximately a 14-fold increase in LD50 (415 
OBs per larva) when compared to Ac∆chitinasePol+ (30 OBs per larvae). In the second 
bioassay, the increase in LD50 (195 OBs per larva) was approximately only four-fold when 
compared to Ac∆chitinasePol+ (48 OBs per larva) in the second bioassay. This gives an 
average nine-fold increase of LD50 for the Ac∆odv-e66
Pol+ that is similar to the 10-fold 
increase reported by Xiang et al. (2011) for their odv-e66 deletion mutant virus. However, 
there was a statistically very significant difference seen between the infectivity of OBs 
produced from larva infected with Ac∆chitinasePol+ compared to Ac∆odv-e66Pol+. Therefore 
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both bioassays suggest that odv-e66 plays a role in oral infection. When BV from Ac∆odv-
e66Pol+ infected cells was injected into the hemocoels of fourth instar T. ni larvae, 100% 
mortality was seen. There was no significant difference between Ac∆odv-e66Pol+ and 
Ac∆chitinasePol+ survival times at the top dose of 10,000 OBs/larva, which suggests there 
is no difference between the replication efficiencies of the two viruses in the host larva. 
This information strongly suggests that odv-e66 plays a role in oral infection but that this 
role may not be as critical as the involvement of the pif family. It is not suggested that odv-
e66 should be considered a member of this protein family. 
It could be argued that the decrease in per os infectivity of Ac∆odv-e66Pol+ OBs is a 
consequence of impaired ODV packaging within polyhedra.  However, electron 
microscopy imaging of Ac∆odv-e66Pol+ OBs revealed no apparent difference in structure or 
ODV packaging when compared to images of Ac∆chitinasePol+ OBs. This confirms the 
electron microscopic analysis of deletion mutant virus (∆odv-e66) OB previously published 
(Xiang et al., 2011). This suggests the observed affects seen on oral infection of Ac∆odv-
e66Pol+ OBs is due to the actual function of odv-e66 and not some structural defect caused 
by the deletion of odv-e66. These results also strengthen the view that ODV-E66 is a 
protein bound at the N-terminal to the ODV envelope facing outwards and not inwards. 
This contradicts evidence suggesting that ODV-E66, together with another viral protein 
ODV-E25, are involved in ODV capsid envelopment (Russell et al., 1997).  
It might be interesting to extract ODVs from Ac∆odv-e66Pol+ OBs and compare their per os 
infectivity with parental viruses. This experiment would disassociate the dissolving of OBs 
in the insect mid gut from the initial stages of virus infection. It might also be possible to go 
one stage further and strip the ODV envelopes from the particles and then mediate 
infection of insect cells in vivo or in vitro by using liposomes as carriers. This was done to 
study rotavirus entry to host cells (Bass et al., 1992). The advantage of studying the 
infectivity of artificially enveloped ODVs is that it might be possible to determine if there is 
an inherent difference in particle structure if ODV-E66 is withheld during maturation. 
 
5.9.2 Ac∆cg30 
 
Using the same approach described for Ac∆odv-e66, BV production and virus-infected cell 
viability was assessed during a time course of replication for Ac∆cg30. These results 
showed that there was no significant difference between the cell viability of Ac∆cg30-
infected cells (24%) and AcBAC∆chitinase infected cells (19%) at 120hpi. However, there 
was a significant difference between the BV titres of infectivity for Ac∆cg30 (2.97x107 
pfu/ml) and AcBAC∆chitinase (7.15x107 pfu/ml) at 120hpi, suggesting that the deletion of 
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cg30 had impacted on BV production. This 2.4-fold difference contradicts work already 
done on a cg30 deletion mutant virus that showed it produced slightly more BV than the 
parental virus (Passarelli and Miller, 1994). Therefore, in this study it was investigated 
whether or not the deletion of cg30 had affected the major capsid protein VP39 
expression, since the two genes are neighbours in the AcMNPV genome. However, the 
results from this experiment showed no significant difference between the expression of 
VP39 in Ac∆cg30- and that observed in AcBAC∆chitinase-infected cells. However, this 
analysis did highlight some interesting observations on the size of VP39 that accumulated 
throughout virus infection. In AcMNPV-infected cells two proteins smaller than the 
predicted mass of VP39 were present from 24hpi but accounted for the majority of 
immune-reactive material by 48hpi. In both AcBAC∆chitinase- and Ac∆cg30-infected cells, 
however, these two smaller bands were in the minority until 72hpi. It is conceivable that 
these differences may be accounted for by the lack of the chiA in both viruses. The 
baculovirus chitinase is reported to serve as a chaperone in the maturation of active virus-
encoded cathepsin (Hom et al., 2002; Hodgson et al., 2011). The appearance of lower 
molecular weight species of VP39 in AcMNPV-infected cells may be a consequence of 
cathepsin-mediated processing of protein that is not sequestered within virus particles. A 
definitive test of this hypothesis would be to examine VP39 accumulation in mutants of 
AcMNPV lacking cath. The chiA could also be restored to AcBAC∆chitinase to determine 
if VP39 processing kinetics could be returned to the wild-type profile. While these 
differences in VP39 may be of little consequence to the study of cg30 function, they 
highlight that caution should be exercised in the selection of a parental virus genome for 
making further deletions. It is better to employ a baculovirus genome that only has a 
modified polh, since this encodes a very late protein that should have no effect on earlier 
events in virus replication.   
The apparent decrease in VP39 levels at 96hpi may be indicative of events in the 
Ac∆cg30-infected cells that differ from the parental- or wild type-infected cells. Coupled 
with the apparent sharp increase in BV titre of Ac∆cg30 by 120hpi this indicates that 
further studies of virus replication in the very late stages are merited. It is feasible that BV 
titres of Ac∆cg30 could rise further to near those of AcBAC∆chitinase.  
It was also demonstrated that the deletion of cg30 affected per os infectivity of OBs fed to 
third instar T. ni larvae. This effect was positive as shown by an approximate four-fold and 
seven-fold decrease in LD50 when compared to Ac∆chitinase
Pol+ LD50 in two different 
bioassays. Passarelli and Miller (1994) observed a two-fold decrease in LD50 with their 
cg30 deletion mutant virus in first instar T. ni larvae. However, they suggested this affect 
was conferred by the presence of lacZ within their virus, which could be altering the 
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polyhedron envelope structure. The data collected here suggests that this interpretation 
was incorrect and the decrease in LD50 could have been caused by deletion of cg30 and 
not the presences of lacZ within the virus. There was a very statistically significant 
difference seen between the infectivity of OBs produced from larva infected with 
Ac∆chitinasePol+ compared to Ac∆cg30Pol+. However, there was no significant difference 
between Ac∆cg30Pol+ and Ac∆chitinasePol+ survival times at the top dose of 10,000 OBs. 
This suggests there is no difference between the replication speeds of the two viruses in 
the host larva. This correlates with observations seen before for cg30 deletion mutant 
virus (Passarelli and Miller, 1994). Therefore the Ac∆cg30Pol+ decrease in LD50 is most 
likely caused by increase in the efficiency of midgut infection of Ac∆cg30Pol+ ODVs. 
Electron microscopy imaging of Ac∆cg30Pol+ OBs showed that the polyhedron envelope 
(PE) was deformed and the OBs seem to be degrading due to the loss of the PE. This 
was not seen in the OB images of Ac∆chitinasePol+. This could suggest that the loss of 
cg30 caused the OB to become unstable and during oral infection of fresh Ac∆cg30Pol+ 
OBs. This degradation allows the release of ODV more easily in the midgut of the larva 
during oral infection. Interestingly, deletion of the PE gene also results in unstable OBs 
that have an uneven surface, which are prone to losing ODVs (Russell and Rohrmann, 
1990; Russell et al., 1991). The assembly of the PE on mature OB during the late stages 
of infection has been demonstrated to involve P10 (Gross et al., 1994; Lee et al., 1996). 
Therefore, investigation of the relationship between CG30, P10 and PE during viral 
replication could give insights into the formation of the PE.  
It would be interesting to examine whether or not the increase in oral infection has a cost 
for the Ac∆cg30Pol+ survivability in the long term due to the weakened OB structure. 
Although an increase in polyhedra infectivity would be very advantageous in biocontrol 
programmes, a decrease in product shelf life would negate this. 
 
5.9.3 Ac∆odv-e56 
 
The results from a time course to examine cell viability of Ac∆odv-e56-infected cells (36%) 
and the resultant BV titre (1.52x107 pfu/ml) were significantly different to those of 
AcBAC∆chitinase at 120hpi (19% and 7.15x107 pfu/ml). This does suggest that the 
deletion of odv-e56 has affected both these aspects of the viral replication. However, as 
was the case with the odv-e66 deletion, if the time course had continued past 120hpi most 
likely the titre for Ac∆odv-e56 might have continued to increase due to the cell viability of 
the Ac∆odv-e56 infected cell still being so high at 120hpi. Work currently done on ODV-
E56 suggests its absence has no effect on BV production. However, all of these studies 
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used a disrupted odv-e56 by insertion of lacZ rather than a deletion strategy (Braunagel et 
al., 1996; Harrison et al., 2010; Spark et al., 2011a). Attempts to generate a complete odv-
e56 deletion mutant virus have been unsuccessful in other studies (Braunagel and 
Summers, 2007). 
It was demonstrated here that the deletion of odv-e56 did affect the per os infectivity of 
OBs in third instar T. ni larvae, having an extrapolated LD50 of 2.6x10
10 OBs per larva.  
This indicates that odv-e56 is essential for oral infection because when BV from Ac∆odv-
e56Pol+ infected cells was injected into the hemocoels of fourth instar T. ni larvae, 100% 
mortality was seen. Interestingly, the larva that did die in the top dose of 10,000 Ac∆odv-
e56Pol+ OBs on average had a survival time that was not significantly different to 
Ac∆chitinasePol+ average survival times at the same dose. This degree of impairment of 
oral infectivity observed here for Ac∆odv-e56Pol+ is in agreement with previous studies 
carried out with H. virescens larva (Harrison et al., 2010; Sparks et al., 2011a). 
Electron microscopy imaging of Ac∆odv-e56Pol+ OBs showed no apparent difference in 
structure or ODV packaging when compared to images of OBs from Ac∆chitinasePol+ . 
However, the Ac∆odv-e56Pol+ OBs did seem to be surrounded by another protein structure. 
This was only observed in Ac∆odv-e56Pol+ OBs images and not in those from 
Ac∆chitinasePol+ or the other two deletion mutant viruses, suggesting that this structure has 
been altered in Ac∆odv-e56Pol+ and has survived the purification process. This unidentified 
protein structure is most likely comprised of P10 that has been shown to be involved in 
cell lysis and interacts with host cell microtubules to form a cage like structure around OBs 
inside the nuclei of the infected cells to aid release of the OBs (Patmanidi et al., 2003; 
Carpentier et al., 2008). However, another explanation for this protein structure could be 
due to malformation of the polyhedron envelope, which has allowed other non-specific 
proteins to be incorporated into it causing an expansion of the polyhedron envelope. 
Electron microscopy analysis carried out by Harrison et al. (2010), on deletion mutant odv-
e56 OBs in infected insect cells, showed no obvious differences in structure or ODV 
packaging as shown in Figure 5.8, panel D1-D4. However, these images were of 
unpurified OBs in infected cells and therefore the protein structure observed in Figure 5.8, 
panel D1-D4 wouldn’t have been detected. The presence of this structure still surrounding 
Ac∆odv-e56Pol+ OBs could have affected the breakdown of the OB in the larva midgut 
stopping the release of ODVs and may help explain the results seen in the bioassay. This 
is further confirmed by Sparks et al. (2011a) that demonstrated that ODV purified from 
deletion mutant odv-e56 OBs increased oral infectivity from the five orders of magnitude 
less infectious seen comparing OBs from AcMNPV to two orders of magnitude less 
infectious when compared against AcMNPV ODV. It would be interesting to isolate OBs 
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from Ac∆odv-e56Pol+-infected insect after injection with BV and determine how dissolution 
of polyhedra in the presence of alkaline solutions is affected by this newly observed 
structure. It would also be possible to use immunoblotting to confirm the hypothesis that it 
comprises P10. 
 
5.9.4 Conclusion 
 
For all three virus gene deletion mutants the results obtained from the time course 
observing BV production kinetics seems to conflict with the current literature. Repetition of 
the experiments to ensure reproducibility would be advisable as would deriving further 
recombinant viruses where each gene target has been rescued at the polh locus.  The 
rescue viruses are more easily obtainable now due to the polyhedrin-positive forms having 
a marker to indicate insertion of the rescue gene fragment at the polyhedrin locus. The 
derivation of baculovirus mutants is now relatively facile given the availability of the Red-
ET system in E. coli, but this method is accompanied by the risk of random mutations 
elsewhere in the virus genome.   
It is possible that the deformed PE observed with Ac∆cg30Pol+ OBs is a consequence of 
other mutations in the virus genomes of Ac∆cg30 or Ac∆cg30Pol+ affecting PE envelope 
protein production. Western blot analysis using antibody for PE to demonstrate the 
temporal expression of PE could show if the expression profile for Ac∆cg30Pol+ throughout 
a time course closely matched its parental virus profile; Ac∆chitinasePol+. DNA sequencing 
across the PE locus could indicate whether or not any mutations at the DNA level have 
occurred that could cause the observed effect of deformed PE either through change in 
amino acid sequence or the expression of PE. If the affect is pin pointed to the cg30 
deletion then studies could be directed to the survivability of these degraded OBs to 
different environmental factors such as temperature and UV and the affects these could 
have on oral infectivity of larva. Studies could also be directed towards the reason for the 
deletion of cg30 to cause this loss of PE. CG30 does contain two DNA binding motifs, 
comprising a zinc ring finger motif (C3HC4) and a leucine zipper motif at the C-terminus 
and N-terminus, respectively (Thiem and Miller, 1989). This could suggest that CG30 
directly or indirectly affects PE expression by binding to specific DNA sequences; however 
an indication of this would be given by the western blot analysis and DNA sequencing of 
PE suggested earlier.  
The unidentified protein structure surrounding Ac∆odv-e56Pol+ OBs shown by the election 
microscopy analysis could be further investigated, and either confirmed or denied as P10 
as suggested here by using election microscopy analysis with immunostaining to see if 
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the P10 antibody binds the unidentified protein structure. If it was confirmed as P10 and 
there was no indication of mutation to the p10 sequence in Ac∆odv-e56Pol+ then a double 
deletion mutant virus could be constructed in which both p10 and odv-e56 had been 
deleted (Ac∆p10/odv-e56Pol+). Election microscopy analysis could be used to observe the 
Ac∆p10/odv-e56Pol+ OBs structure and bioassay could be used to test the oral infectivity of 
these OBs compared to parental and single deletion mutant viruses. However, it has been 
suggested that ODV-E56 plays a role in ODV morphogenesis that could suggest that the 
removal of p10 maybe not fully restore the oral infectivity of Ac∆odv-e56Pol+ (Braunagel 
and Summers, 2007). 
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6.1 Introduction 
 
The final two viruses generated using the Red/ET recombination system had deletions in 
pif2 and pif3, respectively, to yield Ac∆pif2 and Ac∆pif3. The baculovirus pif2 and pif3 
have already been characterised as members of the pif family of genes, which have an 
important role in facilitating per os infectivity of ODV. This chapter will provide a brief 
introduction to pif2 and pif3 and then focus on experimental work to investigate the 
possible effects these two deletions could have on recombinant protein expression.  
The Ac∆pif2 virus contains the reporter gene lacZ at the polh locus allowing expression 
tests to be carried out to observe any effects the pif2 deletion has on recombinant protein 
expression under the control of the polh promoter. However, the Ac∆pif3 virus contains no 
reporter gene and requires insertion of such genes at the polh locus using classical 
techniques, using the AvrII site to linearise Ac∆pif3 at the essential gene orf1629 prior to 
cotransfection with a plasmid transfer vector containing the foreign coding region. 
 
6.1.1 per os infectivity factor (PIF) family 
 
The per os infectivity factor (PIF) family contains proteins that are non-essential for viral 
replication but are essential for oral infection of the host lepidopteran larvae by AcMNPV 
and other baculoviruses. To date, the PIF family consists of PIF0 (P74; Faulkner et al., 
1997), PIF1 (ORF119; Kikhno et al., 2002), PIF2 (ORF22; Pijlman et al., 2003), PIF3 
(ORF115; Ohkawa et al., 2005), PIF4 (ODV-E28; Fang et al., 2009) and PIF5 (ODV-E56; 
(Sparks et al., 2011a)) that are all core genes conserved among all sequenced 
baculoviruses. Homologues of the PIF family are also found in nudiviruses, which are 
double-stranded DNA viruses that infect insects and are related to the Baculoviridae 
(Wang et al., 2007). The two proteins of interest in this study were PIF2 (Pijlman et al., 
2003) and PIF3 (Ohkawa et al., 2005) that have already been demonstrated to be 
members of the PIF family. 
 
6.1.2 PIF2 
 
PIF2 was first characterized in Spodoptera exigua multiple nucleopolyhedrovirus 
(SeMNPV) as ORF35 (Pijlman et al., 2003). The pif2 is found in all sequenced 
alphabaculoviruses and betabaculoviruses; alignments of pif2 homologues can be seen in 
Chapter 3. The AcMNPV homologue for pif2 is ORF22 that produces a 44 kDa protein 
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that contains highly conserved hydrophobic N-terminal transmembrane motif, which is 
used to anchor PIF2 to the ODV envelope (Braunagel et al., 2003).   
 
PIF2 is believed to be involved in mediating specific binding of ODV to the primary midgut 
cells in oral infection of larva (Pijlman et al., 2003; Ohkawa et al., 2005). It has been more 
recently demonstrated that PIF2 along with three other conserved PIF proteins, P74, PIF1 
and PIF3, form a stable complex on the surface of the ODV, which is essential for the 
early stages of baculovirus oral infection (Peng et al., 2010). 
 
6.1.3 PIF3 
 
The AcMNPV pif3 (ORF115) produces a 23 kDa protein and is found in all sequenced 
alphabaculoviruses and betabaculoviruses. PIF3, like most other ODV envelope proteins 
contains an N-terminal transmembrane domain, which most likely anchors the protein to 
the ODV envelope (Ohkawa et al., 2005). However, PIF3 was not located to the ODV 
envelope during a protein composition analysis of AcMNPV ODV (Braunagel et al., 2003). 
Peng et al. (2010) further demonstrated this by electron microscopy analysis that localized 
PIF2 to the surface of the ODV with a scattered distribution but was unable to detect PIF3 
on the ODV surface or the nucleocapsid; therefore the localization of PIF3 on the ODV is 
still inconclusive. However, Peng et al. (2010) did demonstrated PIF3 to be part of a 
stable protein complex along with other PIF proteins on the surface of the ODV. 
 
Unlike the other PIF proteins, PIF3 deletion mutant viruses showed similar ODV binding 
levels as wild-type virus, during binding and fusion assays. Therefore, this protein must be 
involved in a critical event in early primary infection such as translocation of the ODV 
capsids along the microvillus of the midgut cells or interacting with cytoskeletal elements 
aiding transport of the ODV, if it is located to the inside of the ODV envelope (Ohkawa et 
al., 2005; Slack and Arif, 2007).  
 
6.2 Characterization of Ac∆pif2 and Ac∆pif3 
 
The Red/ET recombination system was successfully used to produce deletion mutant 
bacmids ∆pif2 and ∆pif3. In ∆pif2, the majority of the pif2 coding region was removed and 
replaced with a kanamycin resistance gene, leaving 50bp of pif2 at the 5’ end to ensure 
that the orf21 promoter was unaffected by the deletion (Figure 6.1, panel A). In the case of 
∆pif3, only part of the pif3 coding region was removed and replaced with a kanamycin 
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resistance gene, leaving 159 bp of at the 5’ end to ensure that the orf114 promoter was 
unaffected by the deletion (Figure 6.1, panel B). Chapter 4 provides a more detailed 
explanation of the method used to create these deletion mutant bacmids using the 
Red/ET recombination system and the methods used to confirm the deletions. 
Ac∆pif2 and Ac∆pif3 were obtained by transfection of Sf9 cells with bacmid DNA and 
recovery of budded virus (as described in Chapter 4). The BV was amplified further in Sf9 
cells to provide working stocks of titrated virus for further study. Ac∆pif2 amplified to 
7.4x107 pfu/ml and Ac∆pif3 amplified to 5.0x106 pfu/ml. 
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Figure 6.1 Schematic of the construction of ∆pif2 (A) and ∆pif3 (B) bacmids 
 
The pif2 and pif3 ORFs were partially deleted by the insertion of a DNA fragment encoding a  
kanamycin resistance cassette between 17351-18449 (A) and 99341-99796 (B) bp positions 
respectively on the AcMNPV genome via homologous recombination in E. coli using the Red/ET 
recombination system.  
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6.3 Temporal analysis of virus replication in Ac∆pif2- and 
AcBacPAK5lacZ/BACpol -infected Sf9 cells. 
 
A time course study was carried out and samples were taken over 120 hours from 
triplicate Sf9 cultures either mock-infected or infected with Ac∆pif2 or 
AcBacPAK5lacZ/BACpol at a moi of 5 pfu/cell. These samples were analysed to determine 
any affects that the pif2 deletion could have on the expression of the recombinant protein 
β-galactosidase, cell viability and BV production kinetics.  
 
6.3.1 Virus-infected cell viability 
Cell viability analysis showed that mock-infected cells remained >96% viable until the end 
of the experiment at 96hpi. The viability of the virus-infected cells began to differ from the 
mock-infected from 24hpi. After this point there was a continuous decrease in cell viability, 
which followed the same trend for both viruses until 72hpi. At the 72hpi and 96hpi 
sampling points, AcBacPAK5lacZ/BACpol infected cells had decreased to approximately 
9% and 5% viability, respectively. The Ac∆pif2 infected cells decreased to approximately 
17% and 9% at these time points (Figure 6.2). The cell viability readings were not taken at 
120hpi due to the reading for 96hpi being so close to zero for both viruses. Anova 
statistical analysis demonstrated that there was no significant difference between 
AcBacPAK5lacZ/BACpol and Ac∆pif2 infected cell viabilities (P>0.05). 
 
6.3.2 Budded virus production  
The AcBacPAK5lacZ/BACpol and Ac∆pif2 infectious virus titres for each time point were 
obtained using the plaque assay method (See methods section 2.3.4a; Figure 6.3). A 
decrease in titre between 0hpi and 12hpi was observed for both viruses. The 
AcBacPAK5lacZ/BACpol titre increased sharply between 12hpi and 48hpi from 1.00x105 
pfu/ml to 9.88x106 pfu/ml. This increase continued to 120hpi, where a final BV titre of 
1.57x107 pfu/ml was reached. The Ac∆pif2 BV production kinetics differed from those of 
AcBacPAK5lacZ/BACpol in that after an inital lag phase until 12hpi, the subsequent 
exponential period of infectious virus release was not as rapid (Figure 6.3). Between 12hpi 
and 48hpi BV titres increased from 2.08x105 pfu/ml to 1.24x107 pfu/ml. By 96hpi, the titres 
of both viruses were almost identical and by 120 hpi Ac∆pif2 attained a titre of 1.58x107 
pfu/ml. Despite these temporal differences, Anova statistical analysis demonstrated that 
there was no significant difference between AcBacPAK5lacZ/BACpol and Ac∆pif2 BV 
production kinetics (P>0.05). A two-tailed student t-test performed on individual time 
points showed no significant difference (P>0.05) between AcBacPAK5lacZ/BACpol and 
Ac∆pif2 titres, confirming these slight differences in BV production kinetics were not 
significant even at individual time points.  
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Figure 6.2 Cell viability of AcBacPAK5lacZ/BACpol or Ac∆pif2-infected Sf9 cells. 
Cultures of Sf9 cells were infected with AcBacPAK5lacZ/BAC
pol 
or Ac∆pif2 (MOI = 5 pfu/cell) and 
cell viability was assessed at the indicated time points. The experiment was terminated before the 
final time point at 120hpi owing to the very low cell viability. Standard error bars are shown. N = 3. 
Figure 6.3 Kinetics of budded virus production by Ac∆pif2 
Budded virus production by AcBacPak5LacZ/Bac
pol 
and Ac∆pif2, The Sf9 cells were infected as 
described in Figure 6.2. Standard error bars are shown. N = 3. 
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6.3.3 β-galactosidase production  
 
The production of β-galactosidase was also measured during the virus-infected cell time 
course (see method section 2.7.3a). Both the virus-infected cell culture medium and cell 
pellets were assayed (Figure 6.4). In the β-galactosidase assay on virus-infected cell 
pellets, there was no detectable enzyme activity until 24hpi for either virus. The 
AcBacPAK5lacZ/BACpol -infected cell pellet β-galactosidase activity increased sharply after 
24hpi reaching a peak of 10.62 u/106 cells at 48hpi. Thereafter, enzyme activity levels in 
virus-infected cells decreased to 1.68 u/106 cells at 120hpi. The activity of β-galactosidase 
in Ac∆pif2-infected cell pellets also increased rapidly between 24hpi and 48hpi reaching 
4.78 u/106 cells at the latter time point. However, the peak activity of β-galactosidase was 
reached at 72 hpi with 5.14 u/106 cells before decreasing to 0.54 u/106 cells at 120 hpi. 
Despite these temporal differences, Anova statistical analysis demonstrated that there 
was no significant difference between AcBacPAK5lacZ/BACpol and Ac∆pif2 cell pellets β-
galactosidase activities (P>0.05). However, the two-tailed student t-test did show a 
significant difference (P<0.05) between the β-galactosidase activity of 
AcBacPAK5lacZ/BACpol and Ac∆pif2-infected cell pellets at 48hpi.  
The levels of β-galactosidase activity in culture medium from virus-infected cells remained 
below those introduced by the virus inocula (less than 0.52 u/106 cells) until 48hpi. The 
levels of β-galactosidase in AcBacPAK5lacZ/BACpol infected cells increased sharply from 
24hpi until 72hpi reaching 1.70 u/106 cells. After this time point, the β-galactosidase 
activity in the medium continued to increase but at a lower rate, reaching a final activity of 
2.14 u/106 cells at 120hpi. In Ac∆pif2-infected cells, β-galactosidase activity increased 
sharply from 24hpi to 48hpi reaching 1.58 u/106 cells, before dropping to 0.92 u/106 cells 
at 72hpi and remaining at a similar level until 120hpi. Anova statistical analysis 
demonstrated that there was no significant difference between the β-galactosidase activity 
in media from AcBacPAK5lacZ/BACpol- and Ac∆pif2-infected cell cultures (P>0.05). 
However, a two-tailed student t-test did show a significant difference (P<0.05) between 
the β-galactosidase activity in media from AcBacPAK5lacZ/BACpol- and Ac∆pif2-infected 
cell cultures between 48hpi and 120hpi. 
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Figure 6.4 β-galactosidase activities in virus-infected cell cultures 
β-galactosidase activity in Sf9 cells infected with AcBacPak5LacZ/Bac
pol 
or Ac∆pif2 (MOI = 5 
pfu/cell). Cell pellets (A) and virus-infected cell culture media (B). Standard error bars are shown 
for the 120 hour time course. N = 3. 
A 
B 
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6.4 Construction of recombinant viruses for urokinase synthesis 
 
The Ac∆pif2 described in the previous section had demonstrated a significant increase in 
the release of β-galactosidase from virus-infected cells at 48hpi compared to 
AcBacPAK5lacZ/BACpol. To investigate this observation further, both Ac∆pif2 and 
AcBacPAK5lacZ/BACpol viruses were modified to express the secreted protein urokinase, 
in place of β-galactosidase. Urokinase was chosen due to the availability of an easy to 
use activity assay kit (Millipore) and a baculovirus transfer vector, which already contained 
urokinase under the polh promoter. 
This modification was carried out by cotransfection of Sf9 cells with a baculovirus transfer 
vector containing urokinase (pBacPAK8-urokinase; R. B. Hitchman, personal 
communication) and either Ac∆pif2 or AcBacPAK5lacZ/BACpol DNA, which had been 
linearized by restriction enzyme digestion with Bsu361. Both of these virus genomes 
contain a single Bsu361 site within lacZ at the polh locus. Recombination between these 
viruses and pBacPAK8-urokinase should remove lacZ/BAC at the polh locus and replace 
it with urokinase. The resulting recombinant viruses were plaque-purified three times, to 
generate genetically homogeneous lacZ-negative plaques (plaques that did not turn blue 
when stained with X-gal; data not shown). Each of the plaque-purified viruses amplified to 
titres of ~9x107 pfu/ml and virus-infected cells did not turn blue in the presence of X-gal 
(data not shown) suggesting an absence of parental  virus. The viruses were designated 
AcBacPAK5urokinasepol and AcBacPAK5urokinasepol∆pif2 (AcUK∆pif2). 
To determine if AcBacPAK5urokinasepol and AcUK∆pif2 were producing urokinase, Sf9 
cells were infected with either of these viruses or with a positive control virus known to 
express urokinase (flashBAC-UK; R. B. Hitchman, personal communication) at an MOI of 
5 pfu/cell and cell pellets and culture medium were harvested at 48hpi. The protein 
content for each of the cell lysates was determined using Quabit (Quigen). Samples 
(15µg) were fractionated by SDS PAGE and either stained with Coomassie blue or blotted 
onto a nitrocellulose membrane (See method section 2.7.1). Western blot analysis was 
then performed by using antibody to urokinase (See method section 2.7.2; Figure 6.5). 
This showed that both AcBacPAK5urokinasepol- and AcUK∆pif2-infected Sf9 cells were 
expressing urokinase from the polyhedrin promoter, demonstrated by the accumulation of 
urokinase at 48hpi. Therefore, confirming that the urokinase had successfully been 
inserted into these two viruses. The next stage was to examine the expression profile of 
urokinase by these two viruses along with the production of BV throughout the replication 
cycle of infected Sf9 cells.  
 
Chapter 6 
 
168 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5 Coomassie blue and western blot analyses of AcBacPAK5urokinasepol and 
AcUK∆pif2-infected Sf9 cells 
Cell lysates from Sf9 cells infected with either flashBAC-UK (P), AcBacPAK5urokinase
pol 
or
 
AcUK∆pif2 were collected at 48 hpi and 15 µg of protein from each lysate was fractionated using 
12% SDS-PAGE before staining with Coomassie blue or transfer to filters for probing with antibody 
to urokinase. M indicates mock-infected cells. Arrow indicates the predicted band for urokinase in 
both images. 
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6.5 Temporal analysis of virus replication in AcBacPAK5urokinasepol and 
AcUK∆pif2 infected Sf9 cells. 
 
Triplicate Sf9 cultures were infected with either AcBacPAK5urokinasepol or AcUK∆pif2 at a 
moi 5 and cell viability, BV production and urokinase synthesis were analysed over 120 
hours to determine any effects of the pif2 deletion on these processes   
 
6.5.1 Cell viability 
 
Cell viability analysis showed that mock-infected cells remained >94% viable until the end 
of the experiment at 120hpi. The viability of the virus-infected cells differed from mock-
infected cells after 24hpi (Figure 6.6). After this point there was a continuous decrease in 
cell viability that followed the same trend for both viruses. However, 
AcBacPAK5urokinasepol infected cells were approximately 5% less viable (48%, 15% and 
6%, respectively) than AcUK∆pif2 infected cells at each time point after 24hpi (Figure 6.6). 
However, these slight differences between BacPAK5urokinasepol and AcUK∆pif2 infected 
cells were shown not to be significantly different (P>0.05) when Anova statistical analysis 
was performed on the data.  
 
6.5.2 Budded virus production  
 
The AcBacPAK5urokinasepol and AcUK∆pif2 titres for each time point were obtained using 
the plaque assay method (See methods section 2.3.4a; Figure 6.7). Neither virus showed 
an increase in BV until after 12hpi. The AcBacPAK5urokinasepol titre increased sharply 
between 12hpi and 24hpi from 3.5x105 to 1.77x108 pfu/ml and reached a final titre of 
3.43x108 pfu/ml at 120hpi. The AcUK∆pif2 BV production kinetics were similar to that of 
AcBacPAK5urokinasepol with a rapid increase between 12hpi and 24hpi from 3.07x104 to 
1.8x108 pfu/ml and reaching a final titre of 2.67x108 pfu/ml at 120hpi. The BV production 
kinetics of AcUK∆pif2 slightly differed from that of AcBacPAK5urokinasepol. However, 
Anova statistical analysis demonstrated that there was no significant difference between 
AcBacPAK5urokinasepol and Ac∆pif2 BV production kinetics (P>0.05). 
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Figure 6.6 Cell viability of AcBacPAK5urokinasepol and AcUK∆pif2-infected Sf9 cells. 
Cultures of Sf9 cells were infected with AcBacPAK5urokinase
pol
 and AcUK∆pif2 (MOI = 5 pfu/cell) 
and cell viability was assessed at the indicated time points. The experiment was terminated before 
the final time point at 120hpi owing to the very low cell viability. Standard error bars are shown. N = 
3. 
Figure 6.7 Kinetics of budded virus production by AcBacPAK5urokinasepol and 
AcUK∆pif2  
Budded virus production by AcBacPAK5urokinase
pol
 and AcUK∆pif2, The Sf9 cells were infected 
as described in Figure 6.6. Standard error bars are shown during 120 hour time course. N = 3. 
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6.5.3 Urokinase production  
 
The production of urokinase was measured during this time course study using a standard 
urokinase assay method (See method section 2.7.3b; Millipore). Measurements were 
taken from both the virus-infected cell culture medium and cell pellets (Figure 6.8).  
The activity of urokinase in AcBacPAK5urokinasepol infected cell pellets increased rapidly 
from 0hpi and reached a peak concentration of 139 units/ml at 48hpi (Figure 6.8 A). After 
this point the activity of urokinase declined to 66 units/ml at 120hpi. In AcUK∆pif2 infected 
cell pellets, urokinase activity followed the same trend as AcBacPAK5urokinasepol. 
However, the peak urokinase activity at 48hpi was only 85 units/ml and 46 units/ml at 120 
hpi. Despite these temporal differences, Anova statistical analysis demonstrated that there 
was no significant difference between AcBacPAK5urokinasepol and AcUK∆pif2 cell pellets 
urokinase activities (P>0.05). However, a two-tailed student t-test performed on individual 
time points did show a significant difference (P<0.05) between 48 hpi to 120 hpi.  
The urokinase activities in the cell culture medium samples from both 
AcBacPAK5urokinasepol and AcUK∆pif2-infected Sf9 cultures were about 25-fold higher 
than in the corresponding cell pellets described above (Figure 6.8 B). The peak urokinase 
activity was approximately 3480 units/ml at 48 hpi for both viruses. This decreased to 
2982 units/ml for AcBacPAK5urokinasepol and to 2671 units/ml for AcUK∆pif2 at 120 hpi. 
Anova statistical analysis demonstrated that there was no significant difference between 
the urokinase activity in media from AcBacPAK5urokinasepol and AcUK∆pif2-infected Sf9 
cultures (P>0.05). However, the two-tailed student t-test showed a significant difference 
(P<0.05) between the urokinase activity in AcBacPAK5urokinasepol and AcUK∆pif2 
infected cell culture medium samples at 72 hpi and the two subsequent time points. 
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Figure 6.8 Graphical presentation of Urokinase expression against time for 
AcUK∆pif2 Time Course.  
 
Urokinase activity in Sf9 cells infected with AcBacPAK5urokinase
pol
 or AcUK∆pif2 (MOI = 5 
pfu/cell). Cell pellets (A) and virus-infected cell culture media (B). Standard error bars are shown 
for the 120 hour time course. N = 3. 
A 
B 
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6.6 AcΔpif3 
 
The results described in Chapter 4 (section 4.5) demonstrated that Ac∆pif3 was infectious 
when Sf9 cells were transfected with ∆pif3 DNA. Firstly, the cells showed signs of a virus-
induced cytopathic effect. Secondly, virus DNA could be purified from the medium 
supporting the growth of Sf9 cells transfected with the ∆pif3 bacmid, which suggested that 
BV had been produced. However, subsequent amplification of the Ac∆pif3 BV showed 
that this virus was unable to produce high titre stocks. Typically, Ac∆pif3 attained titres of 
only 5x106 pfu/ml, whereas other viruses had infectious titres at least 10-fold higher.  The 
low titres of Ac∆pif3 rendered it unsuitable for determining the effect of this gene deletion 
in recombinant protein production. Therefore, the next sections of this chapter describe 
experiments to resolve whether or not the reduction in BV production was due to the 
deletion of pif3 or a bystander effect on a neighbouring gene. 
 
6.6.1 Rescue of pif3 
 
In this study, the region of the AcMNPV genome deleted to remove pif3 (ORF115) 
encompassed nucleotides 99132 – 99796, leaving ORFs 114 and 116 intact. However, 
when the strategy used by Ohkawa et al. (2005) to delete pif3 was compared with the one 
described in Chapter 4, it was noted that the deletion made to the 3’ end of pif3 extended 
to within 40 bp of a potential early promoter (CGTGC) for ORF114. The deletion made by 
Ohkawa et al. (2005) extended to within 64 bp of this sequence. The region deleted at the 
other end of pif3 was very similar in both studies.   
Therefore, to investigate if this 24 bp difference was responsible for the defect in Ac∆pif3 
BV production, an intact orf114 was restored to the polyhedrin locus of Ac∆pif3. In an 
additional experiment, orf116 was also inserted at the polyhedrin locus in Ac∆pif3 to 
ensure that it too hadn’t been affected by the pif3 deletion. Finally, the pif3 was also 
restored and rescued at the polyhedrin locus of Ac∆pif3; to determine if the loss of pif3 
was the cause of the abnormal BV production.  
The orf114, pif3 and orf116 coding regions and their predicted promoters were amplified 
using specific primers with AcMNPV DNA as a template and a proof reading polymerase 
(Expand, Roche). The amplified gene fragments were then inserted into a Topo vector 
and sequenced. The gene fragments were removed from the vector and ligated into a 
modified pBAC1 (pBAC1∆PP) to allow insertion of each gene at the polh locus. The 
modification of pBAC1 involved the removal of the polh promoter to allow the selected 
genes to be expressed by only their own promoters. The modified region of pBAC1∆PP 
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was sequenced. Figure 6.9 describes the cloning strategy used with protocols described 
in methods (section 2.6). All constructs were confirmed by RE mapping (data not shown). 
Insect Sf9 cells were cotransfected with one of pBAC1∆PP-orf114, pBAC1∆PP-pif3 or 
pBAC1∆PP-orf116 and ∆pif3 bacmid DNA purified from E. coli and linearised by restriction 
enzyme digestion with AvrII. The ∆pif3 contains a single AvrII site located within the 
essential gene orf1629. These cotransfections rescued the target gene at the polh locus. 
For the rescue to occur at the pif3 locus, the deletion mutant bacmid DNA purified from E. 
coli was linearised by restriction enzyme digestion with SrfI and cotransfected with the 
Topo vector containing pif3. The deletion mutant bacmids all contain two SrfI sites flanking 
the kanamycin insert.  
The cell culture medium from each cotransfection was titrated using a plaque assay to 
determine if viable recombinant virus was produced. The results demonstrated that 
Ac∆pif3 was only rescued by insertion of pif3 at its own or the polh locus. The 
cotransfections between Ac∆pif3 and pBAC1∆PP-orf114 or pBAC1∆PP-orf116 failed to 
rescue the parental virus.  Interestingly, the cell culture medium from Sf9 cells transfected 
with linearised ∆pif3 bacmid DNA failed to produce plaques in the subsequent assay, 
suggesting that the residual circular DNA was unable to initiate an infection. Further 
attempts to rescue orf114 or orf116 at the polyhedrin locus of the ∆pif3 yielded the same 
results. Only the rescue of pif3 function could restore infectivity to linearised ∆pif3 bacmid 
DNA. Therefore it was decided to continue further analyses with the two viruses rescued 
with pif3 at the polyhedrin locus (Ac∆pif3-Rpif3pol) or its native locus (Ac-pif3r). 
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Figure 6.9 Insertion of baculovirus genes into pBAC1 
 
(A)The baculovirus transfer vectors were constructed using standard classical cloning techniques. 
The target genes were amplified by PCR using Expand DNA polymerase and inserted into the 
Invitrogen Topo vector, where their sequences were confirmed. The target genes were subcloned 
from the Topo vector into the SacI and XhoI sites of the modified pBAC1 (pBAC1∆PP). These 
baculovirus transfer vectors permitted insertion of the target gene under the control of its own 
promoter into the baculovirus genome at the polh locus via homologous recombination in insect 
cells.  
 
(B) Sf9 Cells co-transfected with pBAC1∆PP+Gene and AvrII linearised ∆pif3 bacmid DNA, to form 
Ac∆pif3+Gene
Pol
 bacmid DNA. 
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6.6.2 Infectivity of Ac∆pif3 and rescued viruses Ac∆pif3-Rpif3pol and Ac-pif3r 
 
The next step was to investigate whether or not these pif3-rescued viruses could reach 
normal levels of BV infectivity when amplified in Sf9 cells. Briefly, 500µl of medium from 
each transfection that produced Ac∆pif3-Rpif3pol and Ac-pif3r were added to 50ml of Sf9 
shake cell cultures (2x106 cells/ml) and incubated at 28°C for 5 days to produce p1 stocks. 
The infectivity of each stock was determined by plaque assay. These data allowed P2 
stocks in Sf9 cells to be produced by using an moi of 0.1 pfu/cell. This process was 
repeated to produce p3 virus stocks. The results of the plaque assay titrations for each 
virus stock are summarized in Table 6.1. Similar results were obtained with replicate 
viruses for each genotype. These results clearly show that Ac∆pif3 is unable to achieve 
titres as high as those for either AcBAC∆chitinase or Ac∆pif3-Rpif3pol and Ac-pif3r. Both 
pif3 rescue viruses achieved similar titres to AcBAC∆chitinase at all passages examined, 
which suggests the cause of the low titres observed in Ac∆pif3 is due to the deletion of 
pif3 and not another mutation that could have occurred in the virus during the deletion 
process with the Red/ET recombination system.  
Table 6.1 Budded virus titres for Ac∆pif3, Ac-pif3 and Ac∆pif3-Rpif3pol stocks  
 Titre (pfu/ml)   
Virus P1 stock P2 stock P3 stock 
AcBAC∆chitinase 1.4x108 3.2x108 2.6x108 
AcBAC∆chitinase 1.2x108 2.8x108 2.3x108 
Ac∆pif3 1.7x106 1.9x106 1.4x106 
Ac∆pif3 1.0x107 2.6x106 1.7x106 
Ac-pif3r 1.6x108 5.9x108 2.4x108 
Ac-pif3r 2.2x108 3.5x108 2.9x108 
Ac∆pif3-Rpif3pol 1.1x108 3.4x108 3.1x108 
Ac∆pif3-Rpif3pol 1.2x108 3.0x108 2.8x108 
 
To confirm the identities of the Ac∆pif3, Ac-pif3r and Ac∆pif3-Rpif3pol P3 stocks, DNA was 
purified from virus-infected cells at 48hpi and the pif3 locus in each virus amplified using 
specific primers external and internal to the target locus (Figure 6.10).  
The external primers were specific to a region 96 bp upstream and 123 bp downstream of 
the pif3 locus. The insertion of the kanamycin resistance cassette in lieu of pif3 was 
predicted to result in the amplification of a 1210 bp fragment with this primer set. If the 
original gene was still present, a fragment of 833 bp was predicted. For AcBAC∆chitinase 
(Figure 6.10, lane 3) and Acpif3r (Figure 6.10, lanes 8 and 9), a fragment of approximately 
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800 bp was produced in the PCR. For Ac∆pif3 and Ac∆pif3-Rpif3pol (Fig. 6.10, lanes 4-5 
and 6-7, respectively) a fragment of approximately 1200 bp was amplified. The primers 
internal to pif3 amplified a 295 bp DNA fragment in AcBAC∆chitinase, Ac∆pif3-Rpif3pol and 
Ac-pif3r (Figure 6.10, lanes 3, 6-7 and 8-9, respectively). A pif3-specific DNA fragment 
was not amplified in Ac∆pif3 (Figure 6.10, lanes 4-5). These results confirmed the 
identities of Ac∆pif3, Ac-pif3 and Ac∆pif3-Rpif3pol. 
 
 
Figure 6.10 PCR analyses of Ac∆pif3, Ac-pif3r and Ac∆pif3-Rpif3pol DNA 
 
Template DNA for Ac∆pif3 (lanes 4-5), Ac∆pif3-Rpif3
pol 
(lanes 6-7) and
 
Ac-pif3
r
 (lanes 8-9) was 
isolated from virus-infected cells and analysed by PCR using primers external (ACC15/16; upper 
panel) and internal (ACC39/40; lower panel) to pif3. Lanes 1 and 10, NEB log2 Markers; lane 2, 
negative control; lane 3, AcBAC∆chitinase. 
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6.6.3 Construction of 6xHis-tagged pif3 virus (Ac-hispif3) 
 
To investigate further the role of PIF3 in viral replication, a rescue of ∆pif3 bacmid DNA 
with 3’ polyhistidine-tagged (6xHis-tag) pif3 was performed to allow localisation of the 
protein during viral infection to be observed using confocal microscopy. This was 
necessary because an antibody to PIF3 was not available. 
The virus deletion mutant Ac∆pif3 was modified by inserting a 6xHis-tagged pif3 at the 
native locus to generate Ac-hispif3. The his peptide was added to the C-terminus of PIF3 
as the N-terminus contains a transmembrane domain, which might have prevented 
detection of the his-tag in later experiments.  
A DNA fragment encoding pif3 with his tag sequences at the 3’ end of the gene was 
generated in two rounds of PCR (Figure 6.11). The first round used specific primers 
(hispif3-1F and hispif3-1R) and AcMNPV template DNA to add the sequence encoding the 
C-terminus 6xHis-tag to pif3. In the second round of PCR, the primers added 40 bp of 
sequence homologous to regions flanking pif3. This DNA fragment containing the 
modified pif3 was inserted into a Topo vector prior to sequencing to confirm the fidelity of 
the construction (pTOPO-hispif3) (Figure 6.11).  
Insect Sf9 cells were cotransfected with pTOPO-hispif3 and ∆pif3 bacmid DNA from E. 
coli that had been linearised by restriction enzyme digestion with SrfI. The Ac∆pif3 
contains two SrfI sites flanking the kanamycin insert at the pif3 locus. Recombination 
between the homologous sequences in pTOPO-hispif3 and the native locus for the gene 
target in Ac∆pif3 resulted in insertion of the modified version of pif3. The virus produced, 
Ac-hispif3, was plaque purified for three rounds to ensure the removal of parental Ac∆pif3 
and amplified to a high titre working stock (2.3x108 pfu/ml) in Sf9 cells, suggesting the 
6xHis-tag of pif3 had not affected the replication of the virus.  
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Figure 6.11. Schematic showing the construction of 6xHis-tagged pif3 fragment and 
insertion into Topo vector.  
 
The pif3 was amplified twice by PCR using Expand DNA polymerase; in the first PCR 6xHis-tag 
coding sequence was added to the gene using primers Hispif3-1F and Hispif3-1R. In the second 
PCR homologous arms were added using primers Hispif3-2F and Hispif3-2R. The 6xHis-tagged 
pif3 fragment was inserted into the Invitrogen Topo vector to derive pTOPO-hispif3 prior to 
sequencing and cotransfection with Ac∆pif3 to derive Ac-hispif3. 
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6.6.4 Immunoblotting  analysis of Ac-hispif3 PIF3 expression 
 
To determine if the C-terminus 6xHis-tag coding region added to PIF3 resulted in the 
production of the anticipated protein, Ac-hispif3 was used to infect Sf9 cells prior to 
analysis of the virus-induced polypeptides using immunoblotting.  Successful his-tagging 
of PIF3 would then allow the temporal expression of pif3 to be examined in more detail.   
Nine 35mm dishes, each containing 2x106 Sf9 cells were infected with Ac-hispif3 at an 
MOI of 5. Triplicate dishes were harvested at 12, 24 and 48hpi. and the protein content of 
each cell lysate was determined using Quabit (Quigen). Fifteen µg of protein were then 
fractionated by SDS PAGE and blotted onto nitrocellulose membrane. Western blot 
analysis was then performed by using antibody to the 6xHis-tag (See method section 
2.7.2; Figure 6.12).  
 
 
 
Figure 6.12. Western blot analysis of Ac-hispif3 infected Sf9 cells 
Triplicate Sf9 cell cultures infected with Ac-hispif3 (MOI, 5 pfu/cell) were harvested at 12 (lanes 4, 7 
and 10), 24 (lanes 5, 8 and 11), and 72 (lanes 6, 9 and 12) hpi, lysed and 5µg of protein 
fractionated using a 12% SDS-PAGE.  The proteins were transferred to nitrocellulose and probed 
with antibody to 6xHis-tag. Lanes 1-3 contain mock-infected cells harvested at 12, 24 and 48hpi, 
respectively. An arrow indicates the predicted band for the C-terminus 6xHis-tagged PIF3. 
 
The western blot analysis of Ac-hispif3-infected Sf9 cells using anti-his antibody 
demonstrated that the 6xHis-tag was exposed and detectable between 12 and 48hpi. The 
protein band detected migrated with an apparent molecular mass of 28 kDa, which was 
slightly larger than the predicted 23 kDa for PIF3. This suggested that PIF3 may undergo 
post-translational modification. The three replicate Ac-hispif3 infections for each time point 
demonstrated similar temporal expression of PIF3. His-tagged PIF3 levels at 12 and 24hpi 
were low but by 48hpi had increased significantly, indicating a possible burst of 
expression between 24hpi and 48hpi, most likely from the late promoter (TTAAG) 
indicated in Figure 6.1.   
 
1 2 3 4 5 6 7 8 9 10 11 12 
PIF3 
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6.6.5 Sub cellular localisation of PIF3 during baculovirus infection 
 
The western blot analysis described in the previous section confirmed that the 6xHis-tag 
had been successfully fused with PIF3 and was detectable. Therefore, 
immunofluorescence confocal microscopy with a commercial antibody to the 6xHis-tag 
was used to investigate the localisation of PIF3 during Ac-hispif3 infection of TN-368 cells 
(Method section 2.4.1). The TN-368 cells were chosen due to them being an adherent cell 
line with a fibroblast-like morphology, which allows them to survive the repeated washing 
stages of this procedure.  
In this experiment PIF3 localisation within virus-infected TN-368 cells was determined 
between 12 and 48hpi. The TN-368 cells were infected at moi 5 pfu/cell with AcMNPV, 
Ac-hispif3 or were mocked-infected with media and fixed at various times post-infection to 
allow analysis by immunofluorescence staining and confocal microscopy (Figure 6.13).  
The expression of PIF3 was undetectable at any time point for mock-infected and 
AcMNPV-infected cells, as expected. PIF3 expression by Ac-hispif3 was undetectable by 
immunofluorescence until 18hpi and was localised to the nuclei of cells. At 24hpi, 36hpi 
and 48hpi PIF3 remained localised to the nucleus but increased in concentration over this 
period.  
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Figure 6.13 Time course of PIF3 localisation in Ac-
hispif3 infected TN-368 cells 
Confocal microscopy optical sections of TN-368 cells infected at an 
MOI 5 with AcMNPV or Ac-hispif3 and fixed at various times post 
infection. The cells shown are representative of the majority of 
infected cells. Mock-infected cells were treated with an inoculum 
lacking virus and fixed at 48hpi. DNA stained with DAPI is shown in 
blue and 6xHis-tag fused with PIF3 was detected by a commercial 
6xHis-tag antibody and visualised by a secondary antibody 
conjugated to FITC shown in green to visualise PIF3. Differential 
interference contract is also shown for each section. Scale bars 
represent 20 µm. 
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6.7 Discussion 
 
In this chapter the two viruses modified using the Red/ET recombination system, which 
contained deletions in pif genes (Ac∆pif2 and Ac∆pif3) were characterised initially with 
regard to their effect on recombinant protein expression. However, this was only possible 
for the pif2 deletion due to an unpredicted reduction in BV production in cells infected with 
Ac∆pif3. Therefore, the investigation on Ac∆pif3 focused on attempting to explain this 
observation, particularly since a previous study had shown no effect on BV formation after 
deletion of pif3 (Ohkawa et al., 2005; Song et al., 2012).   
 
6.7.1 Analysis Ac∆pif2-infected cell viability and BV production 
 
During the two time course experiments conducted cell viability and virus titres were 
recorded for the pif2 deletion mutant viruses (Ac∆pif2 or AcUK∆pif2) and their parental 
viruses; AcBacPAK5lacZ/BACpol or AcBacPAK5urokinasepol, respectively. Despite any 
temporal differences during these time course studies, Anova statistical analysis 
demonstrated that there was no significant difference in cell viability or BV production 
(P>0.05) between the parental virus and the pif2 deletion mutant virus. A two-tailed 
student t-test was also performed on the time course studies data for infected cell viability 
and BV production to identity any significant differences at individual times points between 
the parental virus and the pif2 deletion mutant virus. However, no significant difference 
(P>0.05) was observed for any individual time point for either time course study. The 
differences in virus-infected cell viability and BV production for each virus between the two 
time course studies could be due to the variation in passage number and health of the Sf9 
cells used in each study. Therefore the deletion of pif2 has not affected BV production, 
which is in agreement with the literature (Pijlman et al., 2003; Ohkawa et al., 2005). These 
results also demonstrated that the deletion of pif2 had no effect on the rate of decline in 
virus-infected cell viability.  
The effect of deleting pif2 on recombinant protein production in insect cells was examined 
using β-galactosidase and urokinase as reporter targets. These proteins were chosen as 
they allowed easy monitoring of intracellular and extracellular, secreted products through 
activity assays.  
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6.7.1a Analysis of Ac∆pif2 β-galactosidase activity 
 
Anova statistical analysis was used on the data obtained from the β-galactosidase activity 
assays, which were carried out on AcBacPAK5lacZ/BACpol and Ac∆pif2 samples from the 
time course study. This analysis demonstrated that there was no significant difference 
(P>0.05) between AcBacPAK5lacZ/BACpol and Ac∆pif2 β-galactosidase activities during 
the course of infection, for either cell pellets or medium samples from virus-infected cells. 
However, this was misleading due to a clear difference between AcBacPAK5lacZ/BACpol 
and Ac∆pif2 infected cell pellet and medium β-galactosidase activities at 48hpi, which was 
obscured in the Anova statistical analysis due to the similarity of β-galactosidase activity 
at the remaining time points. Also when analysing the β-galactosidase activity during this 
time course, the nature of the polh promoter should be taken into account, which has 
been demonstrated to cause a burst in recombinant protein expression during very late 
phase of infection (~48hpi) (Ooi et al., 1989). Therefore, single analysis of the 48hpi β-
galactosidase activities would give better indication of any effect the deletion of pif2 is 
having on recombinant protein expression from the polh promoter.  
This was confirmed by a two-tailed student t-test, which showed a significant difference 
(P<0.05) between the β-galactosidase activity at 48hpi for either cell pellet or medium 
when these two viruses were compared. Even though Ac∆pif2 showed a significant 
increase (1.7 fold higher, 1.58 u/106 cells) in the release of β-galactosidase at 48hpi 
compared to that of AcBacPAK5lacZ/BACpol (0.94 u/106 cells). Overall the deletion of pif2 
had a negative effect on the peak expression of β-galactosidase, being 1.8 fold lower 
(6.34 u/106 cells) than that of AcBacPAK5lacZ/BACpol (11.55 u/106 cells).  
The increase in β-galactosidase activity at 48hpi in the medium sample from Ac∆pif2 
infected cells could be considered abnormally high due to significant difference shown 
when compared to AcBacPAK5lacZ/BACpol using two-tailed student t-test. Therefore the 
result could have occurred due to an error during either the time course study or activity 
assay. Interestingly, when β-galactosidase is expressed from the polh promoter, the peak 
β-galactosidase activity for the infected cell pellet would be expected at 48hpi (Hitchman 
et al., 2010a). However, the peak β-galactosidase activity in Ac∆pif2 infected cells was 
shifted from 48hpi (4.78 u/106 cells) to 72hpi (5.14 u/106 cells), which could have been 
caused by the increased release of β-galactosidase from these cells at 48hpi. The Ac∆pif2 
infected cell viability at 48hpi was not significantly different to that of 
AcBacPAK5lacZ/BACpol infected cells. This suggests the release of β-galactosidase was 
not caused by a decline in cell viability at this time point, which normally would be 
associated with such an increase in activity in the medium sample as the intracellular 
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protein is lost from the dying cells. To further investigate this observation, the time course 
study should be repeated to ensure this initial observation is reproducible and wasn’t due 
to abnormality during this time course study. Also SDS PAGEs could be used to further 
confirm the results seen in the activity assay. 
After the peak β-galactosidase activity for all three virus-infected cell samples, there was a 
rapid decrease in their β-galactosidase activities. This decrease in β-galactosidase activity 
does coincide with a decline in cell viability and increase of β-galactosidase activity within 
the medium samples of each virus infected cell culture. This activity increase in the 
medium sample is due to the decline in cell viability, as intracellular β-galactosidase is lost 
from the dying cells. However, the overall loss of β-galactosidase activity from the infected 
cell pellet samples isn’t seen as an increase in β-galactosidase activity for the medium 
samples, for any of the virus infected cultures examined here. This could suggest that β-
galactosidase is being degraded from either a combination of the culture conditions, the 
accumulation of β-galactosidase or proteases from lysed cells.  
 
6.7.1b Analysis of AcUK∆pif2 urokinase activity 
 
Anova statistical analysis was used on the data obtained from the urokinase activity 
assays, which were carried out on AcBacPAK5urokinasepol and AcUK∆pif2 samples from 
the time course study. This analysis demonstrated that there was no significant difference 
(P>0.05) between AcBacPAK5lacZ/BACpol and Ac∆pif2 β-galactosidase activities during 
this time course study, for either cell pellet or medium from virus-infected cells. However, 
as previously discussed the Anova statistical analysis could be misleading due to the very 
late expression from the polh promoter. Therefore, a two-tailed student t-test was 
performed on individual time points to compare the urokinase activities in virus infected 
cell pellets, it showed a significant difference (P<0.05) between 48 hpi to 120 hpi. 
Therefore, the deletion of pif2 had a negative effect on the expression of urokinase in the 
infected cell pellet when compared to its parental virus. However, urokinase is an 
extracellular protein and when considering recombinant protein expression this would not 
be important due to an average 25 fold increase between the infected cell pellet urokinase 
activities and those obtained in the media samples. Also when a two-tailed student t-test 
was performed on individual time points to compare the urokinase activities in samples of 
media from each virus-infected cell culture it showed a significant difference (P<0.05) 
between 72 hpi to 120 hpi. These time points were after the peak urokinase activity 
observed at 48hpi for both viruses (~3480 units/ml), which was not considered significant 
different when compared using the two-tailed student t-test. This suggests that the 
Chapter 6 
 
188 
 
deletion of pif2 does not have a negative effect on the peak expression of urokinase when 
compared to its parental virus.  
It has been demonstrated here that the deletion of pif2 could have a strongly negative 
impact on intracellular recombinant protein expression but this observation was not seen 
for extracellular recombinant protein. It would be interesting to repeat the time course 
studies to ensure these initial findings can be reproduced and also investigate the effect of 
the pif2 deletion on the expression of different intracellular and extracellular recombinant 
proteins. The effect of the pif2 deletion on recombinant proteins expressed from different 
viral promoters such as the late p6.9 promoter could also be investigated to observe the 
effects on recombinant protein expression from different time points.  
 
 6.7.2 Analysis of the deletion mutant virus Ac∆pif3 
 
The observed effect of the pif3 deletion on BV production was unexpected due to 
publications providing evidence that it is a member of the PIF family (Ohkawa et al., 2005; 
Song et al., 2012) and demonstrating that it is non-essential for virus propagation in cell 
culture. However, the reduced BV production of Ac∆pif3 could only be restored with the 
replacement of pif3 at either its own locus or the polh locus. Concerns that the pif3 
deletion might have affected function of ORF114 or ORF116 were largely answered by 
attempting to rescue Ac∆pif3 at the polh locus with copies of either gene. Several 
attempts to place either of these genes at the polh locus and generate viable virus were 
unsuccessful. Interestingly, AvrII or SrfI linearised Ac∆pif3 produced no detectable viral 
growth when Sf9 cells were transfected with these viruses or when attempts were made to 
amplify them after the transfection stage. It is unusual for a baculovirus not to produce any 
background parental progeny from its non linearised virus, suggesting that the impact on 
BV production prevents the remaining non linearised Ac∆pif3 establishing a viral infection. 
Overall this provides evidence to suggest that only the rescue of pif3 can restore normal 
levels of BV production for Ac∆pif3 and neither of the neighboring genes had been 
affected by the deletion of pif3. Furthermore the literature suggests that orf114 and orf116 
are most likely nonessential for viral replication. The deletion of the homologues to orf114 
in BmNPV demonstrated that it was nonessential for viral infectivity as the deletion mutant 
virus appeared to replicate normally in insect cells (Rohrmann, 2011). Homologues to 
orf116 are only found in two other Type I alphabaculoviruses; RoNPV and PlxyNPV, 
which could suggest that like orf114, orf116 is nonessential for viral infection.  
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However, future work could be directed towards further confirming that the deletion of pif3 
does not have an effect on orf114 and/or orf116 transcription. One method could involve 
using qPCR to analysis transcription rates from these two genes via cDNA synthesis and 
compared with transcription rates observed for AcBAC∆chitinase   
The localization of PIF3 was also investigated by fusion with a 6xHis-tag and 
immunofluorescence confocal microscopy, which demonstrated that PIF3 was localised to 
the nucleus of the infected TN-368 cells from 18hpi. This was as expected due to PIF3 
containing an inner nuclear membrane sorting motif, which is involved in targeting proteins 
to the ODV envelope and therefore back to the nucleus of the cell. Song et al. (2012) have 
also demonstrated that Helicoverpa armigera nucleopolyhedrovirus PIF3 is localisated to 
the nuclear ring zone of infected cells using immunofluorescence assays. Western blot 
analysis of 6xHis-tag PIF3 did detect it earlier at 12hpi, unfortunately samples before 
12hpi were not analyzed and therefore no evidence was collected to suggest whether the 
predicted early promoter (CGTGC) for pif3 is active or not. Therefore, future work could be 
directed towards investigating whether the early promoter of pif3 is active, either by using 
the western blot analysis described here for earlier time points or by mapping of 
transcription start sites using 5’ RACE analysis on cDNA. If the early promoter of pif3 is 
found to be active this could suggest that PIF3 does play a role in earlier stages of viral 
infection such as those involved in BV production. However, the conclusion that Ac∆pif3 is 
defective for BV production means that this gene is not suitable for deletion from the 
AcMNPV genome to enhance its attributes as an expression vector. It was removed from 
further work plans in this project.   
 
6.7.3 Conclusion 
 
In this chapter the two deletion mutant viruses containing deletions from the PIF family, 
Ac∆pif2 and Ac∆pif3, were analysed further. The results from this work demonstrated the 
possibility that the deletion of pif2 negatively affects intracellular recombinant protein 
production but did not impact the expression of extracellular recombinant proteins, when 
expressed from the polh promoter. Unfortunately, the effects of the pif3 deletion on 
recombinant protein expression could not be observed here due to Ac∆pif3 BV production 
being reduced. However, further investigation into this suggested that the cause of this 
reduced BV production was the deletion of pif3 itself. Clearly, the deletion of pif3 from 
AcMNPV reduces BV production significantly, but the modified virus was still capable of 
replication and in forming plaques in titrations of infectivity. Therefore, PIF3 may have 
another function that is yet to be fully characterized.  
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7.1 Introduction 
 
The Red/ET recombination system was successfully used to generate eight deletion 
mutant viruses, which were discussed in the previous chapters. In this chapter, a ninth 
deletion mutant virus constructed using the Red/ET recombination system is presented for 
the first time. This deletion mutant virus was not discussed in any of the previous chapters 
as it represents a double deletion of two adjacent genes, orf118 and pif1.       
The role of the predicted ORF118 product in baculovirus infection is unknown. However, 
in earlier studies the deletion of orf118 from AcMNPV demonstrated that it was 
nonessential for viral infectivity as the deletion mutant virus appeared to replicate normally 
in insect cells (R.D. Possee, personal communication). Homologues of orf118 are only 
found in two other Type I alphabaculoviruses; RoNPV and PlxyNPV (Rohrmann, 2011). In 
contrast, the role of PIF1 (ORF119) in the baculovirus infection is better defined as it has 
been demonstrated to be essential for oral infection of larvae (Kikhno et al., 2002). The 
deletion of pif1 from the virus genome does not affect baculovirus infection in insect cell 
culture (Kikhno et al., 2002; Ohkawa et al., 2005). PIF1 is believed to be involved in 
mediating specific binding of ODV to the primary midgut cells in oral infection of larva and 
has been localised to the ODV envelope, forming a stable complex with P74, PIF2 and 
PIF3 (Ohkawa et al., 2005; Peng et al., 2010). Since neither ORF118 nor PIF1 have been 
reported to affect virus replication in cell culture, it will be interesting to determine if 
deletion of these genes has any effect on protein production in recombinant virus infect 
cells.  
The pif1 is found in all sequenced alphabaculoviruses and betabaculoviruses and is also 
present in nudivirus genomes (Rohrmann, 2011). A closer inspection of AcMNPV PIF1 
peptide sequence shows that it contains two RGD motifs, which were originally identified 
to mediate cell attachment in fibronectin (D'Souza et al., 1991). Figure 7.1 presents 
alignments of the PIF1 peptide sequence with its homologues in alphabaculovirus Type I, 
which shows that PIF1 is highly conserved and all of the homologues apart from 
EppoNPV PIF1 contain at least one RGD motif. Since the discovery of RGD motifs a 
number of other proteins involved in cell adhesion have been found to contain this motif, 
supporting its role in cell attachment (D'Souza et al., 1991). However, RGD motifs are also 
found in viral envelope proteins and disruption of this motif in a number of different viruses 
can cause reduced infectivity. The role of the RGD motif in viral infection can involve viral 
attachment, internalisation and escape of viral particles from the endosome (van der Most 
et al., 1999; Shayakhmetov et al., 2005; Rothwangl and Rong, 2009). Therefore, to 
investigate whether or not the PIF1 RGD motifs are functionally important, the arginine of 
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these motifs was chosen for mutation. It has been shown in the literature that this 
positively charged amino acid plays a vital role in other protein RGD motifs and active 
sites (van der Most et al., 1999; Shayakhmetov et al., 2005; Rothwangl and Rong, 2009). 
It’s also known to be important for binding to negatively charged groups such as those 
found on the plasma membrane of cells (Futaki et al., 2001).    
The aim of this chapter was first to characterise the deletion of orf118 and pif1 specifically 
in relation to recombinant protein expression and secondly to use mutagenesis to 
investigate the possible role of the PIF1 RGD motifs in oral infection of larvae.  
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Figure 7.1 Sequence alignments of Type I PIF1 Sequences 
 
The sequence alignments of type I alphabaculoviruses PIF1 sequences were shaded using the GeneDoc software package to highlight the conserved amino acid sequences; 
(Conserved mode: X, 100%, 80% X, 60% X). The RGD motifs have been indicated with  . 
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7.2 Construction of a deletion mutant: AcBAC∆orf118/pif1 
 
The deletion of orf118 and pif1 was carried out in a different bacmid 
(AcBAC∆chitinase/cathepsin) to the one used to construct the deletions described in 
chapter 4. This bacmid contained a copy of the AcMNPV genome minus chitinase and 
cathepsin genes. These genes are non-essential for viral replication in cell culture and 
both play a role in host insect liquefaction (Slack et al., 1995; Hawtin et al., 1997). The 
AcBAC∆chitinase/cathepsin bacmid also contains a 42bp deletion at the 5’ end of the 
essential gene orf1629. This deletion removes the requirement for a  selection process 
such as a plaque assay to be carried out after insect cells are transfected with the bacmid 
and a transfer plasmid since no parental virus background is produced (R.D Possee, 
personal communication), and is the basis for the commercial flashBAC expression 
system (Possee et al., 2008; Hitchman et al., 2010a; Hitchman et al., 2010b). This is the 
underlying reason why AcBAC∆chitinase/cathepsin bacmid was chosen for this deletion 
work, as it allows rapid generation of recombinant viruses that do not require any selection 
from non-recombinant parental virus. 
In order to delete orf118 and pif1 from the AcBAC∆chitinase/cathepsin bacmid, it was 
necessary to construct a kanamycin resistance gene cassette flanked by orf118 and pif1-
specific sequences. The kanamycin resistence gene fragment was generated by primers 
that contained these flanking regions: NeoORF118 primer (AAAAAAATTGTGTATAAATAA 
AATACCAAATTTTATTATATCATTTTGTT*neo-F) and NeoORF119 primer (CGTTCGCGAT 
CGTTGTTCAGAAAGAAGCCGCGCAATCTTAACGCTGCAGG*neo-R), see Figure 7.2 for 
kanamycin-specific sequences neo-F/neo-R. The flanking regions were designed to 
remove the whole coding region of orf118 and the majority of the pif1 coding region  with 
the insertion of a kanamycin resistance gene, leaving ~150bp of pif1 at the 3’ end to 
ensure that putative orf120 promoters were unaffected by the deletion (Figure 7.2). The 
modified kanamycin resistance gene fragment was electroporated into Red/ET 
recombination competent E. coli containing the AcBAC∆chitinase/cathepsin bacmid. 
Kanamycin-resistant colonies were picked and the deletion mutant bacmids were 
analysed by PCR and restriction digests to verify that the required sequences had been 
deleted. 
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Figure 7.2 Schematic of the construction of AcBAC∆orf118/pif1 bacmid. 
 
The orf118 and orf119 were mostly deleted by the insertion of kanamycin resistance gene between 
100181 and 102141 bp on the AcMNPV genome via homologous recombination in E. coli using the 
Red/ET recombination system. The kanamycin resistance gene fragment was generated using 
NeoORF118 (AAAAAAATTGTGTATAAATAAAATACCAAATTTTATTATATCATTTTGTTTGGACAG 
CAAGCGAACCGGAATTGC) and NeoORF119 (CGTTCGCGATCGTTGTTCAGAAAGAAGCCGC 
GCAATCTTAACGCTGCAGGTCAGAAGAACTCGTCAAGAAGGCG; sequences in red are 
kanamycin-specific) primers. 
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7.2.1 PCR Analysis of AcBAC∆orf118/pif1 
 
The target genes, orf118 and pif1 were successfully deleted from the 
AcBAC∆chitinase/cathepsin bacmid and the resultant deletion bacmid was designated 
AcBAC∆orf118/pif1. This deletion was confirmed using external primers designed to 99 bp 
upstream and 70 bp downstream of the target locus, which were used in PCR with Taq 
DNA polymerase to amplify the region containing the kanamycin cassette. The insertion of 
the kanamycin coding region into the target locus was predicted to result in the 
amplification of a 1294bp fragment, whereas the product from AcMNPV was 2319bp. The 
first set of external primers designed for this purpose did not amplify any bands, therefore 
a second set of external primers were designed and these were also paired with opposite 
primers from the first set of external primers (Figure 7.3 A). This proved successful and 
generated the DNA fragments described in Figure 7.3, B-C. A negative control (H2O) in 
the PCR did not amplify a product (Figure 7.3 B, lane 2). The original orf118 and pif1 
genes were not detected in any of the AcBAC∆orf118/pif1 samples tested. Therefore, the 
PCR analysis of the AcBAC∆orf118/pif1 clones produced only one DNA fragment with 
each primer pair with a size consistent with the presence of the kanamycin insert. 
However, one of the primer sets did not amplify any band for clone one (Figure 7.3 B, lane 
3). The integrity of these deletion mutants was further characterised by restriction enzyme 
digestion. 
 
7.2.2 Restriction Enzyme Analysis of AcBAC∆orf118/pif1 
 
Restriction enzyme analysis of bacmid DNA (Figure 7.4) was used to confirm the 
successful recombination events: (1) the insertion of the kanamycin resistance gene at the 
target gene locus and (2) that the rest of the virus genome was not affected by the 
recombination process, as judged by restriction enzyme analysis. The HindIII restriction 
fragment pattern of the deletion mutant bacmid was compared to the pattern of the 
parental bacmid. The expected alteration in the fragment pattern was a 976 bp decrease 
in fragment A. This alteration matched the profiles obtained for all of the deletion mutant 
bacmids apart from those in lanes 7 and 10 in Figure 7.4. This suggested that orf118 and 
pif1 were still present in those samples. The gel electrophoresis image in Figure 7.4 also 
showed that the rest of the deletion mutant bacmid profiles matched that of the parental 
bacmid’s genome as expected, and that no random mutations had occurred that could be 
detected using this restriction enzyme.  
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  A 
Primer  5' - 3' Primer Sequence                                                            
First external primer set orf118F CTAGTGACAACATTGAACTG 
 orf119R CGATATCCAAACAAGTCTTG 
Second external primer set orf118F2 GTCATGCATCTGACGGCTAA 
 orf119R2 CCAAATTGCACGCTTCTACA 
 
 
 
Figure 7.3 PCR analysis of AcBAC∆orf118/pif1 DNA 
 
Panel A contains a table displaying the external primers used to confirm orf118 and pif1 deletion 
from AcBAC∆orf118/pif1, with the label given to each primer along with the sequence for each 
primer 
 
Panel B and C. DNA was isolated from colonies containing putative AcBAC∆orf118/pif1 and 
analysed by PCR using primers 99 bp upstream and 70 bp downstream of the target locus and Taq 
DNA polymerase (B lanes 3-17 and C lanes 2-16). PCR results from the ten AcBAC∆orf118/pif1 
clones using orf118F/orf119R2, orf118F2/orf119R and orf118F2/orf119R2 external primers are 
shown in this order for each clone. A negative (water-only) control is shown in A lane 2 and NEB 
log2 Marker (Kbp) shown in A lanes 1/18 and B lanes 1/17 with arrows indicating 1.2 Kbp size. 
 
 
Chapter 7 
 
198 
 
 
 
 
 
 
 
Figure 7.4 HindIII restriction enzyme analyses of deletion mutant bacmids 
 
DNA was isolated from E. coli containing AcBAC∆orf118/pif1 and validated by restriction enzyme 
(HindIII) analysis in a 0.6% agarose gel. Lanes 1 and 13 NEB log2 marker; lane 2, 
AcBAC∆chitinase/cathepsin and lanes 3-12, AcBAC∆orf118/pif1 clones 1-10.  
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7.3 Construction of AclacZ∆orf118/pif1 
 
The AclacZ∆orf118/pif1 was constructed to provide a virus to allow an investigation of the 
possible effects these two deletions (orf118 and pif1) might have on recombinant protein 
expression. To aid this study, lacZ under the control of the polh promoter was introduced 
into the AcBAC∆orf118/pif1 genome. The next sections detail the construction and 
purification of AclacZ∆orf118/pif1.  
Insect Sf9 cells were cotransfected with pBacPAK8-lacZ and bacmid DNA purified from E. 
coli containing AcBAC∆orf118/pif1. The AcBAC∆orf118/pif1 contains a small deletion in 
the essential gene orf1629. This produces a selection marker in which only those viruses 
that are rescued with a transfer plasmid that restores the whole of orf1629 will be viable in 
insect cells (R.D Possee, personal communication). Recombination between 
AcBAC∆orf118/pif1 and pBacPAK8-lacZ should knock-out the BAC at the polh locus and 
replace it with lacZ from the baculovirus transfer vector (Figure 7.5).  
 
 
Figure 7.5 Schematic showing the insertion of lacZ at polh locus for 
AcBAC∆orf118/pif1 
 
The BAC was completely deleted from AcBAC∆orf118/pif1 by the insertion of lacZ at polh locus via 
homologous recombination in Sf9 insect cells between pBacPAK8-lacZ and bacmid genome. 
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The resulting recombinant virus AclacZ∆orf118/pif1 was plaque-purified for one round to 
confirm that beta-galactosidase was synthesised by staining in the presence of X-gal 
(data not shown). The virus selected amplified to titres of 5x107 pfu/ml and infected cells 
turned blue in the presence of X-gal (data not shown) suggesting that the virus was 
replicating normally in insect cells. This confirmed that the lacZ had been correctly 
inserted into the polh locus of AclacZ∆orf118/pif1. 
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7.4 Temporal analysis of virus replication in AclacZ∆orf118/pif1 and 
AclacZ∆chitinase/cathepsin infected Sf9 cells. 
 
Two control viruses were used in this time course study: AcBacPAK6 and 
AclacZ∆chitinase/cathepsin. AcBacPAK6 is a wild-type control virus; its only difference 
from AcMNPV being the presence of lacZ in place of the polh. AclacZ∆chitinase/cathepsin 
is the parental virus of AclacZ∆orf118/pif1; the only difference between these two viruses 
is the deletion of orf118 and pif1. Therefore, any statistically significant difference seen 
between AclacZ∆chitinase/cathepsin and AclacZ∆orf118/pif1 during this time course 
study, could suggest an effect of orf118 and pif1 deletion. Any differences observed 
between AcBacPAK6 and AclacZ∆chitinase/cathepsin is likely to be attributed to the 
chitinase and cathepsin genes.  
A time course study was carried out and samples were taken over 96 hours from triplicate 
shaking cultures of Sf9 cells (2x106 cells/ml) either mock-infected or infected 
(AcBacPAK6, AclacZ∆orf118/pif1 or AclacZ∆chitinase/cathepsin) at a moi of 5 pfu/cell. 
These samples were analysed to determine any affects that the orf118 and pif1 deletion 
could have on the expression of the recombinant protein β-galactosidase, cell viability and 
BV production kinetics.  
 
7.4.1 Cell Viability  
 
The viability of virus-infected Sf9 cells was assessed over a time course between 0-96 
hpi., as described above. Figure 7.6 shows that all virus-infected cells had a viability 
greater than 97% until 24hpi, at which point the cell viability decreased for all of the 
viruses. AcBacPAK6 infected cells showed the highest cell viability through the last three 
time points, dropping from 84% (48hpi) to 31% (96hpi). The viability of 
AclacZ∆orf118/pif1-infected cells showed the lowest cell viability, dropping from 58% 
(48hpi) to 8% (96hpi). The AclacZ∆chitinase/cathepsin infected cell viability dropped to a 
value between AcBacPAK6 and AclacZ∆orf118/pif1 for the 48hpi and 72hpi time points, 
but decreased to 5% at 96hpi.  
A two-tailed student t-test showed a significant difference (P<0.05) in the virus-infected 
cell viability at 48hpi between AclacZ∆orf118/pif1 and the two control viruses, 
AclacZ∆chitinase/cathepsin and AcBacPAK6. A two-tailed student t-test also showed a 
significant difference (P<0.05) in the virus-infected cell viability at 72hpi between all three 
of the viruses. However, despite these temporal differences, Anova statistical analysis 
demonstrated that there was no significant difference between any of the virus infected 
cell viabilities across the time course study (P>0.05). 
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Figure 7.6 Virus-infected cell viabilities. 
Cell viability results for AcBacPAK6-, AclacZ∆orf118/pif1- and AclacZ∆chitinase/cathepsin-infected 
Sf9 cells (MOI = 5 pfu/cell), were obtain using trypan blue stain to visualise dead cells. Standard 
error bars are shown during 96 hour time course. N=3 
 
7.4.2 Budded Virus Production  
 
The virus-infected cell culture medium collected at each time point in the above 
experiment (7.4.1) was titrated using  baculoQUANTTM, a qPCR-based system (Hitchman 
et al., 2007b) as described in methods section 2.3.4 (Figure 7.7). The DNA for qPCR was 
obtained from the samples using the High Pure Viral Nucleic Acid Kit from Roche Applied 
Science. The 0hpi titre values for all three viruses were approximately 2.21x106 pfu/ml due 
to residual virus from the initial inocula used to infect the shake cultures. Significant BV 
production for any virus was not evident until after 12hpi. Both AcAcBacPAK6 and 
AclacZ∆chitinase/cathepsin titres increased rapidly after 12hpi, reaching approximately 
2.6x107pfu/ml at 24hpi. After this time point the virus titres did not increase significantly, 
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reaching 4.54x107pfu/ml and 4.96x107 pfu/ml at 72hpi, respectively. Between 12 and 
24hpi, the titre of AclacZ∆orf118/pif1 didn’t increase as rapidly as the other two viruses.  
By 24hpi, the AclacZ∆orf118/pif1 had reached 6.65x106 pfu/ml.  However, by 72 hpi its 
titre was 4.29x107 pfu/ml, indicating a delay in BV production rather than an inability to 
attain normal levels. Despite the temporal difference seen at 24hpi for AclacZ∆orf118/pif1, 
Anova statistical analysis demonstrated that there was no significant difference between 
any of the BV production kinetics (P>0.05).  
 
 
Figure 7.7 Kinetics of budded virus production for AclacZ∆orf118/pif1 
Budded virus production by values AcBacPAK6-, AclacZ∆orf118/pif1- and 
AclacZ∆chitinase/cathepsin-infected Sf9 cells (MOI = 5 pfu/cell), were obtained using a qPCR-
based system (Hitchman et al., 2007b). Standard error bars are shown during the 72 hour time 
course. N=3 
 
 
 
Chapter 7 
 
204 
 
7.4.3 β-galactosidase production  
 
The production of β-galactosidase for each of the viruses was measured over time using a 
standard β-galactosidase assay method as described in methods section 2.7.3a. 
Measurements were taken from both the harvested medium and cell pellets described 
above (Figure 7.8).  In the cell pellets, β-galactosidase was not detectable until after 12hpi 
for any of the viruses. After 12hpi, all three of the viruses followed the same trend, 
showing a sharp increase in β-galactosidase activity and reaching a peak at 48hpi. After 
this time point the β-galactosidase activity declined to very low levels at 72hpi and 96hpi. 
Although the viruses followed the same trend, the peak activity of β-galactosidase at 48hpi 
varied between them. The activity (in arbitrary units/106 cells) was maximum at 48hpi and 
ranged from 13.75 u/106 cells (AcBacPAK6), to 24.48 u/106 cells (AclacZ∆orf118/pif1) and 
41.80 u/106 cells (AclacZ∆chitinase/cathepsin). Anova statistical analysis demonstrated 
that there was no significant difference between any of the viruses cell pellet β-
galactosidase activities (P>0.05). However, a two-tailed student t-test showed a significant 
difference (P<0.05) between the β-galactosidase activity produced at 48hpi when 
comparing any two of the virus infected cells at this time point.  
The samples of medium from all virus infections had different initial activity levels of β-
galactosidase, which is most likely from the initial viral inoculum used to infect the Sf9 
shake cultures. These initial β-galactosidase activities were approximately 0.5 u/106 cells 
for all three of the viruses. The β-galactosidase activity of AcBacPAK6 medium didn’t 
increase past its initial activity until after 48hpi, whereas both AclacZ∆chitinase/cathepsin 
and AclacZ∆orf118/pif1 mediums increased past their initial β-galactosidase activities after 
24 hpi. The AcBacPAK6 medium β-galactosidase activity increased at a steady rate from 
48hpi to 96hpi reaching 1.84 u/106 cells at this time point. Both 
AclacZ∆chitinase/cathepsin and AclacZ∆orf118/pif1 increased at a steady rate from 24hpi 
to 96hpi reaching approximately 2.60 u/106 cells for AclacZ∆chitinase/cathepsin and 3.00 
u/106 cells for AclacZ∆orf118/pif1. Despite these temporal differences, Anova statistical 
analysis demonstrated that there was no significant difference between any of the virus β-
galactosidase activities in the culture medium (P>0.05). However, a two-tailed student t-
test showed a significant difference (P<0.05) when comparing either AcBacPAK6 or 
AclacZ∆orf118/pif1 with AclacZ∆chitinase/cathepsin β-galactosidase activity between 0 
and 24hpi.  
In summary despite some slight temporal differences, the deletion of orf118 and pif1 in 
AclacZ∆orf118/pif1 did not significantly affect either BV production or infected-cell viability 
during this time course study. However, the deletion did negatively affect β-galactosidase 
production when it was compared to its parental virus; AclacZ∆chitinase/cathepsin. 
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Figure 7.8 β-galactosidase productions by recombinant baculoviruses.  
β-galactosidase activities in the cell pellets and medium for AcBacPAK6, AclacZ∆orf118/pif1 and 
AclacZ∆chitinase/cathepsin, obtained using a β-galactosidase assay. Standard error bars are 
shown during 96 hour time course. N=3 
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7.5 Construction of recombinant viruses with PIF1 RGD motif mutations. 
 
To investigate a potential role for PIF1 RGD motifs in the fusion between the ODV and the 
larva midgut, viruses were constructed that contained single or double mutations within 
the pif1 coding sequence (Figure 7.9). These mutations resulted in an arginine to alanine 
change within each RGD motifs. For economy, complete copies of pif1 with modified RGD 
motifs were not synthesized. Instead, the region between 100934-102188 in the AcMNPV 
genome was modified to contain the mutated RGD motifs. The mutations inserted into the 
virus genome are summarized in Table 7.1. 
Table 7.1: Summary of pif1 mutant viruses. 
 
Name 
 
Virus description 
 
Titres 
Ac∆pif1Pol+ Control virus that contains the deletion of 
pif1, with restored polyhedrin production 
using pAcUW21 that contained no pif1  
8.2 x107 pfu/ml 
Acpif1Pol+ Control virus that contains a restored wild 
type pif1 at the polh locus 
9.3x107 pfu/ml 
Acpif1Arg96AlaPol+ Test virus with restored pif1 function at the 
polh locus, which contains amino acid 
change at position 96 going from arginine to 
alanine  
8.7x107 pfu/ml 
Acpif1Arg478AlaPol+ Test virus with restored pif1, which contains 
amino acid change at position 478 going from 
arginine to alanine 
9.4x107 pfu/ml 
Acpif1Arg96/478AlaPol+ Test virus that contains both the above amino 
acids changes to its restored pif1.  
8.6x107 pfu/ml 
 
For these modified pif1 sequences to be inserted into the AcMNPV genome, a parental 
virus was required that was missing the wild-type gene. Such a parental virus would allow 
reliable homologous recombination between the mutant fragments and the virus genome, 
and ensure no further mutations would be introduced through the slippage of the 
homologous arms during recombination between the plasmid transfer vector and the virus 
genome.   
The initial method (Figure 7.10) and parental virus chosen for this was Ac∆pif1lacZ, which 
comprises a copy of the AcMNPV genome with lacZ inserted into the XhoI site (AcMNPV 
genome 101806-101811 bp) of pif1 (R.D Possee, personal communication). However, this 
virus still contained the complete pif1 coding region, which would have meant that 
homologous recombination between plasmid and virus might have resulted in retention of 
the original RGD motifs. Therefore, Ac∆pif1lacZ was modified in insect cells by replacing 
the lacZ and the majority of the pif1 coding region with a kanamycin resistance gene 
fragment (Figure 7.10). The Ac∆pif1lacZ DNA was linearized by restriction enzyme 
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digestion with Bsu361, which contains a single Bsu361 site within lacZ. Insect Sf9 cells 
were then cotransfected with the linearized Ac∆pif1lacZ DNA and PCR generated 
kanamycin resistance gene cassette flanked by pif1 sequences. The resulting 
recombinant virus (Ac∆pif1Neo) was plaque-purified until only lacZ-negative plaques were 
generated (plaques that did not turn blue when stained with X-gal) (data not shown). 
The next stage was to construct the pif1 mutant viruses using Ac∆pif1Neo and the 
pBSArg96Ala; Arg478Ala; Arg96/478Ala plasmids (Figure 7.10) by cotransfection of Sf9 cell. The 
progeny virus was titrated using a plaque assay and well-isolated plaques were picked 
and used to infect a single well within a 24 well plate containing 5x105 Sf9 cells. After 
72hpi, DNA from the BV was extracted using the High Pure Viral Nucleic Acid Kit (Roche 
Applied Science) and used in PCR with primers external to the pif1 locus. However, 
despite several attempts this method didn’t produce a single isolate indicating the 
presence of modified pif1. All of the viruses isolated and subsequently sequenced 
retained the original RGD motif coding regions. Therefore, a second method was 
designed and is described in the following section.  
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Figure 7.9 Schematic of the pif1 mutations 
Mutations were introduced into the pif1 sequence to derive pBS variants containing mutations to 
the RGD motif as indicated, resulting in either or both amino acids 96 and 478 to be changed from 
arginine to alanine. Mutations were synthesized by Advantagen. 
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Figure 7.10 Schematic of the initial method used to construct pif1 mutant viruses 
The pif1 was mostly deleted by the insertion of the kanamycin resistance gene between 100934 
and 102188 bp on the AcMNPV genome via homologous recombination in insect cells. Attempts to 
rescue pif1 with the fragments were then undertaken. The rescued viruses could then be isolated 
using plaque purification and identified using PCR with AcORF119F (AGGATCCGCAATTGTTTTT 
GCGATATC)/AcORF119R(AGGATCCAAACAAGTCTTGGCCC) primers.  
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7.5.1 AcBAC∆pif1 
 
The parental virus for the construction of AcBAC∆pif1 was AcBAC1629∆chitinase, which is 
a copy of the AcMNPV genome minus chitinase and 42bp of the essential gene orf1629. 
The small deletion of orf1629 removes the need for a selection process to be carried out 
after insect cells are transfected with the bacmid and a transfer plasmid as no parental 
virus background is produced (R.D Possee, personal communication). First, the Red/ET 
recombination system was used to modify AcBAC1629∆chitinase by replacing pif1 with a 
kanamycin resistance cassette to derive AcBAC∆pif1 (Figure 7.11).  
 
 
Figure 7.11 Schematic of the construction of AcBAC∆pif1 bacmid 
 
The pif1 was mostly deleted using a kanamycin resistance gene fragment generated using 
ACC67(AAGGATTAGCCAACTGCCAGTTGTTTGACGAAGATACAATAGTCAAGATGGCCCGGCT 
GGACAGCAAGCGAACCGGAATTGC)/ACC68(TTCGCGATCGTTGTTCAGAAAGAAGCCGCGCA 
ATCTTAACGCTGCAGGCGCGCCCGGGCTCAGAAGAACTCGTCAAGAAGGCG; sequences in 
red are kanamycin-specific) primers that could be inserted into the AcMNPV genome between 
100934 and 102188 bp via homologous recombination in E. coli using the Red/ET recombination 
system. 
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This pif1 deletion mutant (AcBAC∆pif1) became the parental virus into which modified 
versions of pif1 could be inserted at the polh locus.  However, since the pif1 RGD mutants 
were contained within an incomplete copy of the coding region (Figure 7.9), it was first 
necessary to restore the sequences omitted from the 5’ and 3’ ends of the gene and place 
them within a transfer vector suitable for subsequent insertion into the virus genome 
(Figure 7.12).  PCR was used to synthesize two DNA fragments that contained the two 
ends of the pif1 coding region. These were then mixed with each vector containing the 
RGD mutants and cross over PCR used to produce the complete pif1 coding region. The 
amplified gene fragments were then inserted into a pGEM-T vector (Promega) and 
sequenced to confirm the fidelity of the amplification process.  
The gene fragments were then removed from pGEM-T and inserted into a modified 
pAcUW21 (Lopez-Ferber et al., 1995). This vector contains a copy of the p10 promoter 
inserted upstream and in the opposite orientation to polh. It was modified by removal of 
the p10 promoter with XbaI and EcoRI and replacing it with a synthetic multiple cloning 
site containing ApaI and SacI sites to produce pAcUW21∆p10 (Figure 7.12).  Three 
derivatives of this vector, containing either single or double RGD mutations within pif1 
were produced. All constructs were confirmed by RE mapping (data not shown).  These 
plasmids could then be used to insert pif1 under the control of its own promoter upstream 
of the AcMNPV polyhedrin gene.  
Insect Sf9 cells were then cotransfected with one of three modified pAcUW21 vectors 
(pAcUW21∆p10.Arg96Ala; Arg478Ala; Arg96/478Ala) and viral DNA purified from E. coli containing 
AcBAC∆pif1, which on its own is non-infectious. Recombination between AcBAC∆pif1 and 
each transfer vector was predicted to remove the BAC while replacing polh, restoring 
orf1629 to functionality and inserting a RGD-mutated pif1. A summary of the recombinant 
viruses constructed in this section, along with their abbreviations used subsequently in 
this thesis, is shown in Table 7.1.  
The resulting recombinant viruses amplified to titres indicated in Table 7.1.  Virus-infected 
cells contained polyhedra that were visible under the microscope (data not shown).  Viral 
DNA was isolated from infected cells and PCR was used to confirm the successful 
recombination event with insertion of pif1 fragments. Figure 7.13 shows that Ac∆pif1Pol+ 
sample contained only one DNA fragment at 1639 bp, which indicates the presence of the 
kanamycin fragment at the pif1 locus. All of the recombinant viruses also contained this 
fragment as expected, with the addition of a second DNA fragment at 1908 bp suggesting 
the presence of the pif1 coding region.  
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The next stage was to amplify the OB from these now polyhedrin positive viruses to allow 
further experimental work to be carried on ODV. 
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Figure 7.12 Insertion of pif1 coding regions into modified pAcUW21 
 
A, The whole pif1 coding region was constructed by PCR using Expand DNA polymerase with 
fragments generated using AcORF119F (see Figure 7.10)/ORF109RGD1 (CATCTTGACTATTGT 
ATCTTCGTC) primers and ORF109RGD2 (GCGCCTGCAGCGTTAAGATTGCGC)/AcORF119R 
(see Figure 7.10) primers. These fragments were then used in the cross over PCR with the 
fragments containing mutated RGD coding regions and AcORF119F/AcORF119R primers to 
generate the complete pif1, which was then inserted into pGEM-T vector and sequenced. 
B, The pAcUW21 baculovirus transfer vector was modified using standard techniques to remove 
the p10 promoter and replace it with primer generated fragment that contained the restriction sites 
required for the later insertion of the pif1 coding region.   
C, The pif1 coding regions were subcloned from the pGEM-T vecter into the ApaI and SacI sites of 
the modified pAcUW21
∆p10
. This baculovirus transfer vector would restore polyhedrin production 
and allow the insertion of pif1 under the control of its own promoter into the baculovirus genome at 
the polh locus through homologous recombination in insect cells. 
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Figure 7.13 PCR analysis of recombinant virus DNA from pif1 mutants 
 
DNA was isolated from virus-infected cells and analysed by PCR using primers 
AcORF119F/AcORF119R. Lanes 1 and 9, NEB log2 Marker (Kbp); lane 2,  water only negative 
control; lane 3, mock infected cells control; lane 4, positive control virus Ac∆pif1
Pol+
; lanes 5-8, 
recombinant viruses Acpif1
Pol+
, Acpif1
Arg96AlaPol+
, Acpif1
Arg478AlaPol+
 and Acpif1
Arg96/478AlaPol+ 
respectively. 
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7.6 Bioassays for Acpif1Arg96AlaPol+, Acpif1Arg478AlaPol+ and Acpif1Arg96/478AlaPol+ 
 
The BV produced by each polyhedrin positive virus (Table 7.2)  was injected into the 
haemocoel of groups of 50 fourth instar T. ni larvae, with each larva receiving 1x105 pfu to  
ensure 100% mortality. The OBs were then purified from the larvae using centrifugation 
(see methods sections 2.3.9). They were counted using a haemocytometer and assayed 
by oral infection in third instar T. ni larvae at a range of doses to enable calculation of their 
LD50, LD90 and survival time for each virus (Table 7.2).
 
Table 7.2 Infectivity of Acpif1Arg96AlaPol+, Acpif1Arg478AlaPol+ and Acpif1Arg96/478AlaPol+ 
occlusion bodies  
 Lethal dose (OB/larva)   Survival Time 
Virus LD50 LD90 P hpi±SE P 
AcMNPV 41.2 1085.8   173.5±2.3   
Ac∆chitinasePol+ 46.5 1248.6 0.9885 172.2±2.9 0.7236 
Acpif1Pol+ 32.3 971.9 0.7993 165.0±4.2 0.1479 
Ac∆pif1Pol+  N/A N/A N/A N/A N/A 
      
Acpif1Pol+ 32.3 971.9   165.0±4.2   
Acpif1Arg96AlaPol+ 120.0 2722.8 0.0001 170.2±2.7 0.3029 
Acpif1Arg478AlaPol+ 79.9 2270.4 0.0033 176.9±3.9 0.0402 
Acpif1Arg96/478AlaPol+ 24.3 880.4 0.2259 159.9±4.1 0.3883 
 
Notes: Ac∆pif1
Pol+ 
values could not be reliably calculated from linear regression due to low mortality rates of larvae orally 
infected with its OBs.  
 
The lethal dose (LD50 and LD90) values seen in Table 7.2 for each of the viruses tested 
were determined by linear regression. Chi-square analysis was used to determine the P 
value for Ac∆chitinasePol+ compared to AcMNPV and no significant difference was seen 
between the infectivity of OBs from these two viruses. The same statistical method 
showed no significant difference between the infectivity of OBs from Acpif1Pol+ compared 
to that of Ac∆chitinasePol+.   
However, when the three pif1 mutant viruses were compared to Acpif1Pol+ using the same 
chi-square analysis a very statistically significant difference was seen between the 
infectivity of OBs produced from larva infected with Acpif1Pol+ compared to Acpif1Arg96AlaPol+ 
and Acpif1Arg478AlaPol+ OBs. There was no significant difference seen for Acpif1Arg96/478AlaPol+ 
OBs during this comparison with Acpif1Pol+. The infectivity of these viruses was also 
compared using Probit analysis (PoloPlus, LeOra Software). This further confirmed the 
results above suggesting that Acpif1Arg96AlaPol+ and Acpif1Arg478AlaPol+ oral infectivity was 
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significantly different to that of Acpif1Pol+. However, the Probit analysis did suggest that the 
relative potency of both Acpif1Arg96AlaPol+ and Acpif1Arg478AlaPol+ was the same as Acpif1Pol+. 
Interestingly, this analysis also confirmed there was no significant difference between 
Acpif1Arg96/478AlaPol+ and Acpif1Pol+ oral infectivity.  
 
The survival times in hpi were recorded during this bioassay and student t-test was used 
to compare survival times between viruses to determine P values. The survival times for 
Ac∆chitinasePol+ were compared to that of AcMNPV and the student t-test showed no 
significant difference between these two viruses. The survival time for Ac∆chitinasePol+ 
was then compared to Acpif1Pol+ survival time using the student t-test, which showed no 
significant difference between the two viruses. Then the survival time for Acpif1Pol+ was 
compared to the survival times of the test pif1 viruses and no significant difference was 
demonstrated using the student t-test between Acpif1Pol+ and Acpif1Arg96AlaPol+or 
Acpif1Arg96/478AlaPol+. However, a significant difference was shown by the student t-test for 
Acpif1Arg478AlaPol+ when compared to Acpif1Pol+ survival time. Interestingly, when the other 
two control viruses’ survival times were compared to that of the test pif1 viruses using the 
student t-test, some differences were observed to those seen using Acpif1Pol+. For both 
AcMNPV and Ac∆chitinasePol+ there was no significant difference (P>0.05) seen when 
compared to Acpif1Arg478AlaPol+.  
The difference observed for Acpif1Arg478AlaPol+ survival times could be due to slight increase 
in mortality rate for Acpif1Pol+ infected larvae shown in Figure 7.14. This slight increase in 
mortality rate was also seen for Acpif1Arg96/478AlaPol+ infected larvae, whereas the other 
viruses’ infected larvae demonstrated mortality rates similar to those seen for 
Acpif1Arg478AlaPol+ infected larvae. Therefore, the differences seen in survival times could be 
due to variation in the bioassay method itself. However, the majority of virus infected larva 
at the top dose (104 OBs/larva) still died in a narrow window between 5.5-8 days post 
infection for all of the viruses. Also all viruses caused 100% morality at their top dose in 
this bioassay. 
In summary, the bioassay suggests that mutating the PIF1 RGD motifs does not affected 
the replication efficiency of the virus in the host larva. However, single mutations to either 
PIF1 RGD motifs (Acpif1Arg96AlaPol+ and Acpif1Arg478AlaPol+) did seem to decrease oral 
infectivity rates of OBs but mutations to both of the PIF1 RGD motifs (Acpif1Arg96/478AlaPol+) 
seem to negate this decrease in oral infectivity. 
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Figure 7.14 Mortality of AcMNPV, Ac∆chitinasePol+, Acpif1Pol+, Ac∆pif1Pol+, 
Acpif1Arg96AlaPol+, Acpif1Arg478AlaPol+ and Acpif1Arg96/478AlaPol+ infected larvae 
 
The mortality rate of AcMNPV, Ac∆chitinase
Pol+
, Acpif1
Pol+
, Ac∆pif1
Pol+
,
 
Acpif1
Arg96AlaPol+
, 
Acpif1
Arg478AlaPol+
 and Acpif1
Arg96/478AlaPol+ 
infected larvae at the top dose (10
4 
OBs/larva) were 
assessed until all larvae had succumb to viral infection or pupated.  
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7.7 Discussion 
 
In this chapter the Red/ET recombination system was successfully used to create an 
orf118 and pif1 deletion mutant virus (AclacZ∆orf118/pif1). This deletion mutant virus was 
then characterised, with a focus towards any effect the deletion could have on 
recombinant protein (β-galactosidase) expression. This chapter also contains 
investigations towards the possible role of the PIF1 RGD motifs in oral infection of larvae, 
through the use of mutagenesis that resulted in an arginine to alanine change within each 
RGD motifs (Figure 7.9).  
 
7.7.1 Analysis of the deletion mutant virus; AclacZ∆orf118/pif1 
 
The deletion of orf118 and pif1 in AclacZ∆orf118/pif1 did not significantly affect either BV 
production or virus infected-cell viability during a time course study. Despite any slight 
temporal differences between AclacZ∆orf118/pif1 and the two control viruses (parental 
virus; AclacZ∆chitinase/cathepsin and wild-type virus; AcBacPAK6), Anova statistical 
analysis demonstrated that there was no significant difference (P>0.05) between these 
viruses for either BV production or virus infected cell viabilities.  
Although, no significant difference was seen when virus infected-cell viabilities were 
compared during this time course study, there was decrease in AclacZ∆orf118/pif1 
infected-cell viability when compared to that of the two control viruses between 24-96hpi, 
which was not observed for pif1 deletion mutant virus in a previous study (Gutierrez et al., 
2005). This suggests that the decrease in infected-cell viability could be caused by the 
deletion of orf118 in AclacZ∆orf118/pif1. 
However, the temporal analysis of virus infection did show a delay in AclacZ∆orf118/pif1 
BV production at 24hpi, which wasn’t seen for either control virus. When a two-tailed 
student t-test was used to analyse the 24hpi time point, it demonstrated a significant 
difference (P<0.05) between AclacZ∆orf118/pif1 and AclacZ∆chitinase/cathepsin titres at 
this time point. This suggested that the deletion of orf118, pif1 or both altered the BV 
production kinetics of AclacZ∆orf118/pif1, but not affected the virus’s ability to reach 
normal titres. Therefore, this observation does not conflict with the literature that shows 
neither ORF118 nor PIF1 affect virus replication in cell culture (Kikhno et al., 2002; 
Ohkawa et al., 2005; R.D. Possee, personal communication). However, a delay in BV 
production was observed with a pif1 deletion mutant virus and not with an orf118 deletion 
mutant virus (R.D. Possee, personal communication), which suggests the pif1 deletion is 
the cause of the observed affect here with the double deletion virus. 
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The effect of deleting orf118 and pif1 on recombinant protein production in insect cells 
was examined using β-galactosidase as a reporter target. This protein was chosen as it 
allowed easy monitoring of an intracellular protein through activity assays.   
Anova statistical analysis was used on the data obtained from the β-galactosidase activity 
assays, which were carried out on AcBacPAK6, AclacZ∆orf118/pif1 and 
AclacZ∆chitinase/cathepsin samples from the time course study. This analysis 
demonstrated that there was no significant difference between any of the viruses total β-
galactosidase activities during this time course (P>0.05). However, this is misleading due 
to a clear difference between all three viruses infected cells β-galactosidase activities at 
48hpi, which is being obscured in the Anova statistical analysis due to the similarity of β-
galactosidase activity at the remaining time points for all three viruses. Also 48hpi time 
point will hold more significance than the other time points due to the nature of the polh 
promoter, which has been demonstrated to cause a burst in recombinant protein 
expression during very late phase of infection (~48hpi) (Ooi et al., 1989). Therefore, single 
analysis of the 48hpi β-galactosidase activities would give better indication of any effect 
the deletion of orf118/pif1 is having on recombinant protein expression from the polh 
promoter. 
Therefore, a two-tailed student t-test was used, which showed a significant difference 
(P<0.05) between the β-galactosidase activity produced at 48hpi when any of the two 
virus-infected cell pellet values were compared. This demonstrates that the deletion of 
orf118 and pif1 had an overall negative effect on the peak β-galactosidase expression 
from infected insect cells compared to the parental virus, which was 1.7-fold higher (41.80 
u/106 cells). Interestingly, the positive impact of chitinase and cathepsin deletion on 
recombinant protein expression production was not totally abolished by the deletion of 
orf118 and pif1, as AclacZ∆orf118/pif1 (24.48 u/106 cells) peak β-galactosidase activity 
was 1.8-fold higher than that observed for AcBacPAK6 (13.75 u/106 cells) during this time 
course study. This negative effect on the peak β-galactosidase expression caused by the 
deletion of orf118 and pif1 could be due to the deletion of orf118. Since a previous study 
had shown that deletion of pif1 caused a two-fold increase in chloramphenicol 
acetyltransferase expression from the polyhedrin promoter when compared to its parental 
virus (Gutierrez et al., 2005). 
After the peak β-galactosidase activity at 48hpi for all three virus-infected cell samples, 
there was a rapid decrease in their β-galactosidase activities. This decrease in β-
galactosidase activity does coincide with a decline in cell viability and increase of β-
galactosidase activity within the medium samples of each virus infected cell culture. This 
activity increase in the medium sample is due to the decline in cell viability, as intracellular 
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β-galactosidase is lost from the dying cells. However, the overall loss of β-galactosidase 
activity from the infected cell pellet samples isn’t seen as an increase in β-galactosidase 
activity for the medium samples, for any of the virus infected cultures examined here. This 
could suggest that β-galactosidase is being degraded from either a combination of the 
culture conditions, the accumulation of β-galactosidase or proteases from lysed cells.  
It would be interesting to investigate the effect of orf118 and pif1 deletion on recombinant 
proteins expressed from different viral promoters such as the late p6.9 promoter, to 
observe any effect this deletion could have on recombinant protein expression from 
different time points. The effect of orf118 and pif1 deletion on extracellular recombinant 
protein expression could also be investigated to observe any differences there could be 
between the expression of intracellular and extracellular recombinant proteins.  
 
7.7.2 Characterisation summary for pif1 mutant viruses 
 
The initial strategy to construct the pif1 mutant viruses proved unsuccessful. However, the 
pif1 mutant viruses were constructed using an alternative strategy involving the bacmid 
AcBAC∆pif1, which is non-infectious in insect cells. AcBAC∆pif1 was rescued in insect 
cells with a transfer vector containing RGD-mutated pif1 and polyhedrin, which resulted in 
viruses containing the different RGD-mutated pif1 that did not require plaque-purification 
from parental virus. OBs for the RGD-mutated pif1 viruses and several control viruses 
were obtained by injecting fourth instar T. ni larvae in the haemocoel with 1x105 pfu and 
then purifying the resulting OBs for use in the bioassay. The bioassay suggested that 
none of the RGD-mutated pif1 viruses affected the replication efficiency of the virus in the 
host larva when compared to the control viruses. Both Acpif1Arg96AlaPol+ and 
Acpif1Arg478AlaPol+ OBs seemed to have decreased oral infectivity rates when compared to 
their parental virus; Acpif1Pol+. However, Acpif1Arg96/478AlaPol+ OBs oral infectivity seems 
unaffected, which suggests that the negative effect seen with the single PIF1 RGD motif 
mutates is negated when both PIF1 RGD motifs are mutated.  
 
7.7.3 Analysis of the PIF1 RGD motif mutant viruses 
 
It was demonstrated that individual mutations of PIF1 RGD motifs affected per os 
infectivity of OBs fed to third instar T. ni larvae. The bioassay showed an approximate 4-
fold increase in LD50 when Acpif1
Arg96AlaPol+ (120 OBs per larva) was compared to Acpif1Pol+ 
(32 OBs per larvae). For Acpif1Arg478AlaPol+ there was only a 2.5-fold increase in LD50 (80 
OBs per larva) when compared to Acpif1Pol+ (32 OBs per larvae). However, chi-square 
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analysis demonstrated these differences in oral infectivity to be very statistically significant 
when either Acpif1Arg96AlaPol+ or Acpif1Arg478AlaPol+ was compared to their parental virus; 
Acpif1Pol+. Therefore, these results suggest that mutation of either PIF1 RGD motifs 
impacts the function of PIF1 during oral infection, but not to the similar extent of a pif1 
deletion mutant virus that only killed approximately 7% of the larvae at the top dose of 
10,000 OBs/larva in the bioassay carried out here.  
Interestingly, Acpif1Arg96/478AlaPol+ LD50 (23 OBs per larvae) was very similar to that of 
Acpif1Pol+ (32 OBs per larvae) and the chi-square analysis demonstrated no statistically 
significant difference when these two viruses were compared. This suggests that mutation 
of both PIF1 RGD motifs counteracts the negative impact on oral infectivity seen in the 
viruses containing single mutant PIF1 RGD motif. 
There was no significant difference between Acpif1Arg96AlaPol+or Acpif1Arg96/478AlaPol+ and 
Acpif1Pol+ survival times at the top dose of 10,000 OBs/larva, which suggests that neither 
mutated PIF1 has affected the replication efficiency of the virus in the host larva. 
However, a slight significant difference (p=0.0402) between Acpif1Arg478AlaPol+ and Acpif1Pol+ 
survival times was seen, but no significant difference (p=0.4553) was demonstrated 
between Acpif1Arg478AlaPol+ and AcMNPV survival times. Therefore, Acpif1Arg478AlaPol+ 
replication efficiency in the host larva is most likely unaffected by the mutation in the PIF1 
RGD motif. 
The bioassay data collected does indicate an effect on PIF1 function when either PIF1 
RGD motif was disrupted. However, disruption of both PIF1 RGD motifs seems to be 
slightly beneficial for the virus lowering both its LD50, LD90 and larva survival time. 
However, further investigation is required to confirm these initial findings on PIF1 RGD 
motifs and their involvement with PIF1 function and oral infection of larvae. This could 
involve repeating this bioassay to confirm the initial findings and labelling the ODVs with 
self-quenching fluorescent probe octadecyl rhodamine B chloride (R-18) to allow binding, 
fusion and competition assays to be carried out, which will identify any effects the mutant 
PIF1 RGD motifs have on direct binding and fusion with the larva midgut cells. These 
assays were done to study other per os infectivity proteins (Haas-Stapleton et al., 2004; 
Ohkawa et al., 2005). 
 
7.7.4 Conclusion 
 
In this chapter the orf118 and pif1 deletion mutant virus was constructed and analysed 
with a focus on recombinant protein production. The results from this work demonstrated 
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that the deletion of orf118 and pif1 caused some temporal differences in cell viability and 
BV production kinetics when compared to its parental virus. However, these differences 
were not considered significantly different according to statistical analysis. The deletion of 
orf118 and pif1 did have a negative effect on intracellular recombinant protein production 
from the polh promoter; it would be interesting to see if this deletion or single deletions did 
affect the native polyhedrin production.  
This chapter also investigated through mutagenesis the possible role of the PIF1 RGD 
motifs in oral infection of larvae. The initial findings suggest that the PIF1 RGD motifs 
functional role is not very clear, due to disruption of a single PIF1 RGD motif impacts oral 
infection whereas disruption of both PIF1 RGD motif made the virus slightly more orally 
infectious. The role of RGD motif in other viruses is also uncertain. The transmembrane 
glycoprotein E2 from Hepatitis C virus (HCV) contains highly conserved RGD motif and 
mutagenesis of the E2 RGD motif resulted in greatly reduced HCV infectivity. However, 
the mutants E2 were still able to bind to the target receptor suggesting that the role of 
RGD motif does not involve integrin binding (Rothwangl and Rong, 2009). Therefore, PIF1 
RGD motifs could mediate other interactions during viral entry and like that of HCV not be 
involved in integrin binding, which would explain why none of the viruses containing 
mutations of PIF1 RGD motifs displayed similar characteristics to a pif1 deletion mutant 
virus.  
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8.1 Summary of Thesis 
 
The aims of this PhD were to understand the mechanisms involved in the production of 
ODV and determine whether the deletion of ODV-specific genes could improve the 
baculovirus expression vector system (BEVs). To achieve these goals included identifying 
genes encoding structural components of the ODV that were not associated with BV and 
which theoretically could be removed from the AcMNPV genome without affecting virus 
infectivity (Chapter 3). The selected targets (odv-e66, orf79, cg30, odv-e28, pif3, odv-e56, 
pif2 and odv-ec43) were deleted from the AcMNPV genome using the Red/ET 
recombination system. Those deletions that unexpectedly prevented virus replication in 
insect cell culture were characterised further (Chapter 4, orf79, odv-e28, and odv-ec43). 
The remaining modified viruses with deletions in odv-e66, cg30, and odv-e56, which were 
viable in insect cell culture and did not contain a deletion of a known per os infectivity 
factor, were investigated for any effect on ODV production and occlusion into the OBs 
using bioassays and electron microscopy imaging (Chapter 5). Those viruses with 
deletions of known pifs (pif3 and pif2) were analysed for any effect on recombinant protein 
production. Unexpectedly, the pif3 deletion mutant virus was defective in BV production 
and so the cause of this was investigated (Chapter 6). The Red/ET recombination system 
was also used to construct a ninth deletion mutant virus lacking both auxiliary genes; 
orf118 and pif1. The effect of this deletion on recombinant protein production was 
investigated. In addition, the RGD motifs of PIF1 were investigated for any possible role 
they might have in the functional aspect of PIF1 during oral infection of larva (Chapter 7). 
While the mechanism involved in the production of ODV was not elucidated, a number of 
interesting observations have been made about the targeted structural components of the 
ODV. 
The deletion mutant viruses (Ac∆orf79, Ac∆odv-e28 and Ac∆odv-ec43) characterised in 
chapter 4 were non-infectious in insect cell culture. Further analysis demonstrated that 
orf78, orf79 and odv-ec43 most likely comprise essential genes. During this investigation 
no further information on the roles of orf78 or orf79 were uncovered. However, data was 
obtained indicating that odv-ec43 most likely plays a role in the processing of the BV 
particle. The non-viability of Ac∆odv-e28 in insect cell culture was the result of interruption 
to an essential neighboring gene (helicase) and not the deletion of odv-e28. Overall these 
results demonstrated that deleting genes from AcMNPV genome, which contains over-
lapping ORFs and promoters, can cause unforeseen problems. The results also highlight 
that structural components of the ODV such as orf79 and odv-ec43 could play a role in 
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multiple processes during viral replication, and thus both be essential for viral replication 
and located to the ODV.    
The deletion mutant viruses, Ac∆odv-e66, Ac∆cg30 and Ac∆odv-e56 were characterized 
in chapter 5, which demonstrated that all three deletion mutant viruses had slightly 
decreased BV production compared to their parental virus. Interestingly, the deletion of 
odv-e56 altered the overall BV production kinetics of the virus during a time course study. 
This further suggests that structural components of the ODV are not just involved in ODV 
production during viral replication. Bioassays and electron microscopy imaging were used 
to analyse ODV production and occlusion into the OBs for each of the deletion mutant 
viruses. Both the deletions of odv-e66 and odv-e56 negatively affected oral infectivity of 
OBs, furthermore Ac∆odv-e56 OBs seemed wrapped in an unidentified protein, which is 
most likely the polyhedra associated protein P10 (Lee et al., 1996; Patmanidi et al., 2003; 
Carpentier et al., 2008), whereas Ac∆odv-e66 OBs seemed normal under electron 
microscopy. The deletion of cg30 increased the oral infectivity of OBs while electron 
microscopy imaging of Ac∆cg30 OBs suggested that the PE had not formed correctly 
causing the OBs to be deformed and degraded. Alternatively, the aberrant OB structure 
might have affected application of the PE their outer surface. These results suggest that 
both ODV-E56 and CG30 effect on oral infectivity could be due to abnormalities of the 
OBs and possibly to the ODV, whereas ODV-E66 effect on oral infectivity could be due to 
abnormalities isolated to the ODV.  
Some investigations towards the effect of pif2 and orf118/pif1 deletions on recombinant 
protein yield were undertaken in chapters 6 and 7, respectively. Both of these deletions 
were demonstrated to have a negative effect on intracellular recombinant protein (β-
galactosidase) expression from the polh promoter, whereas the pif2 deletion was shown 
not to impact the expression of extracellular recombinant protein (urokinase). Interestingly, 
the deletion of orf118/pif1 altered the viruses BV production kinetics at 24hpi but did not 
affect the virus’s ability to attain normal titres at the end of a time course. The cause of 
this observation was most likely due to the deletion of pif1, as this altered BV production 
kinetics has been demonstrated previously with a pif1 deletion mutant virus (R.D. Possee, 
personal communication). The Ac∆pif3 was observed to have low titres due to reduced BV 
production and further analysis carried out in chapter 6 suggests the most likely cause of 
this observation to be the deletion of pif3 itself. Chapter 7 investigated through 
mutagenesis the possible role of the PIF1 RGD motifs in oral infection of larvae. However, 
this investigation did not clearly elucidate the functional role of PIF1 RGD motifs but did 
indicate the motifs were most likely not involved in integrin binding and further 
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experimental work is required to understand the role(s) these PIF1 RGD motifs could play 
during oral infection of larvae. 
 
8.2 Discussion of thesis results and future work 
 
It is apparent from the studies described in this thesis that they do not support the 
hypothesis that all genes encoding structural proteins of the ODV can be deleted from 
AcMNPV without affecting BV production kinetics. Furthermore, those deletion mutant 
viruses that were tested for recombinant protein expression did not have an advantage for 
recombinant protein production. From a virus evolution perspective this may be explained 
if the genes encoding structural proteins of the ODV were acquired prior to the 
development of this virion phenotype and thus had functional roles involving earlier stages 
of baculovirus replication. Therefore, there may not be a population of genes involved in 
ODV formation within the AcMNPV genome that can be readily deleted without affecting 
BV production.  
 
8.2.1 Construction of deletion mutant viruses 
 
Construction and analysis of AcMNPV gene deletion mutants is problematic due to the 
closely packed nature of the ORFs with over-lapping promoters (Figure 8.1). Therefore, 
deletion sites have to be carefully selected to avoid affecting neighbouring genes. It would 
be ideal to have a thorough knowledge of gene transcription and termination in the 
regions flanking the deletion site to prevent this, but in many cases this information isn’t 
available. However, due to more modern techniques such as 5’ RACE analysis mapping 
transcription start sites along with simple sequencing of the 3’ ends of mRNAs via cDNA 
synthesis and cloning, this information can be obtained relatively easy before performing 
any deletions on the AcMNPV genome.  
Once this information is obtained the target site for deletion can be selected and deleted 
using similar strategies to the ones performed in this thesis. This involves a different 
Red/ET recombination system that contains a counter-selection marker (Counter 
Selection BAC Modification Kit, Gene Bridge). This system is essentially the same as the 
one used in this study to construct the deletion mutant viruses. However, the coding 
region of interest is deleted by the insertion of a kanamycin gene fragment with the 
addition of the rpsL gene. The rpsL gene expresses wild type S12 ribosomal protein, 
which causes streptomycin resistant E. coli strains that contain mutant rpsL genes to 
become streptomycin sensitive. This allows a secondary recombination stage, which is 
used to replace the whole kanamycin insert with a different DNA fragment. The insertion 
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of the new DNA fragment causes the loss of the rpsL gene within the bacmid allowing the 
E. coli containing these recombinant bacmids to be isolated by streptomycin resistance. 
Therefore, if the deletion of the target region proves to be lethal for virus replication, a 
gene rescue using this system could be attempted applying a modified version of the 
target sequences in which the putative translation initiation codon was mutated to a non 
functional triplet. 
This strategy would overcome the problem seen with deletions such as Ac∆orf79 or 
Ac∆odv-e28 that affected the neighbouring gene(s) and ensure the removal of the target 
protein expression from the virus-infected cells. However, care would have to be taken 
with the mutation of the ATG to ensure any involvement it could have in regulatory role for 
upstream or downstream genes was not affected, for example if it coincided with a 
promoter motif. Another target for mutation could be the transcription start site(s) of the 
gene of interest but the same precautions would have to be taken as with the ATG 
mutation not to affect neighbouring genes regulation or amino acid sequence as most 
promoters are within neighbouring genes mRNA sequence.  
 
Figure 8.1 Circular map of the AcMNPV genome. 
Schematic representation of the AcMNPV genome, demonstrating the over-lapping nature of genes 
contain within the AcMNPV genome (Ayres et al., 1994).  
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8.2.2 Construction of Synthetic virus 
 
A different strategy involving the construction of a synthetic virus could be taken to 
elucidate the transition from BV to polyhedra production. Synthetic biology has advanced 
since the first synthetic virus was constructed by Cello et al. (2002), allowing synthesis of 
an entire bacterial genome (Gibson et al., 2008). Therefore, this technology along with the 
availability of yeast and bacteria vectors for maintaining large circular plasmids in these 
hosts, would allow construction of a synthetic baculovirus genome. However, a literature 
review would be required first to identify all of the known essential baculovirus genes for 
viral replication in insect cell culture. These would be used to construct the core of the 
initial synthetic virus and rather than making gene deletions, instead gene additions would 
be used to create a viable virus. The viability of the viruses could be easily accessed by 
the production of plaques during plaque assays. Once a functional virus was constructed, 
examination of its genome compared to AcMNPV could be undertaken to identify any key 
genes involved in ODV production and occlusion.    
 
8.2.3 Construction of Insect expression vector 
 
The BEVs is widely used for the production of recombinant proteins in insect cell culture. 
However, the system cannot provide long term expression of recombinant proteins from a 
single culture due to the lytic properties of the virus. Therefore, an alternative system that 
could allow long term expression from insect culture using the strong polh promoter would 
be ideal. One strategy might be the construction of a stable expression vector, which 
contained all of baculovirus genes that encoded the machinery necessary to express the 
polh promoter. The stable expression vector could be constructed using similar 
techniques to those described in section 8.2.2. However, this stable expression vector 
would be rather large and most likely unstable in the insect cells. For example, a standard 
stable expression vector (~6.3 kbp) that contained just the family of late expression factor 
genes alone would be roughly 19 kbp.  
Therefore, using the same principle as before, a second strategy would attempt to 
integrate the viral sequences into the insect cell genome using transposons. The insect 
cell transposons are capable of integrating sequences to and from baculovirus genome 
and thus this strategy could work using plasmids containing viral sequences in between 
two transposons recognised by the insect cell (Wang and Fraser, 1993; Fraser et al., 
1996)). This would reduce the size of the stable expression vector that could just contain 
the recombinant protein under the control of the polh promoter. The modified insect cell 
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line could then be used to express a number of recombinant proteins using different stable 
expression vectors. The stable expression vector could be further modified to contain 
transcriptional regulator, which would allow the timing of recombinant protein expression 
from the insect cell culture to be controlled. This transcriptional regulator could be similar 
to the operon used in the pRedET plasmid.  
 
8.2.4 Analysis of AcMNPV to other occluded viruses 
 
The evolution of an occlusion viral particle that allows delayed transmission has appeared 
in two other insect-infecting virus taxa: the Entomopoxvirinae subfamily of the Poxviridae 
and the Cypovirus genus of the Reoviridae family (Rohrmann, 1986; Adams and Bonami, 
1991). Therefore, the literature review and bioinformatic analysis that was performed in 
Chapter 3 on genes associated with the AcMNPV ODV could be expanded to compare 
the AcMNPV genome with that of Entomopoxvirinae and Cypovirus members. This could 
identify key proteins involved in either BV production or ODV production/occlusion due to 
none of the other occluded insect virus families containing two virion phenotypes, which is 
unique to the Baculoviridae family. 
The literature contains information on baculoviruses, whose replication seem confined to 
the midgut like that of the cypoviruses. These include NPVs of Diptera, Hymenoptera, and 
certain types of GVs (Federici and Stern, 1990; Moser et al., 2001), which causes the OBs 
to be excreted in the insects faeces (Federici, 1997). Therefore, comparing the AcMNPV 
genome with these baculoviruses could also highlight key proteins involved in either BV 
production or ODV production/occlusion due to the undeveloped BV form. Any key targets 
identified for ODV production or occlusion during these two comparisons could then be 
investigated using the experimental methods out line in this thesis.  
 
8.3 Concluding remarks 
 
After over three decades of research into baculoviruses at the molecular level the major 
transition from BV to ODV production during the baculovirus infection has still not been 
resolved. The understanding of this transition is hindered due the number of baculovirus 
proteins whose roles are still not fully understood, due the complexity of the baculovirus 
replication cycle and multifunctional role of many of these proteins. This study highlights 
the possible multifunctional role of viral proteins due to the deletion of structural 
components of the ODV affecting the viruses BV production kinetics. It strongly suggests 
that the production of BV and ODV could be closely linked and any transition that exists 
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could be due to slight changes in both virus and cellular components during viral 
replication. Furthermore the studies on this transition are difficult due to the uniqueness of 
these two virion phenotypes in one virus, meaning there is no other insect infecting virus 
to compare with baculovirus that may allow the identification of key genes that could be 
involved in this process. 
A deeper understanding of the virogenic stroma where viral transcription (Passarelli and 
Guarino, 2007), DNA replication (Carstens, 2009), and progeny nucleocapsid assembly 
(Volkman, 1988) occur, could give insight into this transition. However, studies of the 
virogneic stroma are difficult due to it being essential for viral replication. Therefore, the 
mechanisms involving the assembly, DNA packaging, and egress of progeny 
nucleocapsids are not well defined.  
Interestingly, two deletion mutant viruses; ∆vp80 (Marek et al., 2011) and ∆orf66 (Ke et 
al., 2008), which interact with the cellular filamentous-actin (F-actin) cytoskeleton 
demonstrated a defect in both BV and ODV production due to failure in nucleocapsid 
transport within the nucleus. It has been demonstrated that the F-actin cytoskeleton forms 
a highly organized three-dimensional network connecting the virogenic stroma physically 
with the nuclear envelope. This interaction is virus driven and required for the transport of 
nucleocapsids to the periphery of the nucleus where they are directed towards the plasma 
membrane for BV production or in later stages of infection held in the periphery of the 
nucleus to form ODV (Ohkawa and Volkman, 1999; Marek et al., 2011). Therefore, a 
study that monitored the interaction of the insect cells cytoskeleton with virogneic stroma 
could give insights into the changes occurring during viral replication, which could cause 
the transition from BV to ODV production. If the transition was caused by rearrangement 
of the insect cells cytoskeleton either within the nucleus or the cytoplasm, further 
investigations using standard molecular techniques would then be required in attempts to 
identify the viral protein(s) causing this rearrangement.  
Until a deeper understanding of the molecular workings of the baculovirus replication 
cycle is obtained, the transition of BV to ODV production will remain a mystery. It is a 
subject deserving of future study. 
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